#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Real-time fMRI neurofeedback reduces auditory hallucinations and modulates resting state connectivity of involved brain regions: Part 2: Default Mode Network -Preliminary evidence-
#Text=Auditory hallucinations (AHs) are one of the most distressing symptoms of schizophrenia (SZ) and are often resistant to medication.
1-1	0-9	Real-time	_	
1-2	10-14	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
1-3	15-28	neurofeedback	_	
1-4	29-36	reduces	_	
1-5	37-45	auditory	_	
1-6	46-60	hallucinations	_	
1-7	61-64	and	_	
1-8	65-74	modulates	_	
1-9	75-82	resting	_	
1-10	83-88	state	_	
1-11	89-101	connectivity	_	
1-12	102-104	of	_	
1-13	105-113	involved	_	
1-14	114-119	brain	_	
1-15	120-127	regions	_	
1-16	127-128	:	_	
1-17	129-133	Part	_	
1-18	134-135	2	_	
1-19	135-136	:	_	
1-20	137-144	Default	_	
1-21	145-149	Mode	_	
1-22	150-157	Network	_	
1-23	158-159	-	_	
1-24	159-170	Preliminary	_	
1-25	171-179	evidence	_	
1-26	179-180	-	_	
1-27	181-189	Auditory	_	
1-28	190-204	hallucinations	_	
1-29	205-206	(	_	
1-30	206-209	AHs	_	
1-31	209-210	)	_	
1-32	211-214	are	_	
1-33	215-218	one	_	
1-34	219-221	of	_	
1-35	222-225	the	_	
1-36	226-230	most	_	
1-37	231-242	distressing	_	
1-38	243-251	symptoms	_	
1-39	252-254	of	_	
1-40	255-268	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
1-41	269-270	(	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
1-42	270-272	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
1-43	272-273	)	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
1-44	274-277	and	_	
1-45	278-281	are	_	
1-46	282-287	often	_	
1-47	288-297	resistant	_	
1-48	298-300	to	_	
1-49	301-311	medication	_	
1-50	311-312	.	_	

#Text=Imaging studies of individuals with SZ show hyperactivation of the default mode network (DMN) and the superior temporal gyrus (STG).
2-1	313-320	Imaging	_	
2-2	321-328	studies	_	
2-3	329-331	of	_	
2-4	332-343	individuals	_	
2-5	344-348	with	_	
2-6	349-351	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
2-7	352-356	show	_	
2-8	357-372	hyperactivation	_	
2-9	373-375	of	_	
2-10	376-379	the	_	
2-11	380-387	default	_	
2-12	388-392	mode	_	
2-13	393-400	network	_	
2-14	401-402	(	_	
2-15	402-405	DMN	_	
2-16	405-406	)	_	
2-17	407-410	and	_	
2-18	411-414	the	_	
2-19	415-423	superior	_	
2-20	424-432	temporal	_	
2-21	433-438	gyrus	_	
2-22	439-440	(	_	
2-23	440-443	STG	_	
2-24	443-444	)	_	
2-25	444-445	.	_	

#Text=Studies in SZ show DMN hyperconnectivity and reduced anticorrelation between DMN and the central executive network (CEN).
3-1	446-453	Studies	_	
3-2	454-456	in	_	
3-3	457-459	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
3-4	460-464	show	_	
3-5	465-468	DMN	_	
3-6	469-486	hyperconnectivity	_	
3-7	487-490	and	_	
3-8	491-498	reduced	_	
3-9	499-514	anticorrelation	_	
3-10	515-522	between	_	
3-11	523-526	DMN	_	
3-12	527-530	and	_	
3-13	531-534	the	_	
3-14	535-542	central	_	
3-15	543-552	executive	_	
3-16	553-560	network	_	
3-17	561-562	(	_	
3-18	562-565	CEN	_	
3-19	565-566	)	_	
3-20	566-567	.	_	

#Text=DMN hyperconnectivity has been associated with positive symptoms such as AHs while reduced DMN anticorrelations with cognitive impairment.
4-1	568-571	DMN	_	
4-2	572-589	hyperconnectivity	_	
4-3	590-593	has	_	
4-4	594-598	been	_	
4-5	599-609	associated	_	
4-6	610-614	with	_	
4-7	615-623	positive	_	
4-8	624-632	symptoms	_	
4-9	633-637	such	_	
4-10	638-640	as	_	
4-11	641-644	AHs	_	
4-12	645-650	while	_	
4-13	651-658	reduced	_	
4-14	659-662	DMN	_	
4-15	663-679	anticorrelations	_	
4-16	680-684	with	_	
4-17	685-694	cognitive	_	
4-18	695-705	impairment	_	
4-19	705-706	.	_	

#Text=Using real-time fMRI neurofeedback (rt-fMRI-NFB) we trained SZ patients to modulate DMN and CEN networks.
5-1	707-712	Using	_	
5-2	713-722	real-time	_	
5-3	723-727	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
5-4	728-741	neurofeedback	_	
5-5	742-743	(	_	
5-6	743-754	rt-fMRI-NFB	_	
5-7	754-755	)	_	
5-8	756-758	we	_	
5-9	759-766	trained	_	
5-10	767-769	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
5-11	770-778	patients	_	
5-12	779-781	to	_	
5-13	782-790	modulate	_	
5-14	791-794	DMN	_	
5-15	795-798	and	_	
5-16	799-802	CEN	_	
5-17	803-811	networks	_	
5-18	811-812	.	_	

#Text=Meditation is effective in reducing AHs in SZ and to modulate brain network integration and increase DMN anticorrelations.
6-1	813-823	Meditation	_	
6-2	824-826	is	_	
6-3	827-836	effective	_	
6-4	837-839	in	_	
6-5	840-848	reducing	_	
6-6	849-852	AHs	_	
6-7	853-855	in	_	
6-8	856-858	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
6-9	859-862	and	_	
6-10	863-865	to	_	
6-11	866-874	modulate	_	
6-12	875-880	brain	_	
6-13	881-888	network	_	
6-14	889-900	integration	_	
6-15	901-904	and	_	
6-16	905-913	increase	_	
6-17	914-917	DMN	_	
6-18	918-934	anticorrelations	_	
6-19	934-935	.	_	

#Text=Consequently, patients were provided with meditation strategies to enhance their abilities to modulate DMN/CEN.
7-1	936-948	Consequently	_	
7-2	948-949	,	_	
7-3	950-958	patients	_	
7-4	959-963	were	_	
7-5	964-972	provided	_	
7-6	973-977	with	_	
7-7	978-988	meditation	_	
7-8	989-999	strategies	_	
7-9	1000-1002	to	_	
7-10	1003-1010	enhance	_	
7-11	1011-1016	their	_	
7-12	1017-1026	abilities	_	
7-13	1027-1029	to	_	
7-14	1030-1038	modulate	_	
7-15	1039-1042	DMN	_	
7-16	1042-1043	/	_	
7-17	1043-1046	CEN	_	
7-18	1046-1047	.	_	

#Text=Results show a reduction of DMN hyperconnectivity and increase in DMN-CEN anticorrelation.
8-1	1048-1055	Results	_	
8-2	1056-1060	show	_	
8-3	1061-1062	a	_	
8-4	1063-1072	reduction	_	
8-5	1073-1075	of	_	
8-6	1076-1079	DMN	_	
8-7	1080-1097	hyperconnectivity	_	
8-8	1098-1101	and	_	
8-9	1102-1110	increase	_	
8-10	1111-1113	in	_	
8-11	1114-1121	DMN-CEN	_	
8-12	1122-1137	anticorrelation	_	
8-13	1137-1138	.	_	

#Text=Furthermore, the change in individual DMN connectivity significantly correlated with reductions in AHs.
9-1	1139-1150	Furthermore	_	
9-2	1150-1151	,	_	
9-3	1152-1155	the	_	
9-4	1156-1162	change	_	
9-5	1163-1165	in	_	
9-6	1166-1176	individual	_	
9-7	1177-1180	DMN	_	
9-8	1181-1193	connectivity	_	
9-9	1194-1207	significantly	_	
9-10	1208-1218	correlated	_	
9-11	1219-1223	with	_	
9-12	1224-1234	reductions	_	
9-13	1235-1237	in	_	
9-14	1238-1241	AHs	_	
9-15	1241-1242	.	_	

#Text=This is the first time that meditation enhanced through rt-fMRI-NFB is used to reduce AHs in SZ.
10-1	1243-1247	This	_	
10-2	1248-1250	is	_	
10-3	1251-1254	the	_	
10-4	1255-1260	first	_	
10-5	1261-1265	time	_	
10-6	1266-1270	that	_	
10-7	1271-1281	meditation	_	
10-8	1282-1290	enhanced	_	
10-9	1291-1298	through	_	
10-10	1299-1310	rt-fMRI-NFB	_	
10-11	1311-1313	is	_	
10-12	1314-1318	used	_	
10-13	1319-1321	to	_	
10-14	1322-1328	reduce	_	
10-15	1329-1332	AHs	_	
10-16	1333-1335	in	_	
10-17	1336-1338	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
10-18	1338-1339	.	_	

#Text=Moreover, it provides the first empirical evidence for a direct causal relation between meditation enhanced rt-fMRI-NFB modulation of DMN-CEN activity and post-intervention modulation of resting state networks ensuing in reductions in frequency and severity of AHs.
11-1	1340-1348	Moreover	_	
11-2	1348-1349	,	_	
11-3	1350-1352	it	_	
11-4	1353-1361	provides	_	
11-5	1362-1365	the	_	
11-6	1366-1371	first	_	
11-7	1372-1381	empirical	_	
11-8	1382-1390	evidence	_	
11-9	1391-1394	for	_	
11-10	1395-1396	a	_	
11-11	1397-1403	direct	_	
11-12	1404-1410	causal	_	
11-13	1411-1419	relation	_	
11-14	1420-1427	between	_	
11-15	1428-1438	meditation	_	
11-16	1439-1447	enhanced	_	
11-17	1448-1459	rt-fMRI-NFB	_	
11-18	1460-1470	modulation	_	
11-19	1471-1473	of	_	
11-20	1474-1481	DMN-CEN	_	
11-21	1482-1490	activity	_	
11-22	1491-1494	and	_	
11-23	1495-1512	post-intervention	_	
11-24	1513-1523	modulation	_	
11-25	1524-1526	of	_	
11-26	1527-1534	resting	_	
11-27	1535-1540	state	_	
11-28	1541-1549	networks	_	
11-29	1550-1557	ensuing	_	
11-30	1558-1560	in	_	
11-31	1561-1571	reductions	_	
11-32	1572-1574	in	_	
11-33	1575-1584	frequency	_	
11-34	1585-1588	and	_	
11-35	1589-1597	severity	_	
11-36	1598-1600	of	_	
11-37	1601-1604	AHs	_	
11-38	1604-1605	.	_	

#Text=Introduction
#Text=The overarching hypothesis adopted in the study was that auditory hallucinations in schizophrenia (SZ) are a product of the network of brain regions whose abnormalities jointly contribute to auditory hallucinations (AHs) (discussed in greater detail in Part I).
12-1	1606-1618	Introduction	_	
12-2	1619-1622	The	_	
12-3	1623-1634	overarching	_	
12-4	1635-1645	hypothesis	_	
12-5	1646-1653	adopted	_	
12-6	1654-1656	in	_	
12-7	1657-1660	the	_	
12-8	1661-1666	study	_	
12-9	1667-1670	was	_	
12-10	1671-1675	that	_	
12-11	1676-1684	auditory	_	
12-12	1685-1699	hallucinations	_	
12-13	1700-1702	in	_	
12-14	1703-1716	schizophrenia	_	
12-15	1717-1718	(	_	
12-16	1718-1720	SZ	_	
12-17	1720-1721	)	_	
12-18	1722-1725	are	_	
12-19	1726-1727	a	_	
12-20	1728-1735	product	_	
12-21	1736-1738	of	_	
12-22	1739-1742	the	_	
12-23	1743-1750	network	_	
12-24	1751-1753	of	_	
12-25	1754-1759	brain	_	
12-26	1760-1767	regions	_	
12-27	1768-1773	whose	_	
12-28	1774-1787	abnormalities	_	
12-29	1788-1795	jointly	_	
12-30	1796-1806	contribute	_	
12-31	1807-1809	to	_	
12-32	1810-1818	auditory	_	
12-33	1819-1833	hallucinations	_	
12-34	1834-1835	(	_	
12-35	1835-1838	AHs	_	
12-36	1838-1839	)	_	
12-37	1840-1841	(	_	
12-38	1841-1850	discussed	_	
12-39	1851-1853	in	_	
12-40	1854-1861	greater	_	
12-41	1862-1868	detail	_	
12-42	1869-1871	in	_	
12-43	1872-1876	Part	_	
12-44	1877-1878	I	_	
12-45	1878-1879	)	_	
12-46	1879-1880	.	_	

#Text=Thus, if AHs are indeed the effect of a network-based abnormality, one would expect that the manipulation of any region within this network should modulate AHs.
13-1	1881-1885	Thus	_	
13-2	1885-1886	,	_	
13-3	1887-1889	if	_	
13-4	1890-1893	AHs	_	
13-5	1894-1897	are	_	
13-6	1898-1904	indeed	_	
13-7	1905-1908	the	_	
13-8	1909-1915	effect	_	
13-9	1916-1918	of	_	
13-10	1919-1920	a	_	
13-11	1921-1934	network-based	_	
13-12	1935-1946	abnormality	_	
13-13	1946-1947	,	_	
13-14	1948-1951	one	_	
13-15	1952-1957	would	_	
13-16	1958-1964	expect	_	
13-17	1965-1969	that	_	
13-18	1970-1973	the	_	
13-19	1974-1986	manipulation	_	
13-20	1987-1989	of	_	
13-21	1990-1993	any	_	
13-22	1994-2000	region	_	
13-23	2001-2007	within	_	
13-24	2008-2012	this	_	
13-25	2013-2020	network	_	
13-26	2021-2027	should	_	
13-27	2028-2036	modulate	_	
13-28	2037-2040	AHs	_	
13-29	2040-2041	.	_	

#Text=In Part I of our paper, we reported that manipulation of the superior temporal gyrus (STG) reduces AHs.
14-1	2042-2044	In	_	
14-2	2045-2049	Part	_	
14-3	2050-2051	I	_	
14-4	2052-2054	of	_	
14-5	2055-2058	our	_	
14-6	2059-2064	paper	_	
14-7	2064-2065	,	_	
14-8	2066-2068	we	_	
14-9	2069-2077	reported	_	
14-10	2078-2082	that	_	
14-11	2083-2095	manipulation	_	
14-12	2096-2098	of	_	
14-13	2099-2102	the	_	
14-14	2103-2111	superior	_	
14-15	2112-2120	temporal	_	
14-16	2121-2126	gyrus	_	
14-17	2127-2128	(	_	
14-18	2128-2131	STG	_	
14-19	2131-2132	)	_	
14-20	2133-2140	reduces	_	
14-21	2141-2144	AHs	_	
14-22	2144-2145	.	_	

#Text=This account is now complemented by Part II of the paper, where we report on the results of a real-time functional magnetic resonance imaging (rt-fMRI) neurofeedback session which targeted default mode network (DMN) and central executive network (CEN) connectivity.
15-1	2146-2150	This	_	
15-2	2151-2158	account	_	
15-3	2159-2161	is	_	
15-4	2162-2165	now	_	
15-5	2166-2178	complemented	_	
15-6	2179-2181	by	_	
15-7	2182-2186	Part	_	
15-8	2187-2189	II	_	
15-9	2190-2192	of	_	
15-10	2193-2196	the	_	
15-11	2197-2202	paper	_	
15-12	2202-2203	,	_	
15-13	2204-2209	where	_	
15-14	2210-2212	we	_	
15-15	2213-2219	report	_	
15-16	2220-2222	on	_	
15-17	2223-2226	the	_	
15-18	2227-2234	results	_	
15-19	2235-2237	of	_	
15-20	2238-2239	a	_	
15-21	2240-2249	real-time	_	
15-22	2250-2260	functional	_	
15-23	2261-2269	magnetic	_	
15-24	2270-2279	resonance	_	
15-25	2280-2287	imaging	_	
15-26	2288-2289	(	_	
15-27	2289-2296	rt-fMRI	_	
15-28	2296-2297	)	_	
15-29	2298-2311	neurofeedback	_	
15-30	2312-2319	session	_	
15-31	2320-2325	which	_	
15-32	2326-2334	targeted	_	
15-33	2335-2342	default	_	
15-34	2343-2347	mode	_	
15-35	2348-2355	network	_	
15-36	2356-2357	(	_	
15-37	2357-2360	DMN	_	
15-38	2360-2361	)	_	
15-39	2362-2365	and	_	
15-40	2366-2373	central	_	
15-41	2374-2383	executive	_	
15-42	2384-2391	network	_	
15-43	2392-2393	(	_	
15-44	2393-2396	CEN	_	
15-45	2396-2397	)	_	
15-46	2398-2410	connectivity	_	
15-47	2410-2411	.	_	

#Text=The expectation here was that similarly to rt-fMRI neurofeedback session focused on the superior temporal gyrus (STG), the DMN-CEN neurofeedback approach would also result in both brain and clinical changes.
16-1	2412-2415	The	_	
16-2	2416-2427	expectation	_	
16-3	2428-2432	here	_	
16-4	2433-2436	was	_	
16-5	2437-2441	that	_	
16-6	2442-2451	similarly	_	
16-7	2452-2454	to	_	
16-8	2455-2462	rt-fMRI	_	
16-9	2463-2476	neurofeedback	_	
16-10	2477-2484	session	_	
16-11	2485-2492	focused	_	
16-12	2493-2495	on	_	
16-13	2496-2499	the	_	
16-14	2500-2508	superior	_	
16-15	2509-2517	temporal	_	
16-16	2518-2523	gyrus	_	
16-17	2524-2525	(	_	
16-18	2525-2528	STG	_	
16-19	2528-2529	)	_	
16-20	2529-2530	,	_	
16-21	2531-2534	the	_	
16-22	2535-2542	DMN-CEN	_	
16-23	2543-2556	neurofeedback	_	
16-24	2557-2565	approach	_	
16-25	2566-2571	would	_	
16-26	2572-2576	also	_	
16-27	2577-2583	result	_	
16-28	2584-2586	in	_	
16-29	2587-2591	both	_	
16-30	2592-2597	brain	_	
16-31	2598-2601	and	_	
16-32	2602-2610	clinical	_	
16-33	2611-2618	changes	_	
16-34	2618-2619	.	_	

#Text=Unlike in the STG focused rt-fMRI neurofeedback study discussed in Part I where we aimed at blood oxygen level dependent (BOLD) signal change in the STG post-NF, here we focused on the pre-to-post changes in resting state network functional connectivity (rsFC).
17-1	2620-2626	Unlike	_	
17-2	2627-2629	in	_	
17-3	2630-2633	the	_	
17-4	2634-2637	STG	_	
17-5	2638-2645	focused	_	
17-6	2646-2653	rt-fMRI	_	
17-7	2654-2667	neurofeedback	_	
17-8	2668-2673	study	_	
17-9	2674-2683	discussed	_	
17-10	2684-2686	in	_	
17-11	2687-2691	Part	_	
17-12	2692-2693	I	_	
17-13	2694-2699	where	_	
17-14	2700-2702	we	_	
17-15	2703-2708	aimed	_	
17-16	2709-2711	at	_	
17-17	2712-2717	blood	_	
17-18	2718-2724	oxygen	_	
17-19	2725-2730	level	_	
17-20	2731-2740	dependent	_	
17-21	2741-2742	(	_	
17-22	2742-2746	BOLD	_	
17-23	2746-2747	)	_	
17-24	2748-2754	signal	_	
17-25	2755-2761	change	_	
17-26	2762-2764	in	_	
17-27	2765-2768	the	_	
17-28	2769-2772	STG	_	
17-29	2773-2780	post-NF	_	
17-30	2780-2781	,	_	
17-31	2782-2786	here	_	
17-32	2787-2789	we	_	
17-33	2790-2797	focused	_	
17-34	2798-2800	on	_	
17-35	2801-2804	the	_	
17-36	2805-2816	pre-to-post	_	
17-37	2817-2824	changes	_	
17-38	2825-2827	in	_	
17-39	2828-2835	resting	_	
17-40	2836-2841	state	_	
17-41	2842-2849	network	_	
17-42	2850-2860	functional	_	
17-43	2861-2873	connectivity	_	
17-44	2874-2875	(	_	
17-45	2875-2879	rsFC	_	
17-46	2879-2880	)	_	
17-47	2880-2881	.	_	

#Text=The theoretical framework for the approach adopted in the study described in Part II has been provided by the models of AHs which emphasize the role of brain regions involved in self-referential processing and self-other distinctions as briefly outlined in Part I and described in more detail below.
18-1	2882-2885	The	_	
18-2	2886-2897	theoretical	_	
18-3	2898-2907	framework	_	
18-4	2908-2911	for	_	
18-5	2912-2915	the	_	
18-6	2916-2924	approach	_	
18-7	2925-2932	adopted	_	
18-8	2933-2935	in	_	
18-9	2936-2939	the	_	
18-10	2940-2945	study	_	
18-11	2946-2955	described	_	
18-12	2956-2958	in	_	
18-13	2959-2963	Part	_	
18-14	2964-2966	II	_	
18-15	2967-2970	has	_	
18-16	2971-2975	been	_	
18-17	2976-2984	provided	_	
18-18	2985-2987	by	_	
18-19	2988-2991	the	_	
18-20	2992-2998	models	_	
18-21	2999-3001	of	_	
18-22	3002-3005	AHs	_	
18-23	3006-3011	which	_	
18-24	3012-3021	emphasize	_	
18-25	3022-3025	the	_	
18-26	3026-3030	role	_	
18-27	3031-3033	of	_	
18-28	3034-3039	brain	_	
18-29	3040-3047	regions	_	
18-30	3048-3056	involved	_	
18-31	3057-3059	in	_	
18-32	3060-3076	self-referential	_	
18-33	3077-3087	processing	_	
18-34	3088-3091	and	_	
18-35	3092-3102	self-other	_	
18-36	3103-3115	distinctions	_	
18-37	3116-3118	as	_	
18-38	3119-3126	briefly	_	
18-39	3127-3135	outlined	_	
18-40	3136-3138	in	_	
18-41	3139-3143	Part	_	
18-42	3144-3145	I	_	
18-43	3146-3149	and	_	
18-44	3150-3159	described	_	
18-45	3160-3162	in	_	
18-46	3163-3167	more	_	
18-47	3168-3174	detail	_	
18-48	3175-3180	below	_	
18-49	3180-3181	.	_	

#Text=Self-referential processing, MPFC, STG and AHs
#Text=Self-referential processing involves tasks that require participants to introspect about oneself, accessing one’s attitudes (e.g., “how patient am I?”
19-1	3182-3198	Self-referential	_	
19-2	3199-3209	processing	_	
19-3	3209-3210	,	_	
19-4	3211-3215	MPFC	_	
19-5	3215-3216	,	_	
19-6	3217-3220	STG	_	
19-7	3221-3224	and	_	
19-8	3225-3228	AHs	_	
19-9	3229-3245	Self-referential	_	
19-10	3246-3256	processing	_	
19-11	3257-3265	involves	_	
19-12	3266-3271	tasks	_	
19-13	3272-3276	that	_	
19-14	3277-3284	require	_	
19-15	3285-3297	participants	_	
19-16	3298-3300	to	_	
19-17	3301-3311	introspect	_	
19-18	3312-3317	about	_	
19-19	3318-3325	oneself	_	
19-20	3325-3326	,	_	
19-21	3327-3336	accessing	_	
19-22	3337-3340	one	_	
19-23	3340-3341	’	_	
19-24	3341-3342	s	_	
19-25	3343-3352	attitudes	_	
19-26	3353-3354	(	_	
19-27	3354-3357	e.g	_	
19-28	3357-3358	.	_	
19-29	3358-3359	,	_	
19-30	3360-3361	“	_	
19-31	3361-3364	how	_	
19-32	3365-3372	patient	_	
19-33	3373-3375	am	_	
19-34	3376-3377	I	_	
19-35	3377-3378	?	_	
19-36	3378-3379	”	_	

#Text=, “how am I feeling right now?”
20-1	3379-3380	,	_	
20-2	3381-3382	“	_	
20-3	3382-3385	how	_	
20-4	3386-3388	am	_	
20-5	3389-3390	I	_	
20-6	3391-3398	feeling	_	
20-7	3399-3404	right	_	
20-8	3405-3408	now	_	
20-9	3408-3409	?	_	
20-10	3409-3410	”	_	

#Text=, etc.), as opposed to inferring the contents of another person’s mind (e.g., “how patient was Abe Lincoln?”
21-1	3410-3411	,	_	
21-2	3412-3415	etc	_	
21-3	3415-3416	.	_	
21-4	3416-3417	)	_	
21-5	3417-3418	,	_	
21-6	3419-3421	as	_	
21-7	3422-3429	opposed	_	
21-8	3430-3432	to	_	
21-9	3433-3442	inferring	_	
21-10	3443-3446	the	_	
21-11	3447-3455	contents	_	
21-12	3456-3458	of	_	
21-13	3459-3466	another	_	
21-14	3467-3473	person	_	
21-15	3473-3474	’	_	
21-16	3474-3475	s	_	
21-17	3476-3480	mind	_	
21-18	3481-3482	(	_	
21-19	3482-3485	e.g	_	
21-20	3485-3486	.	_	
21-21	3486-3487	,	_	
21-22	3488-3489	“	_	
21-23	3489-3492	how	_	
21-24	3493-3500	patient	_	
21-25	3501-3504	was	_	
21-26	3505-3508	Abe	_	
21-27	3509-3516	Lincoln	_	
21-28	3516-3517	?	_	
21-29	3517-3518	”	_	

#Text=, “how is my friend feeling right now?”
22-1	3518-3519	,	_	
22-2	3520-3521	“	_	
22-3	3521-3524	how	_	
22-4	3525-3527	is	_	
22-5	3528-3530	my	_	
22-6	3531-3537	friend	_	
22-7	3538-3545	feeling	_	
22-8	3546-3551	right	_	
22-9	3552-3555	now	_	
22-10	3555-3556	?	_	
22-11	3556-3557	”	_	

#Text=, etc.).
23-1	3557-3558	,	_	
23-2	3559-3562	etc	_	
23-3	3562-3563	.	_	
23-4	3563-3564	)	_	
23-5	3564-3565	.	_	

#Text=The processing associated with these tasks converges on a key brain region, the medial prefrontal cortex (MPFC) (see for reviews).
24-1	3566-3569	The	_	
24-2	3570-3580	processing	_	
24-3	3581-3591	associated	_	
24-4	3592-3596	with	_	
24-5	3597-3602	these	_	
24-6	3603-3608	tasks	_	
24-7	3609-3618	converges	_	
24-8	3619-3621	on	_	
24-9	3622-3623	a	_	
24-10	3624-3627	key	_	
24-11	3628-3633	brain	_	
24-12	3634-3640	region	_	
24-13	3640-3641	,	_	
24-14	3642-3645	the	_	
24-15	3646-3652	medial	_	
24-16	3653-3663	prefrontal	_	
24-17	3664-3670	cortex	_	
24-18	3671-3672	(	_	
24-19	3672-3676	MPFC	_	
24-20	3676-3677	)	_	
24-21	3678-3679	(	_	
24-22	3679-3682	see	_	
24-23	3683-3686	for	_	
24-24	3687-3694	reviews	_	
24-25	3694-3695	)	_	
24-26	3695-3696	.	_	

#Text=In addition, as discussed below, MPFC belongs to the DMN network whose abnormalities have been prominently associated with positive symptoms in SZ.
25-1	3697-3699	In	_	
25-2	3700-3708	addition	_	
25-3	3708-3709	,	_	
25-4	3710-3712	as	_	
25-5	3713-3722	discussed	_	
25-6	3723-3728	below	_	
25-7	3728-3729	,	_	
25-8	3730-3734	MPFC	_	
25-9	3735-3742	belongs	_	
25-10	3743-3745	to	_	
25-11	3746-3749	the	_	
25-12	3750-3753	DMN	_	
25-13	3754-3761	network	_	
25-14	3762-3767	whose	_	
25-15	3768-3781	abnormalities	_	
25-16	3782-3786	have	_	
25-17	3787-3791	been	_	
25-18	3792-3803	prominently	_	
25-19	3804-3814	associated	_	
25-20	3815-3819	with	_	
25-21	3820-3828	positive	_	
25-22	3829-3837	symptoms	_	
25-23	3838-3840	in	_	
25-24	3841-3843	SZ	_	
25-25	3843-3844	.	_	

#Text=Another region found involved in self-other distinctions by interacting with MPFC is the STG (see for reviews).
26-1	3845-3852	Another	_	
26-2	3853-3859	region	_	
26-3	3860-3865	found	_	
26-4	3866-3874	involved	_	
26-5	3875-3877	in	_	
26-6	3878-3888	self-other	_	
26-7	3889-3901	distinctions	_	
26-8	3902-3904	by	_	
26-9	3905-3916	interacting	_	
26-10	3917-3921	with	_	
26-11	3922-3926	MPFC	_	
26-12	3927-3929	is	_	
26-13	3930-3933	the	_	
26-14	3934-3937	STG	_	
26-15	3938-3939	(	_	
26-16	3939-3942	see	_	
26-17	3943-3946	for	_	
26-18	3947-3954	reviews	_	
26-19	3954-3955	)	_	
26-20	3955-3956	.	_	

#Text=While the STG role in self-referential thinking has been well established, it is also primarily responsible for auditory perception and speech analysis.
27-1	3957-3962	While	_	
27-2	3963-3966	the	_	
27-3	3967-3970	STG	_	
27-4	3971-3975	role	_	
27-5	3976-3978	in	_	
27-6	3979-3995	self-referential	_	
27-7	3996-4004	thinking	_	
27-8	4005-4008	has	_	
27-9	4009-4013	been	_	
27-10	4014-4018	well	_	
27-11	4019-4030	established	_	
27-12	4030-4031	,	_	
27-13	4032-4034	it	_	
27-14	4035-4037	is	_	
27-15	4038-4042	also	_	
27-16	4043-4052	primarily	_	
27-17	4053-4064	responsible	_	
27-18	4065-4068	for	_	
27-19	4069-4077	auditory	_	
27-20	4078-4088	perception	_	
27-21	4089-4092	and	_	
27-22	4093-4099	speech	_	
27-23	4100-4108	analysis	_	
27-24	4108-4109	.	_	

#Text=Importantly, increased connectivity between the dorsal MPFC and the STG has been observed in SZ patients with hallucinations compared to non-hallucinating SZ patients and HCs, suggesting that AHs may be associated with higher MPFC-STG connectivity.
28-1	4110-4121	Importantly	_	
28-2	4121-4122	,	_	
28-3	4123-4132	increased	_	
28-4	4133-4145	connectivity	_	
28-5	4146-4153	between	_	
28-6	4154-4157	the	_	
28-7	4158-4164	dorsal	_	
28-8	4165-4169	MPFC	_	
28-9	4170-4173	and	_	
28-10	4174-4177	the	_	
28-11	4178-4181	STG	_	
28-12	4182-4185	has	_	
28-13	4186-4190	been	_	
28-14	4191-4199	observed	_	
28-15	4200-4202	in	_	
28-16	4203-4205	SZ	_	
28-17	4206-4214	patients	_	
28-18	4215-4219	with	_	
28-19	4220-4234	hallucinations	_	
28-20	4235-4243	compared	_	
28-21	4244-4246	to	_	
28-22	4247-4264	non-hallucinating	_	
28-23	4265-4267	SZ	_	
28-24	4268-4276	patients	_	
28-25	4277-4280	and	_	
28-26	4281-4284	HCs	_	
28-27	4284-4285	,	_	
28-28	4286-4296	suggesting	_	
28-29	4297-4301	that	_	
28-30	4302-4305	AHs	_	
28-31	4306-4309	may	_	
28-32	4310-4312	be	_	
28-33	4313-4323	associated	_	
28-34	4324-4328	with	_	
28-35	4329-4335	higher	_	
28-36	4336-4344	MPFC-STG	_	
28-37	4345-4357	connectivity	_	
28-38	4357-4358	.	_	

#Text=Altered activation and connectivity in this self-referential network has been associated with positive symptoms of SZ, and a recent review by suggests that a deficiency in reality monitoring creates a failure to deactivate this network.
29-1	4359-4366	Altered	_	
29-2	4367-4377	activation	_	
29-3	4378-4381	and	_	
29-4	4382-4394	connectivity	_	
29-5	4395-4397	in	_	
29-6	4398-4402	this	_	
29-7	4403-4419	self-referential	_	
29-8	4420-4427	network	_	
29-9	4428-4431	has	_	
29-10	4432-4436	been	_	
29-11	4437-4447	associated	_	
29-12	4448-4452	with	_	
29-13	4453-4461	positive	_	
29-14	4462-4470	symptoms	_	
29-15	4471-4473	of	_	
29-16	4474-4476	SZ	_	
29-17	4476-4477	,	_	
29-18	4478-4481	and	_	
29-19	4482-4483	a	_	
29-20	4484-4490	recent	_	
29-21	4491-4497	review	_	
29-22	4498-4500	by	_	
29-23	4501-4509	suggests	_	
29-24	4510-4514	that	_	
29-25	4515-4516	a	_	
29-26	4517-4527	deficiency	_	
29-27	4528-4530	in	_	
29-28	4531-4538	reality	_	
29-29	4539-4549	monitoring	_	
29-30	4550-4557	creates	_	
29-31	4558-4559	a	_	
29-32	4560-4567	failure	_	
29-33	4568-4570	to	_	
29-34	4571-4581	deactivate	_	
29-35	4582-4586	this	_	
29-36	4587-4594	network	_	
29-37	4594-4595	.	_	

#Text=In addition, abnormal functional connectivity between the STG and brain networks involved in language, auditory, memory and emotion processing has been observed.
30-1	4596-4598	In	_	
30-2	4599-4607	addition	_	
30-3	4607-4608	,	_	
30-4	4609-4617	abnormal	_	
30-5	4618-4628	functional	_	
30-6	4629-4641	connectivity	_	
30-7	4642-4649	between	_	
30-8	4650-4653	the	_	
30-9	4654-4657	STG	_	
30-10	4658-4661	and	_	
30-11	4662-4667	brain	_	
30-12	4668-4676	networks	_	
30-13	4677-4685	involved	_	
30-14	4686-4688	in	_	
30-15	4689-4697	language	_	
30-16	4697-4698	,	_	
30-17	4699-4707	auditory	_	
30-18	4707-4708	,	_	
30-19	4709-4715	memory	_	
30-20	4716-4719	and	_	
30-21	4720-4727	emotion	_	
30-22	4728-4738	processing	_	
30-23	4739-4742	has	_	
30-24	4743-4747	been	_	
30-25	4748-4756	observed	_	
30-26	4756-4757	.	_	

#Text=In a meta-analysis of existing fMRI and positron emission tomography (PET) studies the STG has been shown to be hypoactive during the presentation, and hyperactive in the absence of external auditory stimuli in SZ patients with a history of AHs compared to matched healthy controls (HCs).
31-1	4758-4760	In	_	
31-2	4761-4762	a	_	
31-3	4763-4776	meta-analysis	_	
31-4	4777-4779	of	_	
31-5	4780-4788	existing	_	
31-6	4789-4793	fMRI	_	
31-7	4794-4797	and	_	
31-8	4798-4806	positron	_	
31-9	4807-4815	emission	_	
31-10	4816-4826	tomography	_	
31-11	4827-4828	(	_	
31-12	4828-4831	PET	_	
31-13	4831-4832	)	_	
31-14	4833-4840	studies	_	
31-15	4841-4844	the	_	
31-16	4845-4848	STG	_	
31-17	4849-4852	has	_	
31-18	4853-4857	been	_	
31-19	4858-4863	shown	_	
31-20	4864-4866	to	_	
31-21	4867-4869	be	_	
31-22	4870-4880	hypoactive	_	
31-23	4881-4887	during	_	
31-24	4888-4891	the	_	
31-25	4892-4904	presentation	_	
31-26	4904-4905	,	_	
31-27	4906-4909	and	_	
31-28	4910-4921	hyperactive	_	
31-29	4922-4924	in	_	
31-30	4925-4928	the	_	
31-31	4929-4936	absence	_	
31-32	4937-4939	of	_	
31-33	4940-4948	external	_	
31-34	4949-4957	auditory	_	
31-35	4958-4965	stimuli	_	
31-36	4966-4968	in	_	
31-37	4969-4971	SZ	_	
31-38	4972-4980	patients	_	
31-39	4981-4985	with	_	
31-40	4986-4987	a	_	
31-41	4988-4995	history	_	
31-42	4996-4998	of	_	
31-43	4999-5002	AHs	_	
31-44	5003-5011	compared	_	
31-45	5012-5014	to	_	
31-46	5015-5022	matched	_	
31-47	5023-5030	healthy	_	
31-48	5031-5039	controls	_	
31-49	5040-5041	(	_	
31-50	5041-5044	HCs	_	
31-51	5044-5045	)	_	
31-52	5045-5046	.	_	

#Text=Overactivation of the auditory cortex in the absence of external stimuli has also been noted in another meta-analysis of studies in SZ patients experiencing AHs, suggesting that abnormal activation in the STG is consistently reported in the pathophysiology of AHs.
32-1	5047-5061	Overactivation	_	
32-2	5062-5064	of	_	
32-3	5065-5068	the	_	
32-4	5069-5077	auditory	_	
32-5	5078-5084	cortex	_	
32-6	5085-5087	in	_	
32-7	5088-5091	the	_	
32-8	5092-5099	absence	_	
32-9	5100-5102	of	_	
32-10	5103-5111	external	_	
32-11	5112-5119	stimuli	_	
32-12	5120-5123	has	_	
32-13	5124-5128	also	_	
32-14	5129-5133	been	_	
32-15	5134-5139	noted	_	
32-16	5140-5142	in	_	
32-17	5143-5150	another	_	
32-18	5151-5164	meta-analysis	_	
32-19	5165-5167	of	_	
32-20	5168-5175	studies	_	
32-21	5176-5178	in	_	
32-22	5179-5181	SZ	_	
32-23	5182-5190	patients	_	
32-24	5191-5203	experiencing	_	
32-25	5204-5207	AHs	_	
32-26	5207-5208	,	_	
32-27	5209-5219	suggesting	_	
32-28	5220-5224	that	_	
32-29	5225-5233	abnormal	_	
32-30	5234-5244	activation	_	
32-31	5245-5247	in	_	
32-32	5248-5251	the	_	
32-33	5252-5255	STG	_	
32-34	5256-5258	is	_	
32-35	5259-5271	consistently	_	
32-36	5272-5280	reported	_	
32-37	5281-5283	in	_	
32-38	5284-5287	the	_	
32-39	5288-5303	pathophysiology	_	
32-40	5304-5306	of	_	
32-41	5307-5310	AHs	_	
32-42	5310-5311	.	_	

#Text=Self-reflection, DMN and AHs
#Text=The DMN, identified in both task-based and resting-state fMRI studies, is comprised of several brain regions including the MPFC, the posterior cingulate cortex (PCC), lateral parietal cortices, and the hippocampus.
33-1	5312-5327	Self-reflection	_	
33-2	5327-5328	,	_	
33-3	5329-5332	DMN	_	
33-4	5333-5336	and	_	
33-5	5337-5340	AHs	_	
33-6	5341-5344	The	_	
33-7	5345-5348	DMN	_	
33-8	5348-5349	,	_	
33-9	5350-5360	identified	_	
33-10	5361-5363	in	_	
33-11	5364-5368	both	_	
33-12	5369-5379	task-based	_	
33-13	5380-5383	and	_	
33-14	5384-5397	resting-state	_	
33-15	5398-5402	fMRI	_	
33-16	5403-5410	studies	_	
33-17	5410-5411	,	_	
33-18	5412-5414	is	_	
33-19	5415-5424	comprised	_	
33-20	5425-5427	of	_	
33-21	5428-5435	several	_	
33-22	5436-5441	brain	_	
33-23	5442-5449	regions	_	
33-24	5450-5459	including	_	
33-25	5460-5463	the	_	
33-26	5464-5468	MPFC	_	
33-27	5468-5469	,	_	
33-28	5470-5473	the	_	
33-29	5474-5483	posterior	_	
33-30	5484-5493	cingulate	_	
33-31	5494-5500	cortex	_	
33-32	5501-5502	(	_	
33-33	5502-5505	PCC	_	
33-34	5505-5506	)	_	
33-35	5506-5507	,	_	
33-36	5508-5515	lateral	_	
33-37	5516-5524	parietal	_	
33-38	5525-5533	cortices	_	
33-39	5533-5534	,	_	
33-40	5535-5538	and	_	
33-41	5539-5542	the	_	
33-42	5543-5554	hippocampus	_	
33-43	5554-5555	.	_	

#Text=It is more active during rest than in a wide variety of cognitive tasks.
34-1	5556-5558	It	_	
34-2	5559-5561	is	_	
34-3	5562-5566	more	_	
34-4	5567-5573	active	_	
34-5	5574-5580	during	_	
34-6	5581-5585	rest	_	
34-7	5586-5590	than	_	
34-8	5591-5593	in	_	
34-9	5594-5595	a	_	
34-10	5596-5600	wide	_	
34-11	5601-5608	variety	_	
34-12	5609-5611	of	_	
34-13	5612-5621	cognitive	_	
34-14	5622-5627	tasks	_	
34-15	5627-5628	.	_	

#Text=Considerable evidence suggests that the two core medial hubs of the DMN (MPFC and PCC) mediate one’s thoughts and feelings about self, often referred to as self-referential processing or self-reflection, and active when the brain is not processing external information.
35-1	5629-5641	Considerable	_	
35-2	5642-5650	evidence	_	
35-3	5651-5659	suggests	_	
35-4	5660-5664	that	_	
35-5	5665-5668	the	_	
35-6	5669-5672	two	_	
35-7	5673-5677	core	_	
35-8	5678-5684	medial	_	
35-9	5685-5689	hubs	_	
35-10	5690-5692	of	_	
35-11	5693-5696	the	_	
35-12	5697-5700	DMN	_	
35-13	5701-5702	(	_	
35-14	5702-5706	MPFC	_	
35-15	5707-5710	and	_	
35-16	5711-5714	PCC	_	
35-17	5714-5715	)	_	
35-18	5716-5723	mediate	_	
35-19	5724-5727	one	_	
35-20	5727-5728	’	_	
35-21	5728-5729	s	_	
35-22	5730-5738	thoughts	_	
35-23	5739-5742	and	_	
35-24	5743-5751	feelings	_	
35-25	5752-5757	about	_	
35-26	5758-5762	self	_	
35-27	5762-5763	,	_	
35-28	5764-5769	often	_	
35-29	5770-5778	referred	_	
35-30	5779-5781	to	_	
35-31	5782-5784	as	_	
35-32	5785-5801	self-referential	_	
35-33	5802-5812	processing	_	
35-34	5813-5815	or	_	
35-35	5816-5831	self-reflection	_	
35-36	5831-5832	,	_	
35-37	5833-5836	and	_	
35-38	5837-5843	active	_	
35-39	5844-5848	when	_	
35-40	5849-5852	the	_	
35-41	5853-5858	brain	_	
35-42	5859-5861	is	_	
35-43	5862-5865	not	_	
35-44	5866-5876	processing	_	
35-45	5877-5885	external	_	
35-46	5886-5897	information	_	
35-47	5897-5898	.	_	

#Text=In contrast, performing cognitive tasks leads to suppression of the DMN activation.
36-1	5899-5901	In	_	
36-2	5902-5910	contrast	_	
36-3	5910-5911	,	_	
36-4	5912-5922	performing	_	
36-5	5923-5932	cognitive	_	
36-6	5933-5938	tasks	_	
36-7	5939-5944	leads	_	
36-8	5945-5947	to	_	
36-9	5948-5959	suppression	_	
36-10	5960-5962	of	_	
36-11	5963-5966	the	_	
36-12	5967-5970	DMN	_	
36-13	5971-5981	activation	_	
36-14	5981-5982	.	_	

#Text=Furthermore, greater suppression of the DMN is associated with better memory formation, fewer lapses of attention, better learning of cognitive skills and less mind wandering.
37-1	5983-5994	Furthermore	_	
37-2	5994-5995	,	_	
37-3	5996-6003	greater	_	
37-4	6004-6015	suppression	_	
37-5	6016-6018	of	_	
37-6	6019-6022	the	_	
37-7	6023-6026	DMN	_	
37-8	6027-6029	is	_	
37-9	6030-6040	associated	_	
37-10	6041-6045	with	_	
37-11	6046-6052	better	_	
37-12	6053-6059	memory	_	
37-13	6060-6069	formation	_	
37-14	6069-6070	,	_	
37-15	6071-6076	fewer	_	
37-16	6077-6083	lapses	_	
37-17	6084-6086	of	_	
37-18	6087-6096	attention	_	
37-19	6096-6097	,	_	
37-20	6098-6104	better	_	
37-21	6105-6113	learning	_	
37-22	6114-6116	of	_	
37-23	6117-6126	cognitive	_	
37-24	6127-6133	skills	_	
37-25	6134-6137	and	_	
37-26	6138-6142	less	_	
37-27	6143-6147	mind	_	
37-28	6148-6157	wandering	_	
37-29	6157-6158	.	_	

#Text=Functional connectivity analyses provide evidence that the MPFC and the PCC are highly temporally correlated during rest, while the DMN is anticorrelated with brain regions activated during attention demanding tasks (e.g., CEN.
38-1	6159-6169	Functional	_	
38-2	6170-6182	connectivity	_	
38-3	6183-6191	analyses	_	
38-4	6192-6199	provide	_	
38-5	6200-6208	evidence	_	
38-6	6209-6213	that	_	
38-7	6214-6217	the	_	
38-8	6218-6222	MPFC	_	
38-9	6223-6226	and	_	
38-10	6227-6230	the	_	
38-11	6231-6234	PCC	_	
38-12	6235-6238	are	_	
38-13	6239-6245	highly	_	
38-14	6246-6256	temporally	_	
38-15	6257-6267	correlated	_	
38-16	6268-6274	during	_	
38-17	6275-6279	rest	_	
38-18	6279-6280	,	_	
38-19	6281-6286	while	_	
38-20	6287-6290	the	_	
38-21	6291-6294	DMN	_	
38-22	6295-6297	is	_	
38-23	6298-6312	anticorrelated	_	
38-24	6313-6317	with	_	
38-25	6318-6323	brain	_	
38-26	6324-6331	regions	_	
38-27	6332-6341	activated	_	
38-28	6342-6348	during	_	
38-29	6349-6358	attention	_	
38-30	6359-6368	demanding	_	
38-31	6369-6374	tasks	_	
38-32	6375-6376	(	_	
38-33	6376-6379	e.g	_	
38-34	6379-6380	.	_	
38-35	6380-6381	,	_	
38-36	6382-6385	CEN	_	
38-37	6385-6386	.	_	

#Text=In healthy individuals, greater magnitude of the DMN-CEN (e.g., MPFC-DLPFC) anticorrelation is associated with superior cognitive functions such as complex working memory tasks.
39-1	6387-6389	In	_	
39-2	6390-6397	healthy	_	
39-3	6398-6409	individuals	_	
39-4	6409-6410	,	_	
39-5	6411-6418	greater	_	
39-6	6419-6428	magnitude	_	
39-7	6429-6431	of	_	
39-8	6432-6435	the	_	
39-9	6436-6443	DMN-CEN	_	
39-10	6444-6445	(	_	
39-11	6445-6448	e.g	_	
39-12	6448-6449	.	_	
39-13	6449-6450	,	_	
39-14	6451-6461	MPFC-DLPFC	_	
39-15	6461-6462	)	_	
39-16	6463-6478	anticorrelation	_	
39-17	6479-6481	is	_	
39-18	6482-6492	associated	_	
39-19	6493-6497	with	_	
39-20	6498-6506	superior	_	
39-21	6507-6516	cognitive	_	
39-22	6517-6526	functions	_	
39-23	6527-6531	such	_	
39-24	6532-6534	as	_	
39-25	6535-6542	complex	_	
39-26	6543-6550	working	_	
39-27	6551-6557	memory	_	
39-28	6558-6563	tasks	_	
39-29	6563-6564	.	_	

#Text=In SZ the MPFC-DLPFC anticorrelation is significantly reduced, while the self-reference nodes of the DMN (i.e.
40-1	6565-6567	In	_	
40-2	6568-6570	SZ	_	
40-3	6571-6574	the	_	
40-4	6575-6585	MPFC-DLPFC	_	
40-5	6586-6601	anticorrelation	_	
40-6	6602-6604	is	_	
40-7	6605-6618	significantly	_	
40-8	6619-6626	reduced	_	
40-9	6626-6627	,	_	
40-10	6628-6633	while	_	
40-11	6634-6637	the	_	
40-12	6638-6652	self-reference	_	
40-13	6653-6658	nodes	_	
40-14	6659-6661	of	_	
40-15	6662-6665	the	_	
40-16	6666-6669	DMN	_	
40-17	6670-6671	(	_	
40-18	6671-6674	i.e	_	
40-19	6674-6675	.	_	

#Text=MPFC and PCC) are hyperconnected during rest.
41-1	6676-6680	MPFC	_	
41-2	6681-6684	and	_	
41-3	6685-6688	PCC	_	
41-4	6688-6689	)	_	
41-5	6690-6693	are	_	
41-6	6694-6708	hyperconnected	_	
41-7	6709-6715	during	_	
41-8	6716-6720	rest	_	
41-9	6720-6721	.	_	

#Text=Finally, the DMN has also been shown to be hyperconnected with the auditory cortex in hallucinating SZ patients.
42-1	6722-6729	Finally	_	
42-2	6729-6730	,	_	
42-3	6731-6734	the	_	
42-4	6735-6738	DMN	_	
42-5	6739-6742	has	_	
42-6	6743-6747	also	_	
42-7	6748-6752	been	_	
42-8	6753-6758	shown	_	
42-9	6759-6761	to	_	
42-10	6762-6764	be	_	
42-11	6765-6779	hyperconnected	_	
42-12	6780-6784	with	_	
42-13	6785-6788	the	_	
42-14	6789-6797	auditory	_	
42-15	6798-6804	cortex	_	
42-16	6805-6807	in	_	
42-17	6808-6821	hallucinating	_	
42-18	6822-6824	SZ	_	
42-19	6825-6833	patients	_	
42-20	6833-6834	.	_	

#Text=Specifically, as stated before, the increased connectivity between the dorsal MPFC and the STG has been observed in SZ patients with hallucinations compared to non-hallucinating SZ patients and HCs, suggesting that AHs may be associated with higher MPFC-STG connectivity.
43-1	6835-6847	Specifically	_	
43-2	6847-6848	,	_	
43-3	6849-6851	as	_	
43-4	6852-6858	stated	_	
43-5	6859-6865	before	_	
43-6	6865-6866	,	_	
43-7	6867-6870	the	_	
43-8	6871-6880	increased	_	
43-9	6881-6893	connectivity	_	
43-10	6894-6901	between	_	
43-11	6902-6905	the	_	
43-12	6906-6912	dorsal	_	
43-13	6913-6917	MPFC	_	
43-14	6918-6921	and	_	
43-15	6922-6925	the	_	
43-16	6926-6929	STG	_	
43-17	6930-6933	has	_	
43-18	6934-6938	been	_	
43-19	6939-6947	observed	_	
43-20	6948-6950	in	_	
43-21	6951-6953	SZ	_	
43-22	6954-6962	patients	_	
43-23	6963-6967	with	_	
43-24	6968-6982	hallucinations	_	
43-25	6983-6991	compared	_	
43-26	6992-6994	to	_	
43-27	6995-7012	non-hallucinating	_	
43-28	7013-7015	SZ	_	
43-29	7016-7024	patients	_	
43-30	7025-7028	and	_	
43-31	7029-7032	HCs	_	
43-32	7032-7033	,	_	
43-33	7034-7044	suggesting	_	
43-34	7045-7049	that	_	
43-35	7050-7053	AHs	_	
43-36	7054-7057	may	_	
43-37	7058-7060	be	_	
43-38	7061-7071	associated	_	
43-39	7072-7076	with	_	
43-40	7077-7083	higher	_	
43-41	7084-7092	MPFC-STG	_	
43-42	7093-7105	connectivity	_	
43-43	7105-7106	.	_	

#Text=Meditation and its clinical applications
#Text=Following the stated findings, we here chose the DMN-CEN BOLD activity differential (see Methods) as another target of rt-fMRI neurofeedback.
44-1	7107-7117	Meditation	_	
44-2	7118-7121	and	_	
44-3	7122-7125	its	_	
44-4	7126-7134	clinical	_	
44-5	7135-7147	applications	_	
44-6	7148-7157	Following	_	
44-7	7158-7161	the	_	
44-8	7162-7168	stated	_	
44-9	7169-7177	findings	_	
44-10	7177-7178	,	_	
44-11	7179-7181	we	_	
44-12	7182-7186	here	_	
44-13	7187-7192	chose	_	
44-14	7193-7196	the	_	
44-15	7197-7204	DMN-CEN	_	
44-16	7205-7209	BOLD	_	
44-17	7210-7218	activity	_	
44-18	7219-7231	differential	_	
44-19	7232-7233	(	_	
44-20	7233-7236	see	_	
44-21	7237-7244	Methods	_	
44-22	7244-7245	)	_	
44-23	7246-7248	as	_	
44-24	7249-7256	another	_	
44-25	7257-7263	target	_	
44-26	7264-7266	of	_	
44-27	7267-7274	rt-fMRI	_	
44-28	7275-7288	neurofeedback	_	
44-29	7288-7289	.	_	

#Text=This approach was further motivated by evidence that functional connectivity of resting state networks is plastic and can be modulated by (1) pharmacological and (2) behavioral interventions.
45-1	7290-7294	This	_	
45-2	7295-7303	approach	_	
45-3	7304-7307	was	_	
45-4	7308-7315	further	_	
45-5	7316-7325	motivated	_	
45-6	7326-7328	by	_	
45-7	7329-7337	evidence	_	
45-8	7338-7342	that	_	
45-9	7343-7353	functional	_	
45-10	7354-7366	connectivity	_	
45-11	7367-7369	of	_	
45-12	7370-7377	resting	_	
45-13	7378-7383	state	_	
45-14	7384-7392	networks	_	
45-15	7393-7395	is	_	
45-16	7396-7403	plastic	_	
45-17	7404-7407	and	_	
45-18	7408-7411	can	_	
45-19	7412-7414	be	_	
45-20	7415-7424	modulated	_	
45-21	7425-7427	by	_	
45-22	7428-7429	(	_	
45-23	7429-7430	1	_	
45-24	7430-7431	)	_	
45-25	7432-7447	pharmacological	_	
45-26	7448-7451	and	_	
45-27	7452-7453	(	_	
45-28	7453-7454	2	_	
45-29	7454-7455	)	_	
45-30	7456-7466	behavioral	_	
45-31	7467-7480	interventions	_	
45-32	7480-7481	.	_	

#Text=For example, pharmacological interventions in SZ have resulted in decreased DMN hyperconnectivity and increased DMN-CEN anticorrelations which were associated with increased working memory performance.
46-1	7482-7485	For	_	
46-2	7486-7493	example	_	
46-3	7493-7494	,	_	
46-4	7495-7510	pharmacological	_	
46-5	7511-7524	interventions	_	
46-6	7525-7527	in	_	
46-7	7528-7530	SZ	_	
46-8	7531-7535	have	_	
46-9	7536-7544	resulted	_	
46-10	7545-7547	in	_	
46-11	7548-7557	decreased	_	
46-12	7558-7561	DMN	_	
46-13	7562-7579	hyperconnectivity	_	
46-14	7580-7583	and	_	
46-15	7584-7593	increased	_	
46-16	7594-7601	DMN-CEN	_	
46-17	7602-7618	anticorrelations	_	
46-18	7619-7624	which	_	
46-19	7625-7629	were	_	
46-20	7630-7640	associated	_	
46-21	7641-7645	with	_	
46-22	7646-7655	increased	_	
46-23	7656-7663	working	_	
46-24	7664-7670	memory	_	
46-25	7671-7682	performance	_	
46-26	7682-7683	.	_	

#Text=Importantly, it has been also demonstrated that meditation practice modulates brain network integration leads to the decreased DMN activation and increased DMN-CEN anticorrelations.
47-1	7684-7695	Importantly	_	
47-2	7695-7696	,	_	
47-3	7697-7699	it	_	
47-4	7700-7703	has	_	
47-5	7704-7708	been	_	
47-6	7709-7713	also	_	
47-7	7714-7726	demonstrated	_	
47-8	7727-7731	that	_	
47-9	7732-7742	meditation	_	
47-10	7743-7751	practice	_	
47-11	7752-7761	modulates	_	
47-12	7762-7767	brain	_	
47-13	7768-7775	network	_	
47-14	7776-7787	integration	_	
47-15	7788-7793	leads	_	
47-16	7794-7796	to	_	
47-17	7797-7800	the	_	
47-18	7801-7810	decreased	_	
47-19	7811-7814	DMN	_	
47-20	7815-7825	activation	_	
47-21	7826-7829	and	_	
47-22	7830-7839	increased	_	
47-23	7840-7847	DMN-CEN	_	
47-24	7848-7864	anticorrelations	_	
47-25	7864-7865	.	_	

#Text=Furthermore, several studies have shown that meditators, compared with nonmeditator groups, are more likely to engage task-positive brain regions (and not DMN) that are involved in conflict monitoring, working memory, and cognitive control.
48-1	7866-7877	Furthermore	_	
48-2	7877-7878	,	_	
48-3	7879-7886	several	_	
48-4	7887-7894	studies	_	
48-5	7895-7899	have	_	
48-6	7900-7905	shown	_	
48-7	7906-7910	that	_	
48-8	7911-7921	meditators	_	
48-9	7921-7922	,	_	
48-10	7923-7931	compared	_	
48-11	7932-7936	with	_	
48-12	7937-7949	nonmeditator	_	
48-13	7950-7956	groups	_	
48-14	7956-7957	,	_	
48-15	7958-7961	are	_	
48-16	7962-7966	more	_	
48-17	7967-7973	likely	_	
48-18	7974-7976	to	_	
48-19	7977-7983	engage	_	
48-20	7984-7997	task-positive	_	
48-21	7998-8003	brain	_	
48-22	8004-8011	regions	_	
48-23	8012-8013	(	_	
48-24	8013-8016	and	_	
48-25	8017-8020	not	_	
48-26	8021-8024	DMN	_	
48-27	8024-8025	)	_	
48-28	8026-8030	that	_	
48-29	8031-8034	are	_	
48-30	8035-8043	involved	_	
48-31	8044-8046	in	_	
48-32	8047-8055	conflict	_	
48-33	8056-8066	monitoring	_	
48-34	8066-8067	,	_	
48-35	8068-8075	working	_	
48-36	8076-8082	memory	_	
48-37	8082-8083	,	_	
48-38	8084-8087	and	_	
48-39	8088-8097	cognitive	_	
48-40	8098-8105	control	_	
48-41	8105-8106	.	_	

#Text=Therefore, meditation may be a suitable candidate for modulating DMN and DMN-CEN anticorrelation.
49-1	8107-8116	Therefore	_	
49-2	8116-8117	,	_	
49-3	8118-8128	meditation	_	
49-4	8129-8132	may	_	
49-5	8133-8135	be	_	
49-6	8136-8137	a	_	
49-7	8138-8146	suitable	_	
49-8	8147-8156	candidate	_	
49-9	8157-8160	for	_	
49-10	8161-8171	modulating	_	
49-11	8172-8175	DMN	_	
49-12	8176-8179	and	_	
49-13	8180-8187	DMN-CEN	_	
49-14	8188-8203	anticorrelation	_	
49-15	8203-8204	.	_	

#Text=Meditation training can be defined as nonjudgmental attention to experiences in the present moment.
50-1	8205-8215	Meditation	_	
50-2	8216-8224	training	_	
50-3	8225-8228	can	_	
50-4	8229-8231	be	_	
50-5	8232-8239	defined	_	
50-6	8240-8242	as	_	
50-7	8243-8256	nonjudgmental	_	
50-8	8257-8266	attention	_	
50-9	8267-8269	to	_	
50-10	8270-8281	experiences	_	
50-11	8282-8284	in	_	
50-12	8285-8288	the	_	
50-13	8289-8296	present	_	
50-14	8297-8303	moment	_	
50-15	8303-8304	.	_	

#Text=With this approach, individuals learn to monitor internal thoughts and feelings in the moment, such that they can learn to observe them without getting “caught up” in them.
51-1	8305-8309	With	_	
51-2	8310-8314	this	_	
51-3	8315-8323	approach	_	
51-4	8323-8324	,	_	
51-5	8325-8336	individuals	_	
51-6	8337-8342	learn	_	
51-7	8343-8345	to	_	
51-8	8346-8353	monitor	_	
51-9	8354-8362	internal	_	
51-10	8363-8371	thoughts	_	
51-11	8372-8375	and	_	
51-12	8376-8384	feelings	_	
51-13	8385-8387	in	_	
51-14	8388-8391	the	_	
51-15	8392-8398	moment	_	
51-16	8398-8399	,	_	
51-17	8400-8404	such	_	
51-18	8405-8409	that	_	
51-19	8410-8414	they	_	
51-20	8415-8418	can	_	
51-21	8419-8424	learn	_	
51-22	8425-8427	to	_	
51-23	8428-8435	observe	_	
51-24	8436-8440	them	_	
51-25	8441-8448	without	_	
51-26	8449-8456	getting	_	
51-27	8457-8458	“	_	
51-28	8458-8464	caught	_	
51-29	8465-8467	up	_	
51-30	8467-8468	”	_	
51-31	8469-8471	in	_	
51-32	8472-8476	them	_	
51-33	8476-8477	.	_	

#Text=Meditation training has been gaining strong clinical support for its ability to help with various psychiatric disorders including SZ.
52-1	8478-8488	Meditation	_	
52-2	8489-8497	training	_	
52-3	8498-8501	has	_	
52-4	8502-8506	been	_	
52-5	8507-8514	gaining	_	
52-6	8515-8521	strong	_	
52-7	8522-8530	clinical	_	
52-8	8531-8538	support	_	
52-9	8539-8542	for	_	
52-10	8543-8546	its	_	
52-11	8547-8554	ability	_	
52-12	8555-8557	to	_	
52-13	8558-8562	help	_	
52-14	8563-8567	with	_	
52-15	8568-8575	various	_	
52-16	8576-8587	psychiatric	_	
52-17	8588-8597	disorders	_	
52-18	8598-8607	including	_	
52-19	8608-8610	SZ	_	
52-20	8610-8611	.	_	

#Text=Early clinical trials suggest that mindfulness-based approaches can reduce re-hospitalization rates, improve aspects of neuro-cognition, bring clinical improvement, and reduce negative symptoms in SZ.
53-1	8612-8617	Early	_	
53-2	8618-8626	clinical	_	
53-3	8627-8633	trials	_	
53-4	8634-8641	suggest	_	
53-5	8642-8646	that	_	
53-6	8647-8664	mindfulness-based	_	
53-7	8665-8675	approaches	_	
53-8	8676-8679	can	_	
53-9	8680-8686	reduce	_	
53-10	8687-8705	re-hospitalization	_	
53-11	8706-8711	rates	_	
53-12	8711-8712	,	_	
53-13	8713-8720	improve	_	
53-14	8721-8728	aspects	_	
53-15	8729-8731	of	_	
53-16	8732-8747	neuro-cognition	_	
53-17	8747-8748	,	_	
53-18	8749-8754	bring	_	
53-19	8755-8763	clinical	_	
53-20	8764-8775	improvement	_	
53-21	8775-8776	,	_	
53-22	8777-8780	and	_	
53-23	8781-8787	reduce	_	
53-24	8788-8796	negative	_	
53-25	8797-8805	symptoms	_	
53-26	8806-8808	in	_	
53-27	8809-8811	SZ	_	
53-28	8811-8812	.	_	

#Text=A recent study with SZ patients with more than 20 years of treatment history showed that meditation effectively reduces hallucinations.
54-1	8813-8814	A	_	
54-2	8815-8821	recent	_	
54-3	8822-8827	study	_	
54-4	8828-8832	with	_	
54-5	8833-8835	SZ	_	
54-6	8836-8844	patients	_	
54-7	8845-8849	with	_	
54-8	8850-8854	more	_	
54-9	8855-8859	than	_	
54-10	8860-8862	20	_	
54-11	8863-8868	years	_	
54-12	8869-8871	of	_	
54-13	8872-8881	treatment	_	
54-14	8882-8889	history	_	
54-15	8890-8896	showed	_	
54-16	8897-8901	that	_	
54-17	8902-8912	meditation	_	
54-18	8913-8924	effectively	_	
54-19	8925-8932	reduces	_	
54-20	8933-8947	hallucinations	_	
54-21	8947-8948	.	_	

#Text=In early psychosis, meditation training has also led to improved emotion regulation, anxiety, and depression.
55-1	8949-8951	In	_	
55-2	8952-8957	early	_	
55-3	8958-8967	psychosis	_	
55-4	8967-8968	,	_	
55-5	8969-8979	meditation	_	
55-6	8980-8988	training	_	
55-7	8989-8992	has	_	
55-8	8993-8997	also	_	
55-9	8998-9001	led	_	
55-10	9002-9004	to	_	
55-11	9005-9013	improved	_	
55-12	9014-9021	emotion	_	
55-13	9022-9032	regulation	_	
55-14	9032-9033	,	_	
55-15	9034-9041	anxiety	_	
55-16	9041-9042	,	_	
55-17	9043-9046	and	_	
55-18	9047-9057	depression	_	
55-19	9057-9058	.	_	

#Text=In this study, we have used a type of meditation called mental noting practice as described below.
56-1	9059-9061	In	_	
56-2	9062-9066	this	_	
56-3	9067-9072	study	_	
56-4	9072-9073	,	_	
56-5	9074-9076	we	_	
56-6	9077-9081	have	_	
56-7	9082-9086	used	_	
56-8	9087-9088	a	_	
56-9	9089-9093	type	_	
56-10	9094-9096	of	_	
56-11	9097-9107	meditation	_	
56-12	9108-9114	called	_	
56-13	9115-9121	mental	_	
56-14	9122-9128	noting	_	
56-15	9129-9137	practice	_	
56-16	9138-9140	as	_	
56-17	9141-9150	described	_	
56-18	9151-9156	below	_	
56-19	9156-9157	.	_	

#Text=Hypotheses of this study
#Text=In the current study, we used rt-fMRI neurofeedback in conjunction with mental noting to target activity within the DMN and CEN (see Methods for details).
57-1	9158-9168	Hypotheses	_	
57-2	9169-9171	of	_	
57-3	9172-9176	this	_	
57-4	9177-9182	study	_	
57-5	9183-9185	In	_	
57-6	9186-9189	the	_	
57-7	9190-9197	current	_	
57-8	9198-9203	study	_	
57-9	9203-9204	,	_	
57-10	9205-9207	we	_	
57-11	9208-9212	used	_	
57-12	9213-9220	rt-fMRI	_	
57-13	9221-9234	neurofeedback	_	
57-14	9235-9237	in	_	
57-15	9238-9249	conjunction	_	
57-16	9250-9254	with	_	
57-17	9255-9261	mental	_	
57-18	9262-9268	noting	_	
57-19	9269-9271	to	_	
57-20	9272-9278	target	_	
57-21	9279-9287	activity	_	
57-22	9288-9294	within	_	
57-23	9295-9298	the	_	
57-24	9299-9302	DMN	_	
57-25	9303-9306	and	_	
57-26	9307-9310	CEN	_	
57-27	9311-9312	(	_	
57-28	9312-9315	see	_	
57-29	9316-9323	Methods	_	
57-30	9324-9327	for	_	
57-31	9328-9335	details	_	
57-32	9335-9336	)	_	
57-33	9336-9337	.	_	

#Text=We hypothesized that this intervention would lead to a) reduced DMN connectivity (specifically between MPFC and PCC; b) increased DMN-CEN anticorrelations; c) reduced MPFC-STG connectivity d) reduction of AHs and e) correlations between changes in connectivity and AHs reductions, post-neurofeedback.
58-1	9338-9340	We	_	
58-2	9341-9353	hypothesized	_	
58-3	9354-9358	that	_	
58-4	9359-9363	this	_	
58-5	9364-9376	intervention	_	
58-6	9377-9382	would	_	
58-7	9383-9387	lead	_	
58-8	9388-9390	to	_	
58-9	9391-9392	a	_	
58-10	9392-9393	)	_	
58-11	9394-9401	reduced	_	
58-12	9402-9405	DMN	_	
58-13	9406-9418	connectivity	_	
58-14	9419-9420	(	_	
58-15	9420-9432	specifically	_	
58-16	9433-9440	between	_	
58-17	9441-9445	MPFC	_	
58-18	9446-9449	and	_	
58-19	9450-9453	PCC	_	
58-20	9453-9454	;	_	
58-21	9455-9456	b	_	
58-22	9456-9457	)	_	
58-23	9458-9467	increased	_	
58-24	9468-9475	DMN-CEN	_	
58-25	9476-9492	anticorrelations	_	
58-26	9492-9493	;	_	
58-27	9494-9495	c	_	
58-28	9495-9496	)	_	
58-29	9497-9504	reduced	_	
58-30	9505-9513	MPFC-STG	_	
58-31	9514-9526	connectivity	_	
58-32	9527-9528	d	_	
58-33	9528-9529	)	_	
58-34	9530-9539	reduction	_	
58-35	9540-9542	of	_	
58-36	9543-9546	AHs	_	
58-37	9547-9550	and	_	
58-38	9551-9552	e	_	
58-39	9552-9553	)	_	
58-40	9554-9566	correlations	_	
58-41	9567-9574	between	_	
58-42	9575-9582	changes	_	
58-43	9583-9585	in	_	
58-44	9586-9598	connectivity	_	
58-45	9599-9602	and	_	
58-46	9603-9606	AHs	_	
58-47	9607-9617	reductions	_	
58-48	9617-9618	,	_	
58-49	9619-9637	post-neurofeedback	_	
58-50	9637-9638	.	_	

#Text=We used a control condition involving the somatosensory motor cortex (SMC) to demonstrate that reductions in AHs would be observed only when rt-fMRI neurofeedback was provided from a brain region involved in AHs.
59-1	9639-9641	We	_	
59-2	9642-9646	used	_	
59-3	9647-9648	a	_	
59-4	9649-9656	control	_	
59-5	9657-9666	condition	_	
59-6	9667-9676	involving	_	
59-7	9677-9680	the	_	
59-8	9681-9694	somatosensory	_	
59-9	9695-9700	motor	_	
59-10	9701-9707	cortex	_	
59-11	9708-9709	(	_	
59-12	9709-9712	SMC	_	
59-13	9712-9713	)	_	
59-14	9714-9716	to	_	
59-15	9717-9728	demonstrate	_	
59-16	9729-9733	that	_	
59-17	9734-9744	reductions	_	
59-18	9745-9747	in	_	
59-19	9748-9751	AHs	_	
59-20	9752-9757	would	_	
59-21	9758-9760	be	_	
59-22	9761-9769	observed	_	
59-23	9770-9774	only	_	
59-24	9775-9779	when	_	
59-25	9780-9787	rt-fMRI	_	
59-26	9788-9801	neurofeedback	_	
59-27	9802-9805	was	_	
59-28	9806-9814	provided	_	
59-29	9815-9819	from	_	
59-30	9820-9821	a	_	
59-31	9822-9827	brain	_	
59-32	9828-9834	region	_	
59-33	9835-9843	involved	_	
59-34	9844-9846	in	_	
59-35	9847-9850	AHs	_	
59-36	9850-9851	.	_	

#Text=Materials and Methods
#Text=Participants
#Text=Eleven patients (mean age = 43.5 years (SD = 10.3years); 1 female) diagnosed with SZ or schizoaffective disorder using DSM-5 criteria participated in the experiment.
60-1	9852-9861	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[2]	
60-2	9862-9865	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[2]	
60-3	9866-9873	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[2]	
60-4	9874-9886	Participants	_	
60-5	9887-9893	Eleven	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-6	9894-9902	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-7	9903-9904	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-8	9904-9908	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-9	9909-9912	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-10	9913-9914	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-11	9915-9919	43.5	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-12	9920-9925	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-13	9926-9927	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-14	9927-9929	SD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-15	9930-9931	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-16	9932-9941	10.3years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-17	9941-9942	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-18	9942-9943	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-19	9944-9945	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-20	9946-9952	female	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-21	9952-9953	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-22	9954-9963	diagnosed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-23	9964-9968	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-24	9969-9971	SZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[4]	
60-25	9972-9974	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-26	9975-9990	schizoaffective	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#SchizoaffectiveDisorder[5]	
60-27	9991-9999	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#SchizoaffectiveDisorder[5]	
60-28	10000-10005	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-29	10006-10009	DSM	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-30	10009-10010	-	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-31	10010-10011	5	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-32	10012-10020	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-33	10021-10033	participated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-34	10034-10036	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-35	10037-10040	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-36	10041-10051	experiment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
60-37	10051-10052	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	

#Text=Ten out of eleven patients tested in this study participated in the experiment described in Part I of the paper.
61-1	10053-10056	Ten	_	
61-2	10057-10060	out	_	
61-3	10061-10063	of	_	
61-4	10064-10070	eleven	_	
61-5	10071-10079	patients	_	
61-6	10080-10086	tested	_	
61-7	10087-10089	in	_	
61-8	10090-10094	this	_	
61-9	10095-10100	study	_	
61-10	10101-10113	participated	_	
61-11	10114-10116	in	_	
61-12	10117-10120	the	_	
61-13	10121-10131	experiment	_	
61-14	10132-10141	described	_	
61-15	10142-10144	in	_	
61-16	10145-10149	Part	_	
61-17	10150-10151	I	_	
61-18	10152-10154	of	_	
61-19	10155-10158	the	_	
61-20	10159-10164	paper	_	
61-21	10164-10165	.	_	

#Text=The exclusion criteria included neurologic illness or major head trauma, electroconvulsive therapy, alcohol or drug dependence, alcohol or drug abuse within the past five years, verbal IQ below 70, and the absence of auditory hallucinations not responsive to medication as assessed with the SCID interview.
62-1	10166-10169	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-2	10170-10179	exclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-3	10180-10188	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-4	10189-10197	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-5	10198-10208	neurologic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-6	10209-10216	illness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-7	10217-10219	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-8	10220-10225	major	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-9	10226-10230	head	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-10	10231-10237	trauma	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-11	10237-10238	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-12	10239-10256	electroconvulsive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-13	10257-10264	therapy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-14	10264-10265	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-15	10266-10273	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-16	10274-10276	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-17	10277-10281	drug	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-18	10282-10292	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-19	10292-10293	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-20	10294-10301	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-21	10302-10304	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-22	10305-10309	drug	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-23	10310-10315	abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-24	10316-10322	within	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-25	10323-10326	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-26	10327-10331	past	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-27	10332-10336	five	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-28	10337-10342	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-29	10342-10343	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-30	10344-10350	verbal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-31	10351-10353	IQ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-32	10354-10359	below	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-33	10360-10362	70	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-34	10362-10363	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-35	10364-10367	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-36	10368-10371	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-37	10372-10379	absence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-38	10380-10382	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-39	10383-10391	auditory	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-40	10392-10406	hallucinations	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-41	10407-10410	not	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-42	10411-10421	responsive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-43	10422-10424	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-44	10425-10435	medication	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-45	10436-10438	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-46	10439-10447	assessed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-47	10448-10452	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-48	10453-10456	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-49	10457-10461	SCID	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[7]	
62-50	10462-10471	interview	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
62-51	10471-10472	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=All participants were native English speakers and were right handed.
63-1	10473-10476	All	_	
63-2	10477-10489	participants	_	
63-3	10490-10494	were	_	
63-4	10495-10501	native	_	
63-5	10502-10509	English	_	
63-6	10510-10518	speakers	_	
63-7	10519-10522	and	_	
63-8	10523-10527	were	_	
63-9	10528-10533	right	_	
63-10	10534-10540	handed	_	
63-11	10540-10541	.	_	

#Text=The participants’ verbal IQ as assessed with WAIS was 101.8 (SD = 10.3) and their performance IQ was 94.5 (SD = 5.8).
64-1	10542-10545	The	_	
64-2	10546-10558	participants	_	
64-3	10558-10559	’	_	
64-4	10560-10566	verbal	_	
64-5	10567-10569	IQ	_	
64-6	10570-10572	as	_	
64-7	10573-10581	assessed	_	
64-8	10582-10586	with	_	
64-9	10587-10591	WAIS	_	
64-10	10592-10595	was	_	
64-11	10596-10601	101.8	_	
64-12	10602-10603	(	_	
64-13	10603-10605	SD	_	
64-14	10606-10607	=	_	
64-15	10608-10612	10.3	_	
64-16	10612-10613	)	_	
64-17	10614-10617	and	_	
64-18	10618-10623	their	_	
64-19	10624-10635	performance	_	
64-20	10636-10638	IQ	_	
64-21	10639-10642	was	_	
64-22	10643-10647	94.5	_	
64-23	10648-10649	(	_	
64-24	10649-10651	SD	_	
64-25	10652-10653	=	_	
64-26	10654-10657	5.8	_	
64-27	10657-10658	)	_	
64-28	10658-10659	.	_	

#Text=All patients experienced AHs that were not controlled with antipsychotic medication at least once daily within the two weeks prior to the assessment (The list of prescribed medications, across patients, was the following: Aripiprizole, Clozapine, Abilify, Chlondapine, Zoloft, Buspirone, Olanzopine, Citalopram, Risperdal, Gabapentin, and Ziprasidone).
65-1	10660-10663	All	_	
65-2	10664-10672	patients	_	
65-3	10673-10684	experienced	_	
65-4	10685-10688	AHs	_	
65-5	10689-10693	that	_	
65-6	10694-10698	were	_	
65-7	10699-10702	not	_	
65-8	10703-10713	controlled	_	
65-9	10714-10718	with	_	
65-10	10719-10732	antipsychotic	_	
65-11	10733-10743	medication	_	
65-12	10744-10746	at	_	
65-13	10747-10752	least	_	
65-14	10753-10757	once	_	
65-15	10758-10763	daily	_	
65-16	10764-10770	within	_	
65-17	10771-10774	the	_	
65-18	10775-10778	two	_	
65-19	10779-10784	weeks	_	
65-20	10785-10790	prior	_	
65-21	10791-10793	to	_	
65-22	10794-10797	the	_	
65-23	10798-10808	assessment	_	
65-24	10809-10810	(	_	
65-25	10810-10813	The	_	
65-26	10814-10818	list	_	
65-27	10819-10821	of	_	
65-28	10822-10832	prescribed	_	
65-29	10833-10844	medications	_	
65-30	10844-10845	,	_	
65-31	10846-10852	across	_	
65-32	10853-10861	patients	_	
65-33	10861-10862	,	_	
65-34	10863-10866	was	_	
65-35	10867-10870	the	_	
65-36	10871-10880	following	_	
65-37	10880-10881	:	_	
65-38	10882-10894	Aripiprizole	_	
65-39	10894-10895	,	_	
65-40	10896-10905	Clozapine	_	
65-41	10905-10906	,	_	
65-42	10907-10914	Abilify	_	
65-43	10914-10915	,	_	
65-44	10916-10927	Chlondapine	_	
65-45	10927-10928	,	_	
65-46	10929-10935	Zoloft	_	
65-47	10935-10936	,	_	
65-48	10937-10946	Buspirone	_	
65-49	10946-10947	,	_	
65-50	10948-10958	Olanzopine	_	
65-51	10958-10959	,	_	
65-52	10960-10970	Citalopram	_	
65-53	10970-10971	,	_	
65-54	10972-10981	Risperdal	_	
65-55	10981-10982	,	_	
65-56	10983-10993	Gabapentin	_	
65-57	10993-10994	,	_	
65-58	10995-10998	and	_	
65-59	10999-11010	Ziprasidone	_	
65-60	11010-11011	)	_	
65-61	11011-11012	.	_	

#Text=Hallucinatory experience was captured using Auditory Hallucinations Rating Scale (AHRS), developed by R.
66-1	11013-11026	Hallucinatory	_	
66-2	11027-11037	experience	_	
66-3	11038-11041	was	_	
66-4	11042-11050	captured	_	
66-5	11051-11056	using	_	
66-6	11057-11065	Auditory	_	
66-7	11066-11080	Hallucinations	_	
66-8	11081-11087	Rating	_	
66-9	11088-11093	Scale	_	
66-10	11094-11095	(	_	
66-11	11095-11099	AHRS	_	
66-12	11099-11100	)	_	
66-13	11100-11101	,	_	
66-14	11102-11111	developed	_	
66-15	11112-11114	by	_	
66-16	11115-11116	R	_	
66-17	11116-11117	.	_	

#Text=Hoffman, on the day of the rt-fMRI session, i..e, before the first NFB session, within a week after the rt-fMRI NFB session, on the day of the control NFB session, and one week after the control NFB session.
67-1	11118-11125	Hoffman	_	
67-2	11125-11126	,	_	
67-3	11127-11129	on	_	
67-4	11130-11133	the	_	
67-5	11134-11137	day	_	
67-6	11138-11140	of	_	
67-7	11141-11144	the	_	
67-8	11145-11152	rt-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
67-9	11153-11160	session	_	
67-10	11160-11161	,	_	
67-11	11162-11163	i	_	
67-12	11163-11164	.	_	
67-13	11164-11165	.	_	
67-14	11165-11166	e	_	
67-15	11166-11167	,	_	
67-16	11168-11174	before	_	
67-17	11175-11178	the	_	
67-18	11179-11184	first	_	
67-19	11185-11188	NFB	_	
67-20	11189-11196	session	_	
67-21	11196-11197	,	_	
67-22	11198-11204	within	_	
67-23	11205-11206	a	_	
67-24	11207-11211	week	_	
67-25	11212-11217	after	_	
67-26	11218-11221	the	_	
67-27	11222-11229	rt-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
67-28	11230-11233	NFB	_	
67-29	11234-11241	session	_	
67-30	11241-11242	,	_	
67-31	11243-11245	on	_	
67-32	11246-11249	the	_	
67-33	11250-11253	day	_	
67-34	11254-11256	of	_	
67-35	11257-11260	the	_	
67-36	11261-11268	control	_	
67-37	11269-11272	NFB	_	
67-38	11273-11280	session	_	
67-39	11280-11281	,	_	
67-40	11282-11285	and	_	
67-41	11286-11289	one	_	
67-42	11290-11294	week	_	
67-43	11295-11300	after	_	
67-44	11301-11304	the	_	
67-45	11305-11312	control	_	
67-46	11313-11316	NFB	_	
67-47	11317-11324	session	_	
67-48	11324-11325	.	_	

#Text=All participants gave written consent in accordance with the guidelines of Harvard Medical School, MIT and Veterans Affairs (VA) Committees on Human Subjects and they were compensated for their participation.
68-1	11326-11329	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-2	11330-11342	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-3	11343-11347	gave	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-4	11348-11355	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-5	11356-11363	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-6	11364-11366	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-7	11367-11377	accordance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-8	11378-11382	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-9	11383-11386	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-10	11387-11397	guidelines	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-11	11398-11400	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-12	11401-11408	Harvard	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-13	11409-11416	Medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-14	11417-11423	School	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-15	11423-11424	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-16	11425-11428	MIT	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-17	11429-11432	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-18	11433-11441	Veterans	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-19	11442-11449	Affairs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-20	11450-11451	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-21	11451-11453	VA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-22	11453-11454	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-23	11455-11465	Committees	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-24	11466-11468	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-25	11469-11474	Human	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-26	11475-11483	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-27	11484-11487	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-28	11488-11492	they	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-29	11493-11497	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-30	11498-11509	compensated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-31	11510-11513	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-32	11514-11519	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-33	11520-11533	participation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
68-34	11533-11534	.	_	

#Text=Procedure
#Text=The experiment took place over two sessions.
69-1	11535-11544	Procedure	_	
69-2	11545-11548	The	_	
69-3	11549-11559	experiment	_	
69-4	11560-11564	took	_	
69-5	11565-11570	place	_	
69-6	11571-11575	over	_	
69-7	11576-11579	two	_	
69-8	11580-11588	sessions	_	
69-9	11588-11589	.	_	

#Text=In the first session, participants were taught mental noting meditation (see below) as a strategy to effectively modulate the DMN, completed two 6 min resting state (RS) scans (RS-pre & RS-post feedback scans), one T1 weighted structural scan, two no-feedback transfer scans (TT-pre & TT-post feedback scans) and four feedback scans.
70-1	11590-11592	In	_	
70-2	11593-11596	the	_	
70-3	11597-11602	first	_	
70-4	11603-11610	session	_	
70-5	11610-11611	,	_	
70-6	11612-11624	participants	_	
70-7	11625-11629	were	_	
70-8	11630-11636	taught	_	
70-9	11637-11643	mental	_	
70-10	11644-11650	noting	_	
70-11	11651-11661	meditation	_	
70-12	11662-11663	(	_	
70-13	11663-11666	see	_	
70-14	11667-11672	below	_	
70-15	11672-11673	)	_	
70-16	11674-11676	as	_	
70-17	11677-11678	a	_	
70-18	11679-11687	strategy	_	
70-19	11688-11690	to	_	
70-20	11691-11702	effectively	_	
70-21	11703-11711	modulate	_	
70-22	11712-11715	the	_	
70-23	11716-11719	DMN	_	
70-24	11719-11720	,	_	
70-25	11721-11730	completed	_	
70-26	11731-11734	two	_	
70-27	11735-11736	6	_	
70-28	11737-11740	min	_	
70-29	11741-11748	resting	_	
70-30	11749-11754	state	_	
70-31	11755-11756	(	_	
70-32	11756-11758	RS	_	
70-33	11758-11759	)	_	
70-34	11760-11765	scans	_	
70-35	11766-11767	(	_	
70-36	11767-11773	RS-pre	_	
70-37	11774-11775	&	_	
70-38	11776-11783	RS-post	_	
70-39	11784-11792	feedback	_	
70-40	11793-11798	scans	_	
70-41	11798-11799	)	_	
70-42	11799-11800	,	_	
70-43	11801-11804	one	_	
70-44	11805-11807	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[9]	
70-45	11808-11816	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[9]	
70-46	11817-11827	structural	_	
70-47	11828-11832	scan	_	
70-48	11832-11833	,	_	
70-49	11834-11837	two	_	
70-50	11838-11849	no-feedback	_	
70-51	11850-11858	transfer	_	
70-52	11859-11864	scans	_	
70-53	11865-11866	(	_	
70-54	11866-11872	TT-pre	_	
70-55	11873-11874	&	_	
70-56	11875-11882	TT-post	_	
70-57	11883-11891	feedback	_	
70-58	11892-11897	scans	_	
70-59	11897-11898	)	_	
70-60	11899-11902	and	_	
70-61	11903-11907	four	_	
70-62	11908-11916	feedback	_	
70-63	11917-11922	scans	_	
70-64	11922-11923	.	_	

#Text=The second session had exactly the same structure as session one, with the exception that subjects were instructed to tap their fingers during feedback in order to modulate SMC.
71-1	11924-11927	The	_	
71-2	11928-11934	second	_	
71-3	11935-11942	session	_	
71-4	11943-11946	had	_	
71-5	11947-11954	exactly	_	
71-6	11955-11958	the	_	
71-7	11959-11963	same	_	
71-8	11964-11973	structure	_	
71-9	11974-11976	as	_	
71-10	11977-11984	session	_	
71-11	11985-11988	one	_	
71-12	11988-11989	,	_	
71-13	11990-11994	with	_	
71-14	11995-11998	the	_	
71-15	11999-12008	exception	_	
71-16	12009-12013	that	_	
71-17	12014-12022	subjects	_	
71-18	12023-12027	were	_	
71-19	12028-12038	instructed	_	
71-20	12039-12041	to	_	
71-21	12042-12045	tap	_	
71-22	12046-12051	their	_	
71-23	12052-12059	fingers	_	
71-24	12060-12066	during	_	
71-25	12067-12075	feedback	_	
71-26	12076-12078	in	_	
71-27	12079-12084	order	_	
71-28	12085-12087	to	_	
71-29	12088-12096	modulate	_	
71-30	12097-12100	SMC	_	
71-31	12100-12101	.	_	

#Text=Mental noting training
#Text=Before the start of session one, all participants were taught “mental noting” meditation.
72-1	12102-12108	Mental	_	
72-2	12109-12115	noting	_	
72-3	12116-12124	training	_	
72-4	12125-12131	Before	_	
72-5	12132-12135	the	_	
72-6	12136-12141	start	_	
72-7	12142-12144	of	_	
72-8	12145-12152	session	_	
72-9	12153-12156	one	_	
72-10	12156-12157	,	_	
72-11	12158-12161	all	_	
72-12	12162-12174	participants	_	
72-13	12175-12179	were	_	
72-14	12180-12186	taught	_	
72-15	12187-12188	“	_	
72-16	12188-12194	mental	_	
72-17	12195-12201	noting	_	
72-18	12201-12202	”	_	
72-19	12203-12213	meditation	_	
72-20	12213-12214	.	_	

#Text=Mental noting is a major component of Vipassana or insight meditation practice and consists of the factors “concentration”, “observing sensory experience,” “not ‘efforting’“ and “contentment” (, p. 95).
73-1	12215-12221	Mental	_	
73-2	12222-12228	noting	_	
73-3	12229-12231	is	_	
73-4	12232-12233	a	_	
73-5	12234-12239	major	_	
73-6	12240-12249	component	_	
73-7	12250-12252	of	_	
73-8	12253-12262	Vipassana	_	
73-9	12263-12265	or	_	
73-10	12266-12273	insight	_	
73-11	12274-12284	meditation	_	
73-12	12285-12293	practice	_	
73-13	12294-12297	and	_	
73-14	12298-12306	consists	_	
73-15	12307-12309	of	_	
73-16	12310-12313	the	_	
73-17	12314-12321	factors	_	
73-18	12322-12323	“	_	
73-19	12323-12336	concentration	_	
73-20	12336-12337	”	_	
73-21	12337-12338	,	_	
73-22	12339-12340	“	_	
73-23	12340-12349	observing	_	
73-24	12350-12357	sensory	_	
73-25	12358-12368	experience	_	
73-26	12368-12369	,	_	
73-27	12369-12370	”	_	
73-28	12371-12372	“	_	
73-29	12372-12375	not	_	
73-30	12376-12377	‘	_	
73-31	12377-12386	efforting	_	
73-32	12386-12387	’	_	
73-33	12387-12388	“	_	
73-34	12389-12392	and	_	
73-35	12393-12394	“	_	
73-36	12394-12405	contentment	_	
73-37	12405-12406	”	_	
73-38	12407-12408	(	_	
73-39	12408-12409	,	_	
73-40	12410-12411	p	_	
73-41	12411-12412	.	_	
73-42	12413-12415	95	_	
73-43	12415-12416	)	_	
73-44	12416-12417	.	_	

#Text=As part of “mental noting” participants were taught to mentally label whatever experience was most prominent in their sense experience from moment to moment (i.e. seeing, hearing, feeling, thinking, etc).
74-1	12418-12420	As	_	
74-2	12421-12425	part	_	
74-3	12426-12428	of	_	
74-4	12429-12430	“	_	
74-5	12430-12436	mental	_	
74-6	12437-12443	noting	_	
74-7	12443-12444	”	_	
74-8	12445-12457	participants	_	
74-9	12458-12462	were	_	
74-10	12463-12469	taught	_	
74-11	12470-12472	to	_	
74-12	12473-12481	mentally	_	
74-13	12482-12487	label	_	
74-14	12488-12496	whatever	_	
74-15	12497-12507	experience	_	
74-16	12508-12511	was	_	
74-17	12512-12516	most	_	
74-18	12517-12526	prominent	_	
74-19	12527-12529	in	_	
74-20	12530-12535	their	_	
74-21	12536-12541	sense	_	
74-22	12542-12552	experience	_	
74-23	12553-12557	from	_	
74-24	12558-12564	moment	_	
74-25	12565-12567	to	_	
74-26	12568-12574	moment	_	
74-27	12575-12576	(	_	
74-28	12576-12579	i.e	_	
74-29	12579-12580	.	_	
74-30	12581-12587	seeing	_	
74-31	12587-12588	,	_	
74-32	12589-12596	hearing	_	
74-33	12596-12597	,	_	
74-34	12598-12605	feeling	_	
74-35	12605-12606	,	_	
74-36	12607-12615	thinking	_	
74-37	12615-12616	,	_	
74-38	12617-12620	etc	_	
74-39	12620-12621	)	_	
74-40	12621-12622	.	_	

#Text=For example, if someone noticed that they were seeing something, regardless of the object, they would silently label that experience “seeing.”
75-1	12623-12626	For	_	
75-2	12627-12634	example	_	
75-3	12634-12635	,	_	
75-4	12636-12638	if	_	
75-5	12639-12646	someone	_	
75-6	12647-12654	noticed	_	
75-7	12655-12659	that	_	
75-8	12660-12664	they	_	
75-9	12665-12669	were	_	
75-10	12670-12676	seeing	_	
75-11	12677-12686	something	_	
75-12	12686-12687	,	_	
75-13	12688-12698	regardless	_	
75-14	12699-12701	of	_	
75-15	12702-12705	the	_	
75-16	12706-12712	object	_	
75-17	12712-12713	,	_	
75-18	12714-12718	they	_	
75-19	12719-12724	would	_	
75-20	12725-12733	silently	_	
75-21	12734-12739	label	_	
75-22	12740-12744	that	_	
75-23	12745-12755	experience	_	
75-24	12756-12757	“	_	
75-25	12757-12763	seeing	_	
75-26	12763-12764	.	_	
75-27	12764-12765	”	_	

#Text=If hearing, they would label it “hearing”; if thinking, they would label it “thinking” and so on.”
76-1	12766-12768	If	_	
76-2	12769-12776	hearing	_	
76-3	12776-12777	,	_	
76-4	12778-12782	they	_	
76-5	12783-12788	would	_	
76-6	12789-12794	label	_	
76-7	12795-12797	it	_	
76-8	12798-12799	“	_	
76-9	12799-12806	hearing	_	
76-10	12806-12807	”	_	
76-11	12807-12808	;	_	
76-12	12809-12811	if	_	
76-13	12812-12820	thinking	_	
76-14	12820-12821	,	_	
76-15	12822-12826	they	_	
76-16	12827-12832	would	_	
76-17	12833-12838	label	_	
76-18	12839-12841	it	_	
76-19	12842-12843	“	_	
76-20	12843-12851	thinking	_	
76-21	12851-12852	”	_	
76-22	12853-12856	and	_	
76-23	12857-12859	so	_	
76-24	12860-12862	on	_	
76-25	12862-12863	.	_	
76-26	12863-12864	”	_	

#Text=Thus, this practice helps individuals observe “one’s thoughts and feelings as temporary, objective events in the mind, as opposed to reflections of the self that are necessarily true” which is sometimes referred to as “decentering”.
77-1	12865-12869	Thus	_	
77-2	12869-12870	,	_	
77-3	12871-12875	this	_	
77-4	12876-12884	practice	_	
77-5	12885-12890	helps	_	
77-6	12891-12902	individuals	_	
77-7	12903-12910	observe	_	
77-8	12911-12912	“	_	
77-9	12912-12915	one	_	
77-10	12915-12916	’	_	
77-11	12916-12917	s	_	
77-12	12918-12926	thoughts	_	
77-13	12927-12930	and	_	
77-14	12931-12939	feelings	_	
77-15	12940-12942	as	_	
77-16	12943-12952	temporary	_	
77-17	12952-12953	,	_	
77-18	12954-12963	objective	_	
77-19	12964-12970	events	_	
77-20	12971-12973	in	_	
77-21	12974-12977	the	_	
77-22	12978-12982	mind	_	
77-23	12982-12983	,	_	
77-24	12984-12986	as	_	
77-25	12987-12994	opposed	_	
77-26	12995-12997	to	_	
77-27	12998-13009	reflections	_	
77-28	13010-13012	of	_	
77-29	13013-13016	the	_	
77-30	13017-13021	self	_	
77-31	13022-13026	that	_	
77-32	13027-13030	are	_	
77-33	13031-13042	necessarily	_	
77-34	13043-13047	true	_	
77-35	13047-13048	”	_	
77-36	13049-13054	which	_	
77-37	13055-13057	is	_	
77-38	13058-13067	sometimes	_	
77-39	13068-13076	referred	_	
77-40	13077-13079	to	_	
77-41	13080-13082	as	_	
77-42	13083-13084	“	_	
77-43	13084-13095	decentering	_	
77-44	13095-13096	”	_	
77-45	13096-13097	.	_	

#Text=All participants performed a short mental noting session (~30 s) in front of the experimenter during which they verbalized the mental noting out loud to confirm that they could follow the instructions.
78-1	13098-13101	All	_	
78-2	13102-13114	participants	_	
78-3	13115-13124	performed	_	
78-4	13125-13126	a	_	
78-5	13127-13132	short	_	
78-6	13133-13139	mental	_	
78-7	13140-13146	noting	_	
78-8	13147-13154	session	_	
78-9	13155-13156	(	_	
78-10	13156-13157	~	_	
78-11	13157-13159	30	_	
78-12	13160-13161	s	_	
78-13	13161-13162	)	_	
78-14	13163-13165	in	_	
78-15	13166-13171	front	_	
78-16	13172-13174	of	_	
78-17	13175-13178	the	_	
78-18	13179-13191	experimenter	_	
78-19	13192-13198	during	_	
78-20	13199-13204	which	_	
78-21	13205-13209	they	_	
78-22	13210-13220	verbalized	_	
78-23	13221-13224	the	_	
78-24	13225-13231	mental	_	
78-25	13232-13238	noting	_	
78-26	13239-13242	out	_	
78-27	13243-13247	loud	_	
78-28	13248-13250	to	_	
78-29	13251-13258	confirm	_	
78-30	13259-13263	that	_	
78-31	13264-13268	they	_	
78-32	13269-13274	could	_	
78-33	13275-13281	follow	_	
78-34	13282-13285	the	_	
78-35	13286-13298	instructions	_	
78-36	13298-13299	.	_	

#Text=Next, they completed a short silent practice session (~30 s).
79-1	13300-13304	Next	_	
79-2	13304-13305	,	_	
79-3	13306-13310	they	_	
79-4	13311-13320	completed	_	
79-5	13321-13322	a	_	
79-6	13323-13328	short	_	
79-7	13329-13335	silent	_	
79-8	13336-13344	practice	_	
79-9	13345-13352	session	_	
79-10	13353-13354	(	_	
79-11	13354-13355	~	_	
79-12	13355-13357	30	_	
79-13	13358-13359	s	_	
79-14	13359-13360	)	_	
79-15	13360-13361	.	_	

#Text=All participants were able to engage in mental noting.
80-1	13362-13365	All	_	
80-2	13366-13378	participants	_	
80-3	13379-13383	were	_	
80-4	13384-13388	able	_	
80-5	13389-13391	to	_	
80-6	13392-13398	engage	_	
80-7	13399-13401	in	_	
80-8	13402-13408	mental	_	
80-9	13409-13415	noting	_	
80-10	13415-13416	.	_	

#Text=The exact instructions for the mental noting and the practice session are provided in Supplementary Text S1.
81-1	13417-13420	The	_	
81-2	13421-13426	exact	_	
81-3	13427-13439	instructions	_	
81-4	13440-13443	for	_	
81-5	13444-13447	the	_	
81-6	13448-13454	mental	_	
81-7	13455-13461	noting	_	
81-8	13462-13465	and	_	
81-9	13466-13469	the	_	
81-10	13470-13478	practice	_	
81-11	13479-13486	session	_	
81-12	13487-13490	are	_	
81-13	13491-13499	provided	_	
81-14	13500-13502	in	_	
81-15	13503-13516	Supplementary	_	
81-16	13517-13521	Text	_	
81-17	13522-13524	S1	_	
81-18	13524-13525	.	_	

#Text=During the rt-fMRI scans participants performed mental noting with their eyes open.
#Text=fMRI acquisition
#Text=Scanning parameters
#Text=All scans were acquired using a 3T Trio MR System with a 32-channel, phased-array head coil (Siemens Healthcare, Erlangen, Germany).
82-1	13526-13532	During	_	
82-2	13533-13536	the	_	
82-3	13537-13544	rt-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
82-4	13545-13550	scans	_	
82-5	13551-13563	participants	_	
82-6	13564-13573	performed	_	
82-7	13574-13580	mental	_	
82-8	13581-13587	noting	_	
82-9	13588-13592	with	_	
82-10	13593-13598	their	_	
82-11	13599-13603	eyes	_	
82-12	13604-13608	open	_	
82-13	13608-13609	.	_	
82-14	13610-13614	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
82-15	13615-13626	acquisition	_	
82-16	13627-13635	Scanning	_	
82-17	13636-13646	parameters	_	
82-18	13647-13650	All	_	
82-19	13651-13656	scans	_	
82-20	13657-13661	were	_	
82-21	13662-13670	acquired	_	
82-22	13671-13676	using	_	
82-23	13677-13678	a	_	
82-24	13679-13681	3T	_	
82-25	13682-13686	Trio	_	
82-26	13687-13689	MR	_	
82-27	13690-13696	System	_	
82-28	13697-13701	with	_	
82-29	13702-13703	a	_	
82-30	13704-13706	32	_	
82-31	13706-13707	-	_	
82-32	13707-13714	channel	_	
82-33	13714-13715	,	_	
82-34	13716-13728	phased-array	_	
82-35	13729-13733	head	_	
82-36	13734-13738	coil	_	
82-37	13739-13740	(	_	
82-38	13740-13747	Siemens	_	
82-39	13748-13758	Healthcare	_	
82-40	13758-13759	,	_	
82-41	13760-13768	Erlangen	_	
82-42	13768-13769	,	_	
82-43	13770-13777	Germany	_	
82-44	13777-13778	)	_	
82-45	13778-13779	.	_	

#Text=Structural scans were acquired using a three-dimensional T1-weighted MP-RAGE pulse sequence with a voxel resolution of 1 mm3, flip angle (FA) = 7°, echo time (TE) = 1.61 ms, inversion time (TI) = 1,200 ms, and repetition time (TR) = 2530 ms.
83-1	13780-13790	Structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging	
83-2	13791-13796	scans	_	
83-3	13797-13801	were	_	
83-4	13802-13810	acquired	_	
83-5	13811-13816	using	_	
83-6	13817-13818	a	_	
83-7	13819-13836	three-dimensional	_	
83-8	13837-13839	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[10]	
83-9	13839-13840	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[10]	
83-10	13840-13848	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[10]	
83-11	13849-13856	MP-RAGE	_	
83-12	13857-13862	pulse	_	
83-13	13863-13871	sequence	_	
83-14	13872-13876	with	_	
83-15	13877-13878	a	_	
83-16	13879-13884	voxel	_	
83-17	13885-13895	resolution	_	
83-18	13896-13898	of	_	
83-19	13899-13900	1	_	
83-20	13901-13904	mm3	_	
83-21	13904-13905	,	_	
83-22	13906-13910	flip	_	
83-23	13911-13916	angle	_	
83-24	13917-13918	(	_	
83-25	13918-13920	FA	_	
83-26	13920-13921	)	_	
83-27	13922-13923	=	_	
83-28	13924-13925	7	_	
83-29	13925-13926	°	_	
83-30	13926-13927	,	_	
83-31	13928-13932	echo	_	
83-32	13933-13937	time	_	
83-33	13938-13939	(	_	
83-34	13939-13941	TE	_	
83-35	13941-13942	)	_	
83-36	13943-13944	=	_	
83-37	13945-13949	1.61	_	
83-38	13950-13952	ms	_	
83-39	13952-13953	,	_	
83-40	13954-13963	inversion	_	
83-41	13964-13968	time	_	
83-42	13969-13970	(	_	
83-43	13970-13972	TI	_	
83-44	13972-13973	)	_	
83-45	13974-13975	=	_	
83-46	13976-13981	1,200	_	
83-47	13982-13984	ms	_	
83-48	13984-13985	,	_	
83-49	13986-13989	and	_	
83-50	13990-14000	repetition	_	
83-51	14001-14005	time	_	
83-52	14006-14007	(	_	
83-53	14007-14009	TR	_	
83-54	14009-14010	)	_	
83-55	14011-14012	=	_	
83-56	14013-14017	2530	_	
83-57	14018-14020	ms	_	
83-58	14020-14021	.	_	

#Text=For functional images, the BOLD signal was measured using a T2* weighted gradient-echo, echo-planar imaging (EPI) pulse sequence with prospective acquisition correction (PACE) for motion (Thesen et al., 2000) with imaging parameters: TR = 2 s, TE = 30 ms, FA = 90°, voxel size = 3.5 × 3.5 × 3.5 mm3, number of slices = 33, and slice gap = 10%.
84-1	14022-14025	For	_	
84-2	14026-14036	functional	_	
84-3	14037-14043	images	_	
84-4	14043-14044	,	_	
84-5	14045-14048	the	_	
84-6	14049-14053	BOLD	_	
84-7	14054-14060	signal	_	
84-8	14061-14064	was	_	
84-9	14065-14073	measured	_	
84-10	14074-14079	using	_	
84-11	14080-14081	a	_	
84-12	14082-14084	T2	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging[11]	
84-13	14084-14085	*	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging[11]	
84-14	14086-14094	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging[11]	
84-15	14095-14108	gradient-echo	_	
84-16	14108-14109	,	_	
84-17	14110-14121	echo-planar	_	
84-18	14122-14129	imaging	_	
84-19	14130-14131	(	_	
84-20	14131-14134	EPI	_	
84-21	14134-14135	)	_	
84-22	14136-14141	pulse	_	
84-23	14142-14150	sequence	_	
84-24	14151-14155	with	_	
84-25	14156-14167	prospective	_	
84-26	14168-14179	acquisition	_	
84-27	14180-14190	correction	_	
84-28	14191-14192	(	_	
84-29	14192-14196	PACE	_	
84-30	14196-14197	)	_	
84-31	14198-14201	for	_	
84-32	14202-14208	motion	_	
84-33	14209-14210	(	_	
84-34	14210-14216	Thesen	_	
84-35	14217-14219	et	_	
84-36	14220-14222	al	_	
84-37	14222-14223	.	_	
84-38	14223-14224	,	_	
84-39	14225-14229	2000	_	
84-40	14229-14230	)	_	
84-41	14231-14235	with	_	
84-42	14236-14243	imaging	_	
84-43	14244-14254	parameters	_	
84-44	14254-14255	:	_	
84-45	14256-14258	TR	_	
84-46	14259-14260	=	_	
84-47	14261-14262	2	_	
84-48	14263-14264	s	_	
84-49	14264-14265	,	_	
84-50	14266-14268	TE	_	
84-51	14269-14270	=	_	
84-52	14271-14273	30	_	
84-53	14274-14276	ms	_	
84-54	14276-14277	,	_	
84-55	14278-14280	FA	_	
84-56	14281-14282	=	_	
84-57	14283-14285	90	_	
84-58	14285-14286	°	_	
84-59	14286-14287	,	_	
84-60	14288-14293	voxel	_	
84-61	14294-14298	size	_	
84-62	14299-14300	=	_	
84-63	14301-14304	3.5	_	
84-64	14305-14306	×	_	
84-65	14307-14310	3.5	_	
84-66	14311-14312	×	_	
84-67	14313-14316	3.5	_	
84-68	14317-14320	mm3	_	
84-69	14320-14321	,	_	
84-70	14322-14328	number	_	
84-71	14329-14331	of	_	
84-72	14332-14338	slices	_	
84-73	14339-14340	=	_	
84-74	14341-14343	33	_	
84-75	14343-14344	,	_	
84-76	14345-14348	and	_	
84-77	14349-14354	slice	_	
84-78	14355-14358	gap	_	
84-79	14359-14360	=	_	
84-80	14361-14364	10%	_	
84-81	14364-14365	.	_	

#Text=Functional Localizer & ROI definitions
#Text=At the start of session one, a 6-min resting state scan (RS-pre) was acquired in order to extract the subject specific DMN, CEN & SMC networks (Figure 1B).
85-1	14366-14376	Functional	_	
85-2	14377-14386	Localizer	_	
85-3	14387-14388	&	_	
85-4	14389-14392	ROI	_	
85-5	14393-14404	definitions	_	
85-6	14405-14407	At	_	
85-7	14408-14411	the	_	
85-8	14412-14417	start	_	
85-9	14418-14420	of	_	
85-10	14421-14428	session	_	
85-11	14429-14432	one	_	
85-12	14432-14433	,	_	
85-13	14434-14435	a	_	
85-14	14436-14437	6	_	
85-15	14437-14438	-	_	
85-16	14438-14441	min	_	
85-17	14442-14449	resting	_	
85-18	14450-14455	state	_	
85-19	14456-14460	scan	_	
85-20	14461-14462	(	_	
85-21	14462-14468	RS-pre	_	
85-22	14468-14469	)	_	
85-23	14470-14473	was	_	
85-24	14474-14482	acquired	_	
85-25	14483-14485	in	_	
85-26	14486-14491	order	_	
85-27	14492-14494	to	_	
85-28	14495-14502	extract	_	
85-29	14503-14506	the	_	
85-30	14507-14514	subject	_	
85-31	14515-14523	specific	_	
85-32	14524-14527	DMN	_	
85-33	14527-14528	,	_	
85-34	14529-14532	CEN	_	
85-35	14533-14534	&	_	
85-36	14535-14538	SMC	_	
85-37	14539-14547	networks	_	
85-38	14548-14549	(	_	
85-39	14549-14555	Figure	_	
85-40	14556-14558	1B	_	
85-41	14558-14559	)	_	
85-42	14559-14560	.	_	

#Text=Resting state (RS) instructions were: “Keep your eyes open, relax, try not to move and try to stay awake.”
86-1	14561-14568	Resting	_	
86-2	14569-14574	state	_	
86-3	14575-14576	(	_	
86-4	14576-14578	RS	_	
86-5	14578-14579	)	_	
86-6	14580-14592	instructions	_	
86-7	14593-14597	were	_	
86-8	14597-14598	:	_	
86-9	14599-14600	“	_	
86-10	14600-14604	Keep	_	
86-11	14605-14609	your	_	
86-12	14610-14614	eyes	_	
86-13	14615-14619	open	_	
86-14	14619-14620	,	_	
86-15	14621-14626	relax	_	
86-16	14626-14627	,	_	
86-17	14628-14631	try	_	
86-18	14632-14635	not	_	
86-19	14636-14638	to	_	
86-20	14639-14643	move	_	
86-21	14644-14647	and	_	
86-22	14648-14651	try	_	
86-23	14652-14654	to	_	
86-24	14655-14659	stay	_	
86-25	14660-14665	awake	_	
86-26	14665-14666	.	_	
86-27	14666-14667	”	_	

#Text=During the acquisition of the T1 structural scan the RS-pre images were processed through a standard install of FSL build 5.08 and the following workflow: (1) Functional scans were corrected for head motion using MCFLIRT, (2) brain was extracted with Brain extraction tool (BET), (3) FLIRT was used to perform a boundary-based registration of each participant’s functional scan to MNI152 standard space with 6° of freedom affine registration (4), smoothed (6 mm FWHM), (5) low-pass filtered (0.09 Hz threshold) and high-pass filtered (.008 Hz threshold), (6) Independent Components Analysis (ICA) was performed on the preprocessed functional scans using Melodic ICA version 3.14 with dimensionality estimation using the Laplace approximation to the Bayesian evidence of the model; each of the ~30 spatiotemporal components were statistically compared to the spatial map of the DMN, CEN & SMC networks derived from resting-state of approximately 1000 participants using FSL’s “fslcc” tool to calculate Pearson’s r for each pairwise relationship and select the ICA components that, in each case, yielded the highest significant spatial correlation. (8) To obtain the masks for the feedback protocols we thresholded the obtained subject specific DMN, CEN & SMC network to yield the upper 10% and binarized them. (9) Manual inspection was performed to confirm that the obtained networks cover approximate DMN, CEN & SMC brain regions.
87-1	14668-14674	During	_	
87-2	14675-14678	the	_	
87-3	14679-14690	acquisition	_	
87-4	14691-14693	of	_	
87-5	14694-14697	the	_	
87-6	14698-14700	T1	_	
87-7	14701-14711	structural	_	
87-8	14712-14716	scan	_	
87-9	14717-14720	the	_	
87-10	14721-14727	RS-pre	_	
87-11	14728-14734	images	_	
87-12	14735-14739	were	_	
87-13	14740-14749	processed	_	
87-14	14750-14757	through	_	
87-15	14758-14759	a	_	
87-16	14760-14768	standard	_	
87-17	14769-14776	install	_	
87-18	14777-14779	of	_	
87-19	14780-14783	FSL	_	
87-20	14784-14789	build	_	
87-21	14790-14794	5.08	_	
87-22	14795-14798	and	_	
87-23	14799-14802	the	_	
87-24	14803-14812	following	_	
87-25	14813-14821	workflow	_	
87-26	14821-14822	:	_	
87-27	14823-14824	(	_	
87-28	14824-14825	1	_	
87-29	14825-14826	)	_	
87-30	14827-14837	Functional	_	
87-31	14838-14843	scans	_	
87-32	14844-14848	were	_	
87-33	14849-14858	corrected	_	
87-34	14859-14862	for	_	
87-35	14863-14867	head	_	
87-36	14868-14874	motion	_	
87-37	14875-14880	using	_	
87-38	14881-14888	MCFLIRT	_	
87-39	14888-14889	,	_	
87-40	14890-14891	(	_	
87-41	14891-14892	2	_	
87-42	14892-14893	)	_	
87-43	14894-14899	brain	_	
87-44	14900-14903	was	_	
87-45	14904-14913	extracted	_	
87-46	14914-14918	with	_	
87-47	14919-14924	Brain	_	
87-48	14925-14935	extraction	_	
87-49	14936-14940	tool	_	
87-50	14941-14942	(	_	
87-51	14942-14945	BET	_	
87-52	14945-14946	)	_	
87-53	14946-14947	,	_	
87-54	14948-14949	(	_	
87-55	14949-14950	3	_	
87-56	14950-14951	)	_	
87-57	14952-14957	FLIRT	_	
87-58	14958-14961	was	_	
87-59	14962-14966	used	_	
87-60	14967-14969	to	_	
87-61	14970-14977	perform	_	
87-62	14978-14979	a	_	
87-63	14980-14994	boundary-based	_	
87-64	14995-15007	registration	_	
87-65	15008-15010	of	_	
87-66	15011-15015	each	_	
87-67	15016-15027	participant	_	
87-68	15027-15028	’	_	
87-69	15028-15029	s	_	
87-70	15030-15040	functional	_	
87-71	15041-15045	scan	_	
87-72	15046-15048	to	_	
87-73	15049-15055	MNI152	_	
87-74	15056-15064	standard	_	
87-75	15065-15070	space	_	
87-76	15071-15075	with	_	
87-77	15076-15077	6	_	
87-78	15077-15078	°	_	
87-79	15079-15081	of	_	
87-80	15082-15089	freedom	_	
87-81	15090-15096	affine	_	
87-82	15097-15109	registration	_	
87-83	15110-15111	(	_	
87-84	15111-15112	4	_	
87-85	15112-15113	)	_	
87-86	15113-15114	,	_	
87-87	15115-15123	smoothed	_	
87-88	15124-15125	(	_	
87-89	15125-15126	6	_	
87-90	15127-15129	mm	_	
87-91	15130-15134	FWHM	_	
87-92	15134-15135	)	_	
87-93	15135-15136	,	_	
87-94	15137-15138	(	_	
87-95	15138-15139	5	_	
87-96	15139-15140	)	_	
87-97	15141-15149	low-pass	_	
87-98	15150-15158	filtered	_	
87-99	15159-15160	(	_	
87-100	15160-15164	0.09	_	
87-101	15165-15167	Hz	_	
87-102	15168-15177	threshold	_	
87-103	15177-15178	)	_	
87-104	15179-15182	and	_	
87-105	15183-15192	high-pass	_	
87-106	15193-15201	filtered	_	
87-107	15202-15203	(	_	
87-108	15203-15207	.008	_	
87-109	15208-15210	Hz	_	
87-110	15211-15220	threshold	_	
87-111	15220-15221	)	_	
87-112	15221-15222	,	_	
87-113	15223-15224	(	_	
87-114	15224-15225	6	_	
87-115	15225-15226	)	_	
87-116	15227-15238	Independent	_	
87-117	15239-15249	Components	_	
87-118	15250-15258	Analysis	_	
87-119	15259-15260	(	_	
87-120	15260-15263	ICA	_	
87-121	15263-15264	)	_	
87-122	15265-15268	was	_	
87-123	15269-15278	performed	_	
87-124	15279-15281	on	_	
87-125	15282-15285	the	_	
87-126	15286-15298	preprocessed	_	
87-127	15299-15309	functional	_	
87-128	15310-15315	scans	_	
87-129	15316-15321	using	_	
87-130	15322-15329	Melodic	_	
87-131	15330-15333	ICA	_	
87-132	15334-15341	version	_	
87-133	15342-15346	3.14	_	
87-134	15347-15351	with	_	
87-135	15352-15366	dimensionality	_	
87-136	15367-15377	estimation	_	
87-137	15378-15383	using	_	
87-138	15384-15387	the	_	
87-139	15388-15395	Laplace	_	
87-140	15396-15409	approximation	_	
87-141	15410-15412	to	_	
87-142	15413-15416	the	_	
87-143	15417-15425	Bayesian	_	
87-144	15426-15434	evidence	_	
87-145	15435-15437	of	_	
87-146	15438-15441	the	_	
87-147	15442-15447	model	_	
87-148	15447-15448	;	_	
87-149	15449-15453	each	_	
87-150	15454-15456	of	_	
87-151	15457-15460	the	_	
87-152	15461-15462	~	_	
87-153	15462-15464	30	_	
87-154	15465-15479	spatiotemporal	_	
87-155	15480-15490	components	_	
87-156	15491-15495	were	_	
87-157	15496-15509	statistically	_	
87-158	15510-15518	compared	_	
87-159	15519-15521	to	_	
87-160	15522-15525	the	_	
87-161	15526-15533	spatial	_	
87-162	15534-15537	map	_	
87-163	15538-15540	of	_	
87-164	15541-15544	the	_	
87-165	15545-15548	DMN	_	
87-166	15548-15549	,	_	
87-167	15550-15553	CEN	_	
87-168	15554-15555	&	_	
87-169	15556-15559	SMC	_	
87-170	15560-15568	networks	_	
87-171	15569-15576	derived	_	
87-172	15577-15581	from	_	
87-173	15582-15595	resting-state	_	
87-174	15596-15598	of	_	
87-175	15599-15612	approximately	_	
87-176	15613-15617	1000	_	
87-177	15618-15630	participants	_	
87-178	15631-15636	using	_	
87-179	15637-15640	FSL	_	
87-180	15640-15641	’	_	
87-181	15641-15642	s	_	
87-182	15643-15644	“	_	
87-183	15644-15649	fslcc	_	
87-184	15649-15650	”	_	
87-185	15651-15655	tool	_	
87-186	15656-15658	to	_	
87-187	15659-15668	calculate	_	
87-188	15669-15676	Pearson	_	
87-189	15676-15677	’	_	
87-190	15677-15678	s	_	
87-191	15679-15680	r	_	
87-192	15681-15684	for	_	
87-193	15685-15689	each	_	
87-194	15690-15698	pairwise	_	
87-195	15699-15711	relationship	_	
87-196	15712-15715	and	_	
87-197	15716-15722	select	_	
87-198	15723-15726	the	_	
87-199	15727-15730	ICA	_	
87-200	15731-15741	components	_	
87-201	15742-15746	that	_	
87-202	15746-15747	,	_	
87-203	15748-15750	in	_	
87-204	15751-15755	each	_	
87-205	15756-15760	case	_	
87-206	15760-15761	,	_	
87-207	15762-15769	yielded	_	
87-208	15770-15773	the	_	
87-209	15774-15781	highest	_	
87-210	15782-15793	significant	_	
87-211	15794-15801	spatial	_	
87-212	15802-15813	correlation	_	
87-213	15813-15814	.	_	
87-214	15815-15816	(	_	
87-215	15816-15817	8	_	
87-216	15817-15818	)	_	
87-217	15819-15821	To	_	
87-218	15822-15828	obtain	_	
87-219	15829-15832	the	_	
87-220	15833-15838	masks	_	
87-221	15839-15842	for	_	
87-222	15843-15846	the	_	
87-223	15847-15855	feedback	_	
87-224	15856-15865	protocols	_	
87-225	15866-15868	we	_	
87-226	15869-15880	thresholded	_	
87-227	15881-15884	the	_	
87-228	15885-15893	obtained	_	
87-229	15894-15901	subject	_	
87-230	15902-15910	specific	_	
87-231	15911-15914	DMN	_	
87-232	15914-15915	,	_	
87-233	15916-15919	CEN	_	
87-234	15920-15921	&	_	
87-235	15922-15925	SMC	_	
87-236	15926-15933	network	_	
87-237	15934-15936	to	_	
87-238	15937-15942	yield	_	
87-239	15943-15946	the	_	
87-240	15947-15952	upper	_	
87-241	15953-15956	10%	_	
87-242	15957-15960	and	_	
87-243	15961-15970	binarized	_	
87-244	15971-15975	them	_	
87-245	15975-15976	.	_	
87-246	15977-15978	(	_	
87-247	15978-15979	9	_	
87-248	15979-15980	)	_	
87-249	15981-15987	Manual	_	
87-250	15988-15998	inspection	_	
87-251	15999-16002	was	_	
87-252	16003-16012	performed	_	
87-253	16013-16015	to	_	
87-254	16016-16023	confirm	_	
87-255	16024-16028	that	_	
87-256	16029-16032	the	_	
87-257	16033-16041	obtained	_	
87-258	16042-16050	networks	_	
87-259	16051-16056	cover	_	
87-260	16057-16068	approximate	_	
87-261	16069-16072	DMN	_	
87-262	16072-16073	,	_	
87-263	16074-16077	CEN	_	
87-264	16078-16079	&	_	
87-265	16080-16083	SMC	_	
87-266	16084-16089	brain	_	
87-267	16090-16097	regions	_	
87-268	16097-16098	.	_	

#Text=DMN Feedback Scans
#Text=There were six runs in this task, with the first and sixth run having no feedback and serving as transfer tasks (TT-pre & TT-post), while runs 2-5 provided real-time feedback to the participants by means of a Positive Diametric Activity (PDA) metric.This PDA metric is based on the hypothesis that there is a causal neural mechanism by which the CEN negatively regulates the DMN.
88-1	16099-16102	DMN	_	
88-2	16103-16111	Feedback	_	
88-3	16112-16117	Scans	_	
88-4	16118-16123	There	_	
88-5	16124-16128	were	_	
88-6	16129-16132	six	_	
88-7	16133-16137	runs	_	
88-8	16138-16140	in	_	
88-9	16141-16145	this	_	
88-10	16146-16150	task	_	
88-11	16150-16151	,	_	
88-12	16152-16156	with	_	
88-13	16157-16160	the	_	
88-14	16161-16166	first	_	
88-15	16167-16170	and	_	
88-16	16171-16176	sixth	_	
88-17	16177-16180	run	_	
88-18	16181-16187	having	_	
88-19	16188-16190	no	_	
88-20	16191-16199	feedback	_	
88-21	16200-16203	and	_	
88-22	16204-16211	serving	_	
88-23	16212-16214	as	_	
88-24	16215-16223	transfer	_	
88-25	16224-16229	tasks	_	
88-26	16230-16231	(	_	
88-27	16231-16237	TT-pre	_	
88-28	16238-16239	&	_	
88-29	16240-16247	TT-post	_	
88-30	16247-16248	)	_	
88-31	16248-16249	,	_	
88-32	16250-16255	while	_	
88-33	16256-16260	runs	_	
88-34	16261-16262	2	_	
88-35	16262-16263	-	_	
88-36	16263-16264	5	_	
88-37	16265-16273	provided	_	
88-38	16274-16283	real-time	_	
88-39	16284-16292	feedback	_	
88-40	16293-16295	to	_	
88-41	16296-16299	the	_	
88-42	16300-16312	participants	_	
88-43	16313-16315	by	_	
88-44	16316-16321	means	_	
88-45	16322-16324	of	_	
88-46	16325-16326	a	_	
88-47	16327-16335	Positive	_	
88-48	16336-16345	Diametric	_	
88-49	16346-16354	Activity	_	
88-50	16355-16356	(	_	
88-51	16356-16359	PDA	_	
88-52	16359-16360	)	_	
88-53	16361-16372	metric.This	_	
88-54	16373-16376	PDA	_	
88-55	16377-16383	metric	_	
88-56	16384-16386	is	_	
88-57	16387-16392	based	_	
88-58	16393-16395	on	_	
88-59	16396-16399	the	_	
88-60	16400-16410	hypothesis	_	
88-61	16411-16415	that	_	
88-62	16416-16421	there	_	
88-63	16422-16424	is	_	
88-64	16425-16426	a	_	
88-65	16427-16433	causal	_	
88-66	16434-16440	neural	_	
88-67	16441-16450	mechanism	_	
88-68	16451-16453	by	_	
88-69	16454-16459	which	_	
88-70	16460-16463	the	_	
88-71	16464-16467	CEN	_	
88-72	16468-16478	negatively	_	
88-73	16479-16488	regulates	_	
88-74	16489-16492	the	_	
88-75	16493-16496	DMN	_	
88-76	16496-16497	.	_	

#Text=Accordingly, we defined the PDA as follows: 
#Text=Each run lasted 2.5 min, while BOLD fluctuations were measured using rtfMRI analysis as described in.
89-1	16498-16509	Accordingly	_	
89-2	16509-16510	,	_	
89-3	16511-16513	we	_	
89-4	16514-16521	defined	_	
89-5	16522-16525	the	_	
89-6	16526-16529	PDA	_	
89-7	16530-16532	as	_	
89-8	16533-16540	follows	_	
89-9	16540-16541	:	_	
89-10	16543-16547	Each	_	
89-11	16548-16551	run	_	
89-12	16552-16558	lasted	_	
89-13	16559-16562	2.5	_	
89-14	16563-16566	min	_	
89-15	16566-16567	,	_	
89-16	16568-16573	while	_	
89-17	16574-16578	BOLD	_	
89-18	16579-16591	fluctuations	_	
89-19	16592-16596	were	_	
89-20	16597-16605	measured	_	
89-21	16606-16611	using	_	
89-22	16612-16618	rtfMRI	_	
89-23	16619-16627	analysis	_	
89-24	16628-16630	as	_	
89-25	16631-16640	described	_	
89-26	16641-16643	in	_	
89-27	16643-16644	.	_	

#Text=During triggering, functional runs of incoming images from the scanner were analyzed in real-time to estimate mean activation levels in DMN & CEN from the subject specific regions of interest (ROIs) obtained from RS-pre ICA network extraction protocol (see Functional Localizer & ROI definitions).
90-1	16645-16651	During	_	
90-2	16652-16662	triggering	_	
90-3	16662-16663	,	_	
90-4	16664-16674	functional	_	
90-5	16675-16679	runs	_	
90-6	16680-16682	of	_	
90-7	16683-16691	incoming	_	
90-8	16692-16698	images	_	
90-9	16699-16703	from	_	
90-10	16704-16707	the	_	
90-11	16708-16715	scanner	_	
90-12	16716-16720	were	_	
90-13	16721-16729	analyzed	_	
90-14	16730-16732	in	_	
90-15	16733-16742	real-time	_	
90-16	16743-16745	to	_	
90-17	16746-16754	estimate	_	
90-18	16755-16759	mean	_	
90-19	16760-16770	activation	_	
90-20	16771-16777	levels	_	
90-21	16778-16780	in	_	
90-22	16781-16784	DMN	_	
90-23	16785-16786	&	_	
90-24	16787-16790	CEN	_	
90-25	16791-16795	from	_	
90-26	16796-16799	the	_	
90-27	16800-16807	subject	_	
90-28	16808-16816	specific	_	
90-29	16817-16824	regions	_	
90-30	16825-16827	of	_	
90-31	16828-16836	interest	_	
90-32	16837-16838	(	_	
90-33	16838-16842	ROIs	_	
90-34	16842-16843	)	_	
90-35	16844-16852	obtained	_	
90-36	16853-16857	from	_	
90-37	16858-16864	RS-pre	_	
90-38	16865-16868	ICA	_	
90-39	16869-16876	network	_	
90-40	16877-16887	extraction	_	
90-41	16888-16896	protocol	_	
90-42	16897-16898	(	_	
90-43	16898-16901	see	_	
90-44	16902-16912	Functional	_	
90-45	16913-16922	Localizer	_	
90-46	16923-16924	&	_	
90-47	16925-16928	ROI	_	
90-48	16929-16940	definitions	_	
90-49	16940-16941	)	_	
90-50	16941-16942	.	_	

#Text=To accomplish the estimation, a voxel-wise incremental general linear model (GLM) fit was performed where the design matrix included a 30 sec baseline and a 120 sec active block to account for the mean voxel signal and linear trends.
91-1	16943-16945	To	_	
91-2	16946-16956	accomplish	_	
91-3	16957-16960	the	_	
91-4	16961-16971	estimation	_	
91-5	16971-16972	,	_	
91-6	16973-16974	a	_	
91-7	16975-16985	voxel-wise	_	
91-8	16986-16997	incremental	_	
91-9	16998-17005	general	_	
91-10	17006-17012	linear	_	
91-11	17013-17018	model	_	
91-12	17019-17020	(	_	
91-13	17020-17023	GLM	_	
91-14	17023-17024	)	_	
91-15	17025-17028	fit	_	
91-16	17029-17032	was	_	
91-17	17033-17042	performed	_	
91-18	17043-17048	where	_	
91-19	17049-17052	the	_	
91-20	17053-17059	design	_	
91-21	17060-17066	matrix	_	
91-22	17067-17075	included	_	
91-23	17076-17077	a	_	
91-24	17078-17080	30	_	
91-25	17081-17084	sec	_	
91-26	17085-17093	baseline	_	
91-27	17094-17097	and	_	
91-28	17098-17099	a	_	
91-29	17100-17103	120	_	
91-30	17104-17107	sec	_	
91-31	17108-17114	active	_	
91-32	17115-17120	block	_	
91-33	17121-17123	to	_	
91-34	17124-17131	account	_	
91-35	17132-17135	for	_	
91-36	17136-17139	the	_	
91-37	17140-17144	mean	_	
91-38	17145-17150	voxel	_	
91-39	17151-17157	signal	_	
91-40	17158-17161	and	_	
91-41	17162-17168	linear	_	
91-42	17169-17175	trends	_	
91-43	17175-17176	.	_	

#Text=To discount components of the voxel signal due to nuisance sources (e.g., low-frequency signal drifts), the GLM reconstruction of the expected voxel intensity at time t was subtracted from the measured voxel intensity at time t, leaving a residual signal that has components due to two sources: BOLD signal fluctuations and unmodeled fMRI noise.
92-1	17177-17179	To	_	
92-2	17180-17188	discount	_	
92-3	17189-17199	components	_	
92-4	17200-17202	of	_	
92-5	17203-17206	the	_	
92-6	17207-17212	voxel	_	
92-7	17213-17219	signal	_	
92-8	17220-17223	due	_	
92-9	17224-17226	to	_	
92-10	17227-17235	nuisance	_	
92-11	17236-17243	sources	_	
92-12	17244-17245	(	_	
92-13	17245-17248	e.g	_	
92-14	17248-17249	.	_	
92-15	17249-17250	,	_	
92-16	17251-17264	low-frequency	_	
92-17	17265-17271	signal	_	
92-18	17272-17278	drifts	_	
92-19	17278-17279	)	_	
92-20	17279-17280	,	_	
92-21	17281-17284	the	_	
92-22	17285-17288	GLM	_	
92-23	17289-17303	reconstruction	_	
92-24	17304-17306	of	_	
92-25	17307-17310	the	_	
92-26	17311-17319	expected	_	
92-27	17320-17325	voxel	_	
92-28	17326-17335	intensity	_	
92-29	17336-17338	at	_	
92-30	17339-17343	time	_	
92-31	17344-17345	t	_	
92-32	17346-17349	was	_	
92-33	17350-17360	subtracted	_	
92-34	17361-17365	from	_	
92-35	17366-17369	the	_	
92-36	17370-17378	measured	_	
92-37	17379-17384	voxel	_	
92-38	17385-17394	intensity	_	
92-39	17395-17397	at	_	
92-40	17398-17402	time	_	
92-41	17403-17404	t	_	
92-42	17404-17405	,	_	
92-43	17406-17413	leaving	_	
92-44	17414-17415	a	_	
92-45	17416-17424	residual	_	
92-46	17425-17431	signal	_	
92-47	17432-17436	that	_	
92-48	17437-17440	has	_	
92-49	17441-17451	components	_	
92-50	17452-17455	due	_	
92-51	17456-17458	to	_	
92-52	17459-17462	two	_	
92-53	17463-17470	sources	_	
92-54	17470-17471	:	_	
92-55	17472-17476	BOLD	_	
92-56	17477-17483	signal	_	
92-57	17484-17496	fluctuations	_	
92-58	17497-17500	and	_	
92-59	17501-17510	unmodeled	_	
92-60	17511-17515	fMRI	_	
92-61	17516-17521	noise	_	
92-62	17521-17522	.	_	

#Text=This residual is scaled by an estimate of voxel reliability, which is computed as the average GLM residual over the first 15 functional images of the baseline.
93-1	17523-17527	This	_	
93-2	17528-17536	residual	_	
93-3	17537-17539	is	_	
93-4	17540-17546	scaled	_	
93-5	17547-17549	by	_	
93-6	17550-17552	an	_	
93-7	17553-17561	estimate	_	
93-8	17562-17564	of	_	
93-9	17565-17570	voxel	_	
93-10	17571-17582	reliability	_	
93-11	17582-17583	,	_	
93-12	17584-17589	which	_	
93-13	17590-17592	is	_	
93-14	17593-17601	computed	_	
93-15	17602-17604	as	_	
93-16	17605-17608	the	_	
93-17	17609-17616	average	_	
93-18	17617-17620	GLM	_	
93-19	17621-17629	residual	_	
93-20	17630-17634	over	_	
93-21	17635-17638	the	_	
93-22	17639-17644	first	_	
93-23	17645-17647	15	_	
93-24	17648-17658	functional	_	
93-25	17659-17665	images	_	
93-26	17666-17668	of	_	
93-27	17669-17672	the	_	
93-28	17673-17681	baseline	_	
93-29	17681-17682	.	_	

#Text=This analysis results in an estimate of the strength of activation at each voxel at time t in units of standard deviation (SD).
94-1	17683-17687	This	_	
94-2	17688-17696	analysis	_	
94-3	17697-17704	results	_	
94-4	17705-17707	in	_	
94-5	17708-17710	an	_	
94-6	17711-17719	estimate	_	
94-7	17720-17722	of	_	
94-8	17723-17726	the	_	
94-9	17727-17735	strength	_	
94-10	17736-17738	of	_	
94-11	17739-17749	activation	_	
94-12	17750-17752	at	_	
94-13	17753-17757	each	_	
94-14	17758-17763	voxel	_	
94-15	17764-17766	at	_	
94-16	17767-17771	time	_	
94-17	17772-17773	t	_	
94-18	17774-17776	in	_	
94-19	17777-17782	units	_	
94-20	17783-17785	of	_	
94-21	17786-17794	standard	_	
94-22	17795-17804	deviation	_	
94-23	17805-17806	(	_	
94-24	17806-17808	SD	_	
94-25	17808-17809	)	_	
94-26	17809-17810	.	_	

#Text=Activations in DMN & CEN ROIs were computed as the median SD of the voxels in each ROI.
95-1	17811-17822	Activations	_	
95-2	17823-17825	in	_	
95-3	17826-17829	DMN	_	
95-4	17830-17831	&	_	
95-5	17832-17835	CEN	_	
95-6	17836-17840	ROIs	_	
95-7	17841-17845	were	_	
95-8	17846-17854	computed	_	
95-9	17855-17857	as	_	
95-10	17858-17861	the	_	
95-11	17862-17868	median	_	
95-12	17869-17871	SD	_	
95-13	17872-17874	of	_	
95-14	17875-17878	the	_	
95-15	17879-17885	voxels	_	
95-16	17886-17888	in	_	
95-17	17889-17893	each	_	
95-18	17894-17897	ROI	_	
95-19	17897-17898	.	_	

#Text=The participants were provided with a visual feedback of these activation changes in real time.
96-1	17899-17902	The	_	
96-2	17903-17915	participants	_	
96-3	17916-17920	were	_	
96-4	17921-17929	provided	_	
96-5	17930-17934	with	_	
96-6	17935-17936	a	_	
96-7	17937-17943	visual	_	
96-8	17944-17952	feedback	_	
96-9	17953-17955	of	_	
96-10	17956-17961	these	_	
96-11	17962-17972	activation	_	
96-12	17973-17980	changes	_	
96-13	17981-17983	in	_	
96-14	17984-17988	real	_	
96-15	17989-17993	time	_	
96-16	17993-17994	.	_	

#Text=The visual feedback consisted of a rectangle with one centrally displayed white dot and two circles: a red circle located above and a blue circle located below the white central dot.
97-1	17995-17998	The	_	
97-2	17999-18005	visual	_	
97-3	18006-18014	feedback	_	
97-4	18015-18024	consisted	_	
97-5	18025-18027	of	_	
97-6	18028-18029	a	_	
97-7	18030-18039	rectangle	_	
97-8	18040-18044	with	_	
97-9	18045-18048	one	_	
97-10	18049-18058	centrally	_	
97-11	18059-18068	displayed	_	
97-12	18069-18074	white	_	
97-13	18075-18078	dot	_	
97-14	18079-18082	and	_	
97-15	18083-18086	two	_	
97-16	18087-18094	circles	_	
97-17	18094-18095	:	_	
97-18	18096-18097	a	_	
97-19	18098-18101	red	_	
97-20	18102-18108	circle	_	
97-21	18109-18116	located	_	
97-22	18117-18122	above	_	
97-23	18123-18126	and	_	
97-24	18127-18128	a	_	
97-25	18129-18133	blue	_	
97-26	18134-18140	circle	_	
97-27	18141-18148	located	_	
97-28	18149-18154	below	_	
97-29	18155-18158	the	_	
97-30	18159-18164	white	_	
97-31	18165-18172	central	_	
97-32	18173-18176	dot	_	
97-33	18176-18177	.	_	

#Text=The central white dot tracked the increase or decrease of PDA (see above) by moving upwards, i.e., in the direction of a red circle for increased PDA, and downward, i.e., in the direction of the blue circle for decreased PDA.
98-1	18178-18181	The	_	
98-2	18182-18189	central	_	
98-3	18190-18195	white	_	
98-4	18196-18199	dot	_	
98-5	18200-18207	tracked	_	
98-6	18208-18211	the	_	
98-7	18212-18220	increase	_	
98-8	18221-18223	or	_	
98-9	18224-18232	decrease	_	
98-10	18233-18235	of	_	
98-11	18236-18239	PDA	_	
98-12	18240-18241	(	_	
98-13	18241-18244	see	_	
98-14	18245-18250	above	_	
98-15	18250-18251	)	_	
98-16	18252-18254	by	_	
98-17	18255-18261	moving	_	
98-18	18262-18269	upwards	_	
98-19	18269-18270	,	_	
98-20	18271-18274	i.e	_	
98-21	18274-18275	.	_	
98-22	18275-18276	,	_	
98-23	18277-18279	in	_	
98-24	18280-18283	the	_	
98-25	18284-18293	direction	_	
98-26	18294-18296	of	_	
98-27	18297-18298	a	_	
98-28	18299-18302	red	_	
98-29	18303-18309	circle	_	
98-30	18310-18313	for	_	
98-31	18314-18323	increased	_	
98-32	18324-18327	PDA	_	
98-33	18327-18328	,	_	
98-34	18329-18332	and	_	
98-35	18333-18341	downward	_	
98-36	18341-18342	,	_	
98-37	18343-18346	i.e	_	
98-38	18346-18347	.	_	
98-39	18347-18348	,	_	
98-40	18349-18351	in	_	
98-41	18352-18355	the	_	
98-42	18356-18365	direction	_	
98-43	18366-18368	of	_	
98-44	18369-18372	the	_	
98-45	18373-18377	blue	_	
98-46	18378-18384	circle	_	
98-47	18385-18388	for	_	
98-48	18389-18398	decreased	_	
98-49	18399-18402	PDA	_	
98-50	18402-18403	.	_	

#Text=The hop size of the ball movement was proportional to the magnitude of PDA value.
99-1	18404-18407	The	_	
99-2	18408-18411	hop	_	
99-3	18412-18416	size	_	
99-4	18417-18419	of	_	
99-5	18420-18423	the	_	
99-6	18424-18428	ball	_	
99-7	18429-18437	movement	_	
99-8	18438-18441	was	_	
99-9	18442-18454	proportional	_	
99-10	18455-18457	to	_	
99-11	18458-18461	the	_	
99-12	18462-18471	magnitude	_	
99-13	18472-18474	of	_	
99-14	18475-18478	PDA	_	
99-15	18479-18484	value	_	
99-16	18484-18485	.	_	

#Text=To accomplish this visual feedback, a signal was sent to the stimulus computer via a TCP/IP connection, where the stimulus program coded in PsychoPy received this signal and moved the central white dot in the direction corresponding to what PDA indicated.
100-1	18486-18488	To	_	
100-2	18489-18499	accomplish	_	
100-3	18500-18504	this	_	
100-4	18505-18511	visual	_	
100-5	18512-18520	feedback	_	
100-6	18520-18521	,	_	
100-7	18522-18523	a	_	
100-8	18524-18530	signal	_	
100-9	18531-18534	was	_	
100-10	18535-18539	sent	_	
100-11	18540-18542	to	_	
100-12	18543-18546	the	_	
100-13	18547-18555	stimulus	_	
100-14	18556-18564	computer	_	
100-15	18565-18568	via	_	
100-16	18569-18570	a	_	
100-17	18571-18574	TCP	_	
100-18	18574-18575	/	_	
100-19	18575-18577	IP	_	
100-20	18578-18588	connection	_	
100-21	18588-18589	,	_	
100-22	18590-18595	where	_	
100-23	18596-18599	the	_	
100-24	18600-18608	stimulus	_	
100-25	18609-18616	program	_	
100-26	18617-18622	coded	_	
100-27	18623-18625	in	_	
100-28	18626-18634	PsychoPy	_	
100-29	18635-18643	received	_	
100-30	18644-18648	this	_	
100-31	18649-18655	signal	_	
100-32	18656-18659	and	_	
100-33	18660-18665	moved	_	
100-34	18666-18669	the	_	
100-35	18670-18677	central	_	
100-36	18678-18683	white	_	
100-37	18684-18687	dot	_	
100-38	18688-18690	in	_	
100-39	18691-18694	the	_	
100-40	18695-18704	direction	_	
100-41	18705-18718	corresponding	_	
100-42	18719-18721	to	_	
100-43	18722-18726	what	_	
100-44	18727-18730	PDA	_	
100-45	18731-18740	indicated	_	
100-46	18740-18741	.	_	

#Text=The time delay between collection of a complete EPI volume and a trial trigger was 0.5 s.
101-1	18742-18745	The	_	
101-2	18746-18750	time	_	
101-3	18751-18756	delay	_	
101-4	18757-18764	between	_	
101-5	18765-18775	collection	_	
101-6	18776-18778	of	_	
101-7	18779-18780	a	_	
101-8	18781-18789	complete	_	
101-9	18790-18793	EPI	_	
101-10	18794-18800	volume	_	
101-11	18801-18804	and	_	
101-12	18805-18806	a	_	
101-13	18807-18812	trial	_	
101-14	18813-18820	trigger	_	
101-15	18821-18824	was	_	
101-16	18825-18828	0.5	_	
101-17	18829-18830	s	_	
101-18	18830-18831	.	_	

#Text=A schematic depicting the brain state monitoring and the feedback process is shown in Figure 1.
102-1	18832-18833	A	_	
102-2	18834-18843	schematic	_	
102-3	18844-18853	depicting	_	
102-4	18854-18857	the	_	
102-5	18858-18863	brain	_	
102-6	18864-18869	state	_	
102-7	18870-18880	monitoring	_	
102-8	18881-18884	and	_	
102-9	18885-18888	the	_	
102-10	18889-18897	feedback	_	
102-11	18898-18905	process	_	
102-12	18906-18908	is	_	
102-13	18909-18914	shown	_	
102-14	18915-18917	in	_	
102-15	18918-18924	Figure	_	
102-16	18925-18926	1	_	
102-17	18926-18927	.	_	

#Text=Participants were instructed that upward movement of the dot (indicating an increase in PDA) was associated with effective mental noting performance and downward movement (indicating a decrease in PDA) with ineffective mental noting such as self-related processing and mind-wandering.
103-1	18928-18940	Participants	_	
103-2	18941-18945	were	_	
103-3	18946-18956	instructed	_	
103-4	18957-18961	that	_	
103-5	18962-18968	upward	_	
103-6	18969-18977	movement	_	
103-7	18978-18980	of	_	
103-8	18981-18984	the	_	
103-9	18985-18988	dot	_	
103-10	18989-18990	(	_	
103-11	18990-19000	indicating	_	
103-12	19001-19003	an	_	
103-13	19004-19012	increase	_	
103-14	19013-19015	in	_	
103-15	19016-19019	PDA	_	
103-16	19019-19020	)	_	
103-17	19021-19024	was	_	
103-18	19025-19035	associated	_	
103-19	19036-19040	with	_	
103-20	19041-19050	effective	_	
103-21	19051-19057	mental	_	
103-22	19058-19064	noting	_	
103-23	19065-19076	performance	_	
103-24	19077-19080	and	_	
103-25	19081-19089	downward	_	
103-26	19090-19098	movement	_	
103-27	19099-19100	(	_	
103-28	19100-19110	indicating	_	
103-29	19111-19112	a	_	
103-30	19113-19121	decrease	_	
103-31	19122-19124	in	_	
103-32	19125-19128	PDA	_	
103-33	19128-19129	)	_	
103-34	19130-19134	with	_	
103-35	19135-19146	ineffective	_	
103-36	19147-19153	mental	_	
103-37	19154-19160	noting	_	
103-38	19161-19165	such	_	
103-39	19166-19168	as	_	
103-40	19169-19181	self-related	_	
103-41	19182-19192	processing	_	
103-42	19193-19196	and	_	
103-43	19197-19211	mind-wandering	_	
103-44	19211-19212	.	_	

#Text=This instruction was provided so that participants could anchor their subjective experience of engaging in mental noting to the observed PDA level.
104-1	19213-19217	This	_	
104-2	19218-19229	instruction	_	
104-3	19230-19233	was	_	
104-4	19234-19242	provided	_	
104-5	19243-19245	so	_	
104-6	19246-19250	that	_	
104-7	19251-19263	participants	_	
104-8	19264-19269	could	_	
104-9	19270-19276	anchor	_	
104-10	19277-19282	their	_	
104-11	19283-19293	subjective	_	
104-12	19294-19304	experience	_	
104-13	19305-19307	of	_	
104-14	19308-19316	engaging	_	
104-15	19317-19319	in	_	
104-16	19320-19326	mental	_	
104-17	19327-19333	noting	_	
104-18	19334-19336	to	_	
104-19	19337-19340	the	_	
104-20	19341-19349	observed	_	
104-21	19350-19353	PDA	_	
104-22	19354-19359	level	_	
104-23	19359-19360	.	_	

#Text=Participants were instructed to try to move the white dot into the upper-red circle by performing the mental noting.
105-1	19361-19373	Participants	_	
105-2	19374-19378	were	_	
105-3	19379-19389	instructed	_	
105-4	19390-19392	to	_	
105-5	19393-19396	try	_	
105-6	19397-19399	to	_	
105-7	19400-19404	move	_	
105-8	19405-19408	the	_	
105-9	19409-19414	white	_	
105-10	19415-19418	dot	_	
105-11	19419-19423	into	_	
105-12	19424-19427	the	_	
105-13	19428-19437	upper-red	_	
105-14	19438-19444	circle	_	
105-15	19445-19447	by	_	
105-16	19448-19458	performing	_	
105-17	19459-19462	the	_	
105-18	19463-19469	mental	_	
105-19	19470-19476	noting	_	
105-20	19476-19477	.	_	

#Text=Control Feedback Task
#Text=The control feedback task was conducted at least 12 weeks after the neurofeedback study.
106-1	19478-19485	Control	_	
106-2	19486-19494	Feedback	_	
106-3	19495-19499	Task	_	
106-4	19500-19503	The	_	
106-5	19504-19511	control	_	
106-6	19512-19520	feedback	_	
106-7	19521-19525	task	_	
106-8	19526-19529	was	_	
106-9	19530-19539	conducted	_	
106-10	19540-19542	at	_	
106-11	19543-19548	least	_	
106-12	19549-19551	12	_	
106-13	19552-19557	weeks	_	
106-14	19558-19563	after	_	
106-15	19564-19567	the	_	
106-16	19568-19581	neurofeedback	_	
106-17	19582-19587	study	_	
106-18	19587-19588	.	_	

#Text=This task comprised six runs, with the first and sixth run having no feedback and serving as transfer tasks (TT-pre & TT-post), while runs 2-5 provided real-time neurofeedback to the participants by means of a Control Positive Diametric Activity (C-PDA) metric.
107-1	19589-19593	This	_	
107-2	19594-19598	task	_	
107-3	19599-19608	comprised	_	
107-4	19609-19612	six	_	
107-5	19613-19617	runs	_	
107-6	19617-19618	,	_	
107-7	19619-19623	with	_	
107-8	19624-19627	the	_	
107-9	19628-19633	first	_	
107-10	19634-19637	and	_	
107-11	19638-19643	sixth	_	
107-12	19644-19647	run	_	
107-13	19648-19654	having	_	
107-14	19655-19657	no	_	
107-15	19658-19666	feedback	_	
107-16	19667-19670	and	_	
107-17	19671-19678	serving	_	
107-18	19679-19681	as	_	
107-19	19682-19690	transfer	_	
107-20	19691-19696	tasks	_	
107-21	19697-19698	(	_	
107-22	19698-19704	TT-pre	_	
107-23	19705-19706	&	_	
107-24	19707-19714	TT-post	_	
107-25	19714-19715	)	_	
107-26	19715-19716	,	_	
107-27	19717-19722	while	_	
107-28	19723-19727	runs	_	
107-29	19728-19729	2	_	
107-30	19729-19730	-	_	
107-31	19730-19731	5	_	
107-32	19732-19740	provided	_	
107-33	19741-19750	real-time	_	
107-34	19751-19764	neurofeedback	_	
107-35	19765-19767	to	_	
107-36	19768-19771	the	_	
107-37	19772-19784	participants	_	
107-38	19785-19787	by	_	
107-39	19788-19793	means	_	
107-40	19794-19796	of	_	
107-41	19797-19798	a	_	
107-42	19799-19806	Control	_	
107-43	19807-19815	Positive	_	
107-44	19816-19825	Diametric	_	
107-45	19826-19834	Activity	_	
107-46	19835-19836	(	_	
107-47	19836-19841	C-PDA	_	
107-48	19841-19842	)	_	
107-49	19843-19849	metric	_	
107-50	19849-19850	.	_	

#Text=This C-PDA metric compared the right and left SMC (rSMC & lSMC respectively) activity in order to provide feedback for the tapping of fingers in either the right or left hand.
108-1	19851-19855	This	_	
108-2	19856-19861	C-PDA	_	
108-3	19862-19868	metric	_	
108-4	19869-19877	compared	_	
108-5	19878-19881	the	_	
108-6	19882-19887	right	_	
108-7	19888-19891	and	_	
108-8	19892-19896	left	_	
108-9	19897-19900	SMC	_	
108-10	19901-19902	(	_	
108-11	19902-19906	rSMC	_	
108-12	19907-19908	&	_	
108-13	19909-19913	lSMC	_	
108-14	19914-19926	respectively	_	
108-15	19926-19927	)	_	
108-16	19928-19936	activity	_	
108-17	19937-19939	in	_	
108-18	19940-19945	order	_	
108-19	19946-19948	to	_	
108-20	19949-19956	provide	_	
108-21	19957-19965	feedback	_	
108-22	19966-19969	for	_	
108-23	19970-19973	the	_	
108-24	19974-19981	tapping	_	
108-25	19982-19984	of	_	
108-26	19985-19992	fingers	_	
108-27	19993-19995	in	_	
108-28	19996-20002	either	_	
108-29	20003-20006	the	_	
108-30	20007-20012	right	_	
108-31	20013-20015	or	_	
108-32	20016-20020	left	_	
108-33	20021-20025	hand	_	
108-34	20025-20026	.	_	

#Text=Accordingly, we defined the C-PDA as follows:  Each run had 4 randomized blocks comprised of 2 rSMC blocks and 2 lSMC blocks.
109-1	20027-20038	Accordingly	_	
109-2	20038-20039	,	_	
109-3	20040-20042	we	_	
109-4	20043-20050	defined	_	
109-5	20051-20054	the	_	
109-6	20055-20060	C-PDA	_	
109-7	20061-20063	as	_	
109-8	20064-20071	follows	_	
109-9	20071-20072	:	_	
109-10	20074-20078	Each	_	
109-11	20079-20082	run	_	
109-12	20083-20086	had	_	
109-13	20087-20088	4	_	
109-14	20089-20099	randomized	_	
109-15	20100-20106	blocks	_	
109-16	20107-20116	comprised	_	
109-17	20117-20119	of	_	
109-18	20120-20121	2	_	
109-19	20122-20126	rSMC	_	
109-20	20127-20133	blocks	_	
109-21	20134-20137	and	_	
109-22	20138-20139	2	_	
109-23	20140-20144	lSMC	_	
109-24	20145-20151	blocks	_	
109-25	20151-20152	.	_	

#Text=Before each block participants saw a prompt stating either “right” or “left”, so participants knew which hand’s fingers they had to move.
110-1	20153-20159	Before	_	
110-2	20160-20164	each	_	
110-3	20165-20170	block	_	
110-4	20171-20183	participants	_	
110-5	20184-20187	saw	_	
110-6	20188-20189	a	_	
110-7	20190-20196	prompt	_	
110-8	20197-20204	stating	_	
110-9	20205-20211	either	_	
110-10	20212-20213	“	_	
110-11	20213-20218	right	_	
110-12	20218-20219	”	_	
110-13	20220-20222	or	_	
110-14	20223-20224	“	_	
110-15	20224-20228	left	_	
110-16	20228-20229	”	_	
110-17	20229-20230	,	_	
110-18	20231-20233	so	_	
110-19	20234-20246	participants	_	
110-20	20247-20251	knew	_	
110-21	20252-20257	which	_	
110-22	20258-20262	hand	_	
110-23	20262-20263	’	_	
110-24	20263-20264	s	_	
110-25	20265-20272	fingers	_	
110-26	20273-20277	they	_	
110-27	20278-20281	had	_	
110-28	20282-20284	to	_	
110-29	20285-20289	move	_	
110-30	20289-20290	.	_	

#Text=All participants were instructed how to perform finger tapping outside the scanner before the feedback session.
111-1	20291-20294	All	_	
111-2	20295-20307	participants	_	
111-3	20308-20312	were	_	
111-4	20313-20323	instructed	_	
111-5	20324-20327	how	_	
111-6	20328-20330	to	_	
111-7	20331-20338	perform	_	
111-8	20339-20345	finger	_	
111-9	20346-20353	tapping	_	
111-10	20354-20361	outside	_	
111-11	20362-20365	the	_	
111-12	20366-20373	scanner	_	
111-13	20374-20380	before	_	
111-14	20381-20384	the	_	
111-15	20385-20393	feedback	_	
111-16	20394-20401	session	_	
111-17	20401-20402	.	_	

#Text=After each tapping block, a prompt appeared to rate how intense they were tapping their fingers on a scale of 1 (low intensity) to 6 (high intensity).
112-1	20403-20408	After	_	
112-2	20409-20413	each	_	
112-3	20414-20421	tapping	_	
112-4	20422-20427	block	_	
112-5	20427-20428	,	_	
112-6	20429-20430	a	_	
112-7	20431-20437	prompt	_	
112-8	20438-20446	appeared	_	
112-9	20447-20449	to	_	
112-10	20450-20454	rate	_	
112-11	20455-20458	how	_	
112-12	20459-20466	intense	_	
112-13	20467-20471	they	_	
112-14	20472-20476	were	_	
112-15	20477-20484	tapping	_	
112-16	20485-20490	their	_	
112-17	20491-20498	fingers	_	
112-18	20499-20501	on	_	
112-19	20502-20503	a	_	
112-20	20504-20509	scale	_	
112-21	20510-20512	of	_	
112-22	20513-20514	1	_	
112-23	20515-20516	(	_	
112-24	20516-20519	low	_	
112-25	20520-20529	intensity	_	
112-26	20529-20530	)	_	
112-27	20531-20533	to	_	
112-28	20534-20535	6	_	
112-29	20536-20537	(	_	
112-30	20537-20541	high	_	
112-31	20542-20551	intensity	_	
112-32	20551-20552	)	_	
112-33	20552-20553	.	_	

#Text=In the feedback blocks, participants saw a thermometer showing how well they were able to increase their brain activity by tapping their fingers (Figure S2).
#Text=fMRI data analysis
#Text=Preprocessing
#Text=The preprocessing of resting state and feedback images was done using custom software CONN 17.e and SPM 12 software (http://www.fil.ion.ucl.ac.uk/spm) implemented in a MATLAB suite (Mathworks, Inc., Natick, Massachusetts).
113-1	20554-20556	In	_	
113-2	20557-20560	the	_	
113-3	20561-20569	feedback	_	
113-4	20570-20576	blocks	_	
113-5	20576-20577	,	_	
113-6	20578-20590	participants	_	
113-7	20591-20594	saw	_	
113-8	20595-20596	a	_	
113-9	20597-20608	thermometer	_	
113-10	20609-20616	showing	_	
113-11	20617-20620	how	_	
113-12	20621-20625	well	_	
113-13	20626-20630	they	_	
113-14	20631-20635	were	_	
113-15	20636-20640	able	_	
113-16	20641-20643	to	_	
113-17	20644-20652	increase	_	
113-18	20653-20658	their	_	
113-19	20659-20664	brain	_	
113-20	20665-20673	activity	_	
113-21	20674-20676	by	_	
113-22	20677-20684	tapping	_	
113-23	20685-20690	their	_	
113-24	20691-20698	fingers	_	
113-25	20699-20700	(	_	
113-26	20700-20706	Figure	_	
113-27	20707-20709	S2	_	
113-28	20709-20710	)	_	
113-29	20710-20711	.	_	
113-30	20712-20716	fMRI	_	
113-31	20717-20721	data	_	
113-32	20722-20730	analysis	_	
113-33	20731-20744	Preprocessing	_	
113-34	20745-20748	The	_	
113-35	20749-20762	preprocessing	_	
113-36	20763-20765	of	_	
113-37	20766-20773	resting	_	
113-38	20774-20779	state	_	
113-39	20780-20783	and	_	
113-40	20784-20792	feedback	_	
113-41	20793-20799	images	_	
113-42	20800-20803	was	_	
113-43	20804-20808	done	_	
113-44	20809-20814	using	_	
113-45	20815-20821	custom	_	
113-46	20822-20830	software	_	
113-47	20831-20835	CONN	_	
113-48	20836-20838	17	_	
113-49	20838-20839	.	_	
113-50	20839-20840	e	_	
113-51	20841-20844	and	_	
113-52	20845-20848	SPM	_	
113-53	20849-20851	12	_	
113-54	20852-20860	software	_	
113-55	20861-20862	(	_	
113-56	20862-20866	http	_	
113-57	20866-20867	:	_	
113-58	20867-20868	/	_	
113-59	20868-20869	/	_	
113-60	20869-20890	www.fil.ion.ucl.ac.uk	_	
113-61	20890-20891	/	_	
113-62	20891-20894	spm	_	
113-63	20894-20895	)	_	
113-64	20896-20907	implemented	_	
113-65	20908-20910	in	_	
113-66	20911-20912	a	_	
113-67	20913-20919	MATLAB	_	
113-68	20920-20925	suite	_	
113-69	20926-20927	(	_	
113-70	20927-20936	Mathworks	_	
113-71	20936-20937	,	_	
113-72	20938-20941	Inc	_	
113-73	20941-20942	.	_	
113-74	20942-20943	,	_	
113-75	20944-20950	Natick	_	
113-76	20950-20951	,	_	
113-77	20952-20965	Massachusetts	_	
113-78	20965-20966	)	_	
113-79	20966-20967	.	_	

#Text=It included slice time correction, head motion correction, co-registration to subjects’ structural images, segmentation, normalization to Montreal Neurological Institute (MNI) space, linear detrending and smoothing (FWHM = 6 mm).
114-1	20968-20970	It	_	
114-2	20971-20979	included	_	
114-3	20980-20985	slice	_	
114-4	20986-20990	time	_	
114-5	20991-21001	correction	_	
114-6	21001-21002	,	_	
114-7	21003-21007	head	_	
114-8	21008-21014	motion	_	
114-9	21015-21025	correction	_	
114-10	21025-21026	,	_	
114-11	21027-21042	co-registration	_	
114-12	21043-21045	to	_	
114-13	21046-21054	subjects	_	
114-14	21054-21055	’	_	
114-15	21056-21066	structural	_	
114-16	21067-21073	images	_	
114-17	21073-21074	,	_	
114-18	21075-21087	segmentation	_	
114-19	21087-21088	,	_	
114-20	21089-21102	normalization	_	
114-21	21103-21105	to	_	
114-22	21106-21114	Montreal	_	
114-23	21115-21127	Neurological	_	
114-24	21128-21137	Institute	_	
114-25	21138-21139	(	_	
114-26	21139-21142	MNI	_	
114-27	21142-21143	)	_	
114-28	21144-21149	space	_	
114-29	21149-21150	,	_	
114-30	21151-21157	linear	_	
114-31	21158-21168	detrending	_	
114-32	21169-21172	and	_	
114-33	21173-21182	smoothing	_	
114-34	21183-21184	(	_	
114-35	21184-21188	FWHM	_	
114-36	21189-21190	=	_	
114-37	21191-21192	6	_	
114-38	21193-21195	mm	_	
114-39	21195-21196	)	_	
114-40	21196-21197	.	_	

#Text=Functional Connectivity Analysis
#Text=Functional connectivity (FC) analysis was performed using a seed-driven approach with in-house, custom software CONN 17.e.
115-1	21198-21208	Functional	_	
115-2	21209-21221	Connectivity	_	
115-3	21222-21230	Analysis	_	
115-4	21231-21241	Functional	_	
115-5	21242-21254	connectivity	_	
115-6	21255-21256	(	_	
115-7	21256-21258	FC	_	
115-8	21258-21259	)	_	
115-9	21260-21268	analysis	_	
115-10	21269-21272	was	_	
115-11	21273-21282	performed	_	
115-12	21283-21288	using	_	
115-13	21289-21290	a	_	
115-14	21291-21302	seed-driven	_	
115-15	21303-21311	approach	_	
115-16	21312-21316	with	_	
115-17	21317-21325	in-house	_	
115-18	21325-21326	,	_	
115-19	21327-21333	custom	_	
115-20	21334-21342	software	_	
115-21	21343-21347	CONN	_	
115-22	21348-21350	17	_	
115-23	21350-21351	.	_	
115-24	21351-21352	e	_	
115-25	21352-21353	.	_	

#Text=We performed seed-voxel correlations by estimating maps showing temporal correlations between the BOLD time-series from the MPFC & superior temporal gyrus (STG) seeds and that of every brain voxel.
116-1	21354-21356	We	_	
116-2	21357-21366	performed	_	
116-3	21367-21377	seed-voxel	_	
116-4	21378-21390	correlations	_	
116-5	21391-21393	by	_	
116-6	21394-21404	estimating	_	
116-7	21405-21409	maps	_	
116-8	21410-21417	showing	_	
116-9	21418-21426	temporal	_	
116-10	21427-21439	correlations	_	
116-11	21440-21447	between	_	
116-12	21448-21451	the	_	
116-13	21452-21456	BOLD	_	
116-14	21457-21468	time-series	_	
116-15	21469-21473	from	_	
116-16	21474-21477	the	_	
116-17	21478-21482	MPFC	_	
116-18	21483-21484	&	_	
116-19	21485-21493	superior	_	
116-20	21494-21502	temporal	_	
116-21	21503-21508	gyrus	_	
116-22	21509-21510	(	_	
116-23	21510-21513	STG	_	
116-24	21513-21514	)	_	
116-25	21515-21520	seeds	_	
116-26	21521-21524	and	_	
116-27	21525-21529	that	_	
116-28	21530-21532	of	_	
116-29	21533-21538	every	_	
116-30	21539-21544	brain	_	
116-31	21545-21550	voxel	_	
116-32	21550-21551	.	_	

#Text=We defined the MPFC seed following the literature as a 10–mm sphere around the coordinates (−1, 49, −2) in MNI space.
117-1	21552-21554	We	_	
117-2	21555-21562	defined	_	
117-3	21563-21566	the	_	
117-4	21567-21571	MPFC	_	
117-5	21572-21576	seed	_	
117-6	21577-21586	following	_	
117-7	21587-21590	the	_	
117-8	21591-21601	literature	_	
117-9	21602-21604	as	_	
117-10	21605-21606	a	_	
117-11	21607-21609	10	_	
117-12	21609-21610	–	_	
117-13	21610-21612	mm	_	
117-14	21613-21619	sphere	_	
117-15	21620-21626	around	_	
117-16	21627-21630	the	_	
117-17	21631-21642	coordinates	_	
117-18	21643-21644	(	_	
117-19	21644-21645	−	_	
117-20	21645-21646	1	_	
117-21	21646-21647	,	_	
117-22	21648-21650	49	_	
117-23	21650-21651	,	_	
117-24	21652-21653	−	_	
117-25	21653-21654	2	_	
117-26	21654-21655	)	_	
117-27	21656-21658	in	_	
117-28	21659-21662	MNI	_	
117-29	21663-21668	space	_	
117-30	21668-21669	.	_	

#Text=The STG was defined anatomically using WFU PickAtlasROIs (created in WFU PickAtlas; http://fmri.wfubmc.edu/software/PickAtlas).
118-1	21670-21673	The	_	
118-2	21674-21677	STG	_	
118-3	21678-21681	was	_	
118-4	21682-21689	defined	_	
118-5	21690-21702	anatomically	_	
118-6	21703-21708	using	_	
118-7	21709-21712	WFU	_	
118-8	21713-21726	PickAtlasROIs	_	
118-9	21727-21728	(	_	
118-10	21728-21735	created	_	
118-11	21736-21738	in	_	
118-12	21739-21742	WFU	_	
118-13	21743-21752	PickAtlas	_	
118-14	21752-21753	;	_	
118-15	21754-21758	http	_	
118-16	21758-21759	:	_	
118-17	21759-21760	/	_	
118-18	21760-21761	/	_	
118-19	21761-21776	fmri.wfubmc.edu	_	
118-20	21776-21777	/	_	
118-21	21777-21785	software	_	
118-22	21785-21786	/	_	
118-23	21786-21795	PickAtlas	_	
118-24	21795-21796	)	_	
118-25	21796-21797	.	_	

#Text=Physiological and other spurious sources of noise were estimated and regressed out using the anatomical CompCor method (aCompCor).
119-1	21798-21811	Physiological	_	
119-2	21812-21815	and	_	
119-3	21816-21821	other	_	
119-4	21822-21830	spurious	_	
119-5	21831-21838	sources	_	
119-6	21839-21841	of	_	
119-7	21842-21847	noise	_	
119-8	21848-21852	were	_	
119-9	21853-21862	estimated	_	
119-10	21863-21866	and	_	
119-11	21867-21876	regressed	_	
119-12	21877-21880	out	_	
119-13	21881-21886	using	_	
119-14	21887-21890	the	_	
119-15	21891-21901	anatomical	_	
119-16	21902-21909	CompCor	_	
119-17	21910-21916	method	_	
119-18	21917-21918	(	_	
119-19	21918-21926	aCompCor	_	
119-20	21926-21927	)	_	
119-21	21927-21928	.	_	

#Text=Global signal regression, a widely used preprocessing method, was not used because it mathematically mandates anticorrelations, rendering them uninterpretable, and can contribute to group differences in positive correlations.
120-1	21929-21935	Global	_	
120-2	21936-21942	signal	_	
120-3	21943-21953	regression	_	
120-4	21953-21954	,	_	
120-5	21955-21956	a	_	
120-6	21957-21963	widely	_	
120-7	21964-21968	used	_	
120-8	21969-21982	preprocessing	_	
120-9	21983-21989	method	_	
120-10	21989-21990	,	_	
120-11	21991-21994	was	_	
120-12	21995-21998	not	_	
120-13	21999-22003	used	_	
120-14	22004-22011	because	_	
120-15	22012-22014	it	_	
120-16	22015-22029	mathematically	_	
120-17	22030-22038	mandates	_	
120-18	22039-22055	anticorrelations	_	
120-19	22055-22056	,	_	
120-20	22057-22066	rendering	_	
120-21	22067-22071	them	_	
120-22	22072-22087	uninterpretable	_	
120-23	22087-22088	,	_	
120-24	22089-22092	and	_	
120-25	22093-22096	can	_	
120-26	22097-22107	contribute	_	
120-27	22108-22110	to	_	
120-28	22111-22116	group	_	
120-29	22117-22128	differences	_	
120-30	22129-22131	in	_	
120-31	22132-22140	positive	_	
120-32	22141-22153	correlations	_	
120-33	22153-22154	.	_	

#Text=Instead, a CompCor allows for interpretation of anticorrelations and yields higher specificity and sensitivity compared with global signal regression.
121-1	22155-22162	Instead	_	
121-2	22162-22163	,	_	
121-3	22164-22165	a	_	
121-4	22166-22173	CompCor	_	
121-5	22174-22180	allows	_	
121-6	22181-22184	for	_	
121-7	22185-22199	interpretation	_	
121-8	22200-22202	of	_	
121-9	22203-22219	anticorrelations	_	
121-10	22220-22223	and	_	
121-11	22224-22230	yields	_	
121-12	22231-22237	higher	_	
121-13	22238-22249	specificity	_	
121-14	22250-22253	and	_	
121-15	22254-22265	sensitivity	_	
121-16	22266-22274	compared	_	
121-17	22275-22279	with	_	
121-18	22280-22286	global	_	
121-19	22287-22293	signal	_	
121-20	22294-22304	regression	_	
121-21	22304-22305	.	_	

#Text=A temporal band-pass filter of .008 Hz to .09 Hz was applied simultaneously to all regressors in the model.
122-1	22306-22307	A	_	
122-2	22308-22316	temporal	_	
122-3	22317-22326	band-pass	_	
122-4	22327-22333	filter	_	
122-5	22334-22336	of	_	
122-6	22337-22341	.008	_	
122-7	22342-22344	Hz	_	
122-8	22345-22347	to	_	
122-9	22348-22351	.09	_	
122-10	22352-22354	Hz	_	
122-11	22355-22358	was	_	
122-12	22359-22366	applied	_	
122-13	22367-22381	simultaneously	_	
122-14	22382-22384	to	_	
122-15	22385-22388	all	_	
122-16	22389-22399	regressors	_	
122-17	22400-22402	in	_	
122-18	22403-22406	the	_	
122-19	22407-22412	model	_	
122-20	22412-22413	.	_	

#Text=We used methods that minimize the influence of motion and artifact and that allow for valid identification of correlated and anticorrelated networks.
123-1	22414-22416	We	_	
123-2	22417-22421	used	_	
123-3	22422-22429	methods	_	
123-4	22430-22434	that	_	
123-5	22435-22443	minimize	_	
123-6	22444-22447	the	_	
123-7	22448-22457	influence	_	
123-8	22458-22460	of	_	
123-9	22461-22467	motion	_	
123-10	22468-22471	and	_	
123-11	22472-22480	artifact	_	
123-12	22481-22484	and	_	
123-13	22485-22489	that	_	
123-14	22490-22495	allow	_	
123-15	22496-22499	for	_	
123-16	22500-22505	valid	_	
123-17	22506-22520	identification	_	
123-18	22521-22523	of	_	
123-19	22524-22534	correlated	_	
123-20	22535-22538	and	_	
123-21	22539-22553	anticorrelated	_	
123-22	22554-22562	networks	_	
123-23	22562-22563	.	_	

#Text=To address the spurious correlations in resting-state networks caused by head motion we used quality assurance software Artifact Detection Tools to identify problematic time points during the scan.
124-1	22564-22566	To	_	
124-2	22567-22574	address	_	
124-3	22575-22578	the	_	
124-4	22579-22587	spurious	_	
124-5	22588-22600	correlations	_	
124-6	22601-22603	in	_	
124-7	22604-22617	resting-state	_	
124-8	22618-22626	networks	_	
124-9	22627-22633	caused	_	
124-10	22634-22636	by	_	
124-11	22637-22641	head	_	
124-12	22642-22648	motion	_	
124-13	22649-22651	we	_	
124-14	22652-22656	used	_	
124-15	22657-22664	quality	_	
124-16	22665-22674	assurance	_	
124-17	22675-22683	software	_	
124-18	22684-22692	Artifact	_	
124-19	22693-22702	Detection	_	
124-20	22703-22708	Tools	_	
124-21	22709-22711	to	_	
124-22	22712-22720	identify	_	
124-23	22721-22732	problematic	_	
124-24	22733-22737	time	_	
124-25	22738-22744	points	_	
124-26	22745-22751	during	_	
124-27	22752-22755	the	_	
124-28	22756-22760	scan	_	
124-29	22760-22761	.	_	

#Text=Specifically, an image was defined as an outlier if the head displacement in x, y, or z direction was greater than 0.5 mm from the previous frame, or if the global mean intensity in the image was greater than 3 standard deviations from the mean image intensity for the entire resting scan.
125-1	22762-22774	Specifically	_	
125-2	22774-22775	,	_	
125-3	22776-22778	an	_	
125-4	22779-22784	image	_	
125-5	22785-22788	was	_	
125-6	22789-22796	defined	_	
125-7	22797-22799	as	_	
125-8	22800-22802	an	_	
125-9	22803-22810	outlier	_	
125-10	22811-22813	if	_	
125-11	22814-22817	the	_	
125-12	22818-22822	head	_	
125-13	22823-22835	displacement	_	
125-14	22836-22838	in	_	
125-15	22839-22840	x	_	
125-16	22840-22841	,	_	
125-17	22842-22843	y	_	
125-18	22843-22844	,	_	
125-19	22845-22847	or	_	
125-20	22848-22849	z	_	
125-21	22850-22859	direction	_	
125-22	22860-22863	was	_	
125-23	22864-22871	greater	_	
125-24	22872-22876	than	_	
125-25	22877-22880	0.5	_	
125-26	22881-22883	mm	_	
125-27	22884-22888	from	_	
125-28	22889-22892	the	_	
125-29	22893-22901	previous	_	
125-30	22902-22907	frame	_	
125-31	22907-22908	,	_	
125-32	22909-22911	or	_	
125-33	22912-22914	if	_	
125-34	22915-22918	the	_	
125-35	22919-22925	global	_	
125-36	22926-22930	mean	_	
125-37	22931-22940	intensity	_	
125-38	22941-22943	in	_	
125-39	22944-22947	the	_	
125-40	22948-22953	image	_	
125-41	22954-22957	was	_	
125-42	22958-22965	greater	_	
125-43	22966-22970	than	_	
125-44	22971-22972	3	_	
125-45	22973-22981	standard	_	
125-46	22982-22992	deviations	_	
125-47	22993-22997	from	_	
125-48	22998-23001	the	_	
125-49	23002-23006	mean	_	
125-50	23007-23012	image	_	
125-51	23013-23022	intensity	_	
125-52	23023-23026	for	_	
125-53	23027-23030	the	_	
125-54	23031-23037	entire	_	
125-55	23038-23045	resting	_	
125-56	23046-23050	scan	_	
125-57	23050-23051	.	_	

#Text=A single regressor for each outlier image was included in the first level GLM along with motion parameters and first order derivatives (there were no significant differences between runs).
126-1	23052-23053	A	_	
126-2	23054-23060	single	_	
126-3	23061-23070	regressor	_	
126-4	23071-23074	for	_	
126-5	23075-23079	each	_	
126-6	23080-23087	outlier	_	
126-7	23088-23093	image	_	
126-8	23094-23097	was	_	
126-9	23098-23106	included	_	
126-10	23107-23109	in	_	
126-11	23110-23113	the	_	
126-12	23114-23119	first	_	
126-13	23120-23125	level	_	
126-14	23126-23129	GLM	_	
126-15	23130-23135	along	_	
126-16	23136-23140	with	_	
126-17	23141-23147	motion	_	
126-18	23148-23158	parameters	_	
126-19	23159-23162	and	_	
126-20	23163-23168	first	_	
126-21	23169-23174	order	_	
126-22	23175-23186	derivatives	_	
126-23	23187-23188	(	_	
126-24	23188-23193	there	_	
126-25	23194-23198	were	_	
126-26	23199-23201	no	_	
126-27	23202-23213	significant	_	
126-28	23214-23225	differences	_	
126-29	23226-23233	between	_	
126-30	23234-23238	runs	_	
126-31	23238-23239	)	_	
126-32	23239-23240	.	_	

#Text=The anatomical image for each participant was segmented into white matter, grey matter, and cerebrospinal fluid (CSF) masks using SPM12.
127-1	23241-23244	The	_	
127-2	23245-23255	anatomical	_	
127-3	23256-23261	image	_	
127-4	23262-23265	for	_	
127-5	23266-23270	each	_	
127-6	23271-23282	participant	_	
127-7	23283-23286	was	_	
127-8	23287-23296	segmented	_	
127-9	23297-23301	into	_	
127-10	23302-23307	white	_	
127-11	23308-23314	matter	_	
127-12	23314-23315	,	_	
127-13	23316-23320	grey	_	
127-14	23321-23327	matter	_	
127-15	23327-23328	,	_	
127-16	23329-23332	and	_	
127-17	23333-23346	cerebrospinal	_	
127-18	23347-23352	fluid	_	
127-19	23353-23354	(	_	
127-20	23354-23357	CSF	_	
127-21	23357-23358	)	_	
127-22	23359-23364	masks	_	
127-23	23365-23370	using	_	
127-24	23371-23376	SPM12	_	
127-25	23376-23377	.	_	

#Text=To minimize partial voluming with grey matter, the white matter and CSF masks were eroded by one voxel, which resulted in substantially smaller masks than the original segmentations.
128-1	23378-23380	To	_	
128-2	23381-23389	minimize	_	
128-3	23390-23397	partial	_	
128-4	23398-23406	voluming	_	
128-5	23407-23411	with	_	
128-6	23412-23416	grey	_	
128-7	23417-23423	matter	_	
128-8	23423-23424	,	_	
128-9	23425-23428	the	_	
128-10	23429-23434	white	_	
128-11	23435-23441	matter	_	
128-12	23442-23445	and	_	
128-13	23446-23449	CSF	_	
128-14	23450-23455	masks	_	
128-15	23456-23460	were	_	
128-16	23461-23467	eroded	_	
128-17	23468-23470	by	_	
128-18	23471-23474	one	_	
128-19	23475-23480	voxel	_	
128-20	23480-23481	,	_	
128-21	23482-23487	which	_	
128-22	23488-23496	resulted	_	
128-23	23497-23499	in	_	
128-24	23500-23513	substantially	_	
128-25	23514-23521	smaller	_	
128-26	23522-23527	masks	_	
128-27	23528-23532	than	_	
128-28	23533-23536	the	_	
128-29	23537-23545	original	_	
128-30	23546-23559	segmentations	_	
128-31	23559-23560	.	_	

#Text=The eroded white matter and CSF masks were then used as noise regions of interest (ROI).
129-1	23561-23564	The	_	
129-2	23565-23571	eroded	_	
129-3	23572-23577	white	_	
129-4	23578-23584	matter	_	
129-5	23585-23588	and	_	
129-6	23589-23592	CSF	_	
129-7	23593-23598	masks	_	
129-8	23599-23603	were	_	
129-9	23604-23608	then	_	
129-10	23609-23613	used	_	
129-11	23614-23616	as	_	
129-12	23617-23622	noise	_	
129-13	23623-23630	regions	_	
129-14	23631-23633	of	_	
129-15	23634-23642	interest	_	
129-16	23643-23644	(	_	
129-17	23644-23647	ROI	_	
129-18	23647-23648	)	_	
129-19	23648-23649	.	_	

#Text=Based on previous results, five principal components of the signals from white matter and CSF noise ROIs were removed with regression.
130-1	23650-23655	Based	_	
130-2	23656-23658	on	_	
130-3	23659-23667	previous	_	
130-4	23668-23675	results	_	
130-5	23675-23676	,	_	
130-6	23677-23681	five	_	
130-7	23682-23691	principal	_	
130-8	23692-23702	components	_	
130-9	23703-23705	of	_	
130-10	23706-23709	the	_	
130-11	23710-23717	signals	_	
130-12	23718-23722	from	_	
130-13	23723-23728	white	_	
130-14	23729-23735	matter	_	
130-15	23736-23739	and	_	
130-16	23740-23743	CSF	_	
130-17	23744-23749	noise	_	
130-18	23750-23754	ROIs	_	
130-19	23755-23759	were	_	
130-20	23760-23767	removed	_	
130-21	23768-23772	with	_	
130-22	23773-23783	regression	_	
130-23	23783-23784	.	_	

#Text=Time series of all the voxels within each seed were averaged, and first-level correlation maps were produced by extracting the residual blood oxygen level–dependent time course from each seed and computing Pearson correlation coefficients between that time course and the time course of all other voxels.
131-1	23785-23789	Time	_	
131-2	23790-23796	series	_	
131-3	23797-23799	of	_	
131-4	23800-23803	all	_	
131-5	23804-23807	the	_	
131-6	23808-23814	voxels	_	
131-7	23815-23821	within	_	
131-8	23822-23826	each	_	
131-9	23827-23831	seed	_	
131-10	23832-23836	were	_	
131-11	23837-23845	averaged	_	
131-12	23845-23846	,	_	
131-13	23847-23850	and	_	
131-14	23851-23862	first-level	_	
131-15	23863-23874	correlation	_	
131-16	23875-23879	maps	_	
131-17	23880-23884	were	_	
131-18	23885-23893	produced	_	
131-19	23894-23896	by	_	
131-20	23897-23907	extracting	_	
131-21	23908-23911	the	_	
131-22	23912-23920	residual	_	
131-23	23921-23926	blood	_	
131-24	23927-23933	oxygen	_	
131-25	23934-23949	level–dependent	_	
131-26	23950-23954	time	_	
131-27	23955-23961	course	_	
131-28	23962-23966	from	_	
131-29	23967-23971	each	_	
131-30	23972-23976	seed	_	
131-31	23977-23980	and	_	
131-32	23981-23990	computing	_	
131-33	23991-23998	Pearson	_	
131-34	23999-24010	correlation	_	
131-35	24011-24023	coefficients	_	
131-36	24024-24031	between	_	
131-37	24032-24036	that	_	
131-38	24037-24041	time	_	
131-39	24042-24048	course	_	
131-40	24049-24052	and	_	
131-41	24053-24056	the	_	
131-42	24057-24061	time	_	
131-43	24062-24068	course	_	
131-44	24069-24071	of	_	
131-45	24072-24075	all	_	
131-46	24076-24081	other	_	
131-47	24082-24088	voxels	_	
131-48	24088-24089	.	_	

#Text=Correlation coefficients were converted to normally distributed Z-scores using the Fisher transformation to allow for second-level GLM analyses.
132-1	24090-24101	Correlation	_	
132-2	24102-24114	coefficients	_	
132-3	24115-24119	were	_	
132-4	24120-24129	converted	_	
132-5	24130-24132	to	_	
132-6	24133-24141	normally	_	
132-7	24142-24153	distributed	_	
132-8	24154-24162	Z-scores	_	
132-9	24163-24168	using	_	
132-10	24169-24172	the	_	
132-11	24173-24179	Fisher	_	
132-12	24180-24194	transformation	_	
132-13	24195-24197	to	_	
132-14	24198-24203	allow	_	
132-15	24204-24207	for	_	
132-16	24208-24220	second-level	_	
132-17	24221-24224	GLM	_	
132-18	24225-24233	analyses	_	
132-19	24233-24234	.	_	

#Text=Second-level random effects analysis, connectivity maps from MPFC & STG seeds respectively from all participants were entered into a paired t-test, to identify regions with connectivity differences between pre and post RS.
133-1	24235-24247	Second-level	_	
133-2	24248-24254	random	_	
133-3	24255-24262	effects	_	
133-4	24263-24271	analysis	_	
133-5	24271-24272	,	_	
133-6	24273-24285	connectivity	_	
133-7	24286-24290	maps	_	
133-8	24291-24295	from	_	
133-9	24296-24300	MPFC	_	
133-10	24301-24302	&	_	
133-11	24303-24306	STG	_	
133-12	24307-24312	seeds	_	
133-13	24313-24325	respectively	_	
133-14	24326-24330	from	_	
133-15	24331-24334	all	_	
133-16	24335-24347	participants	_	
133-17	24348-24352	were	_	
133-18	24353-24360	entered	_	
133-19	24361-24365	into	_	
133-20	24366-24367	a	_	
133-21	24368-24374	paired	_	
133-22	24375-24381	t-test	_	
133-23	24381-24382	,	_	
133-24	24383-24385	to	_	
133-25	24386-24394	identify	_	
133-26	24395-24402	regions	_	
133-27	24403-24407	with	_	
133-28	24408-24420	connectivity	_	
133-29	24421-24432	differences	_	
133-30	24433-24440	between	_	
133-31	24441-24444	pre	_	
133-32	24445-24448	and	_	
133-33	24449-24453	post	_	
133-34	24454-24456	RS	_	
133-35	24456-24457	.	_	

#Text=Additionally, in order to assess if there was a relationship between AHs and STG-MPFC resting state connectivity, we correlated the individual change in AHs (ΔAHs Score) with the change in STG-MPFC connectivity (ΔSTG-MPFC).
134-1	24458-24470	Additionally	_	
134-2	24470-24471	,	_	
134-3	24472-24474	in	_	
134-4	24475-24480	order	_	
134-5	24481-24483	to	_	
134-6	24484-24490	assess	_	
134-7	24491-24493	if	_	
134-8	24494-24499	there	_	
134-9	24500-24503	was	_	
134-10	24504-24505	a	_	
134-11	24506-24518	relationship	_	
134-12	24519-24526	between	_	
134-13	24527-24530	AHs	_	
134-14	24531-24534	and	_	
134-15	24535-24543	STG-MPFC	_	
134-16	24544-24551	resting	_	
134-17	24552-24557	state	_	
134-18	24558-24570	connectivity	_	
134-19	24570-24571	,	_	
134-20	24572-24574	we	_	
134-21	24575-24585	correlated	_	
134-22	24586-24589	the	_	
134-23	24590-24600	individual	_	
134-24	24601-24607	change	_	
134-25	24608-24610	in	_	
134-26	24611-24614	AHs	_	
134-27	24615-24616	(	_	
134-28	24616-24620	ΔAHs	_	
134-29	24621-24626	Score	_	
134-30	24626-24627	)	_	
134-31	24628-24632	with	_	
134-32	24633-24636	the	_	
134-33	24637-24643	change	_	
134-34	24644-24646	in	_	
134-35	24647-24655	STG-MPFC	_	
134-36	24656-24668	connectivity	_	
134-37	24669-24670	(	_	
134-38	24670-24679	ΔSTG-MPFC	_	
134-39	24679-24680	)	_	
134-40	24680-24681	.	_	

#Text=Statistical tests for AHs, mental noting and finger tapping performance related analyses were conducted using R Studio version 1.0.136 (www.r-project.org).
135-1	24682-24693	Statistical	_	
135-2	24694-24699	tests	_	
135-3	24700-24703	for	_	
135-4	24704-24707	AHs	_	
135-5	24707-24708	,	_	
135-6	24709-24715	mental	_	
135-7	24716-24722	noting	_	
135-8	24723-24726	and	_	
135-9	24727-24733	finger	_	
135-10	24734-24741	tapping	_	
135-11	24742-24753	performance	_	
135-12	24754-24761	related	_	
135-13	24762-24770	analyses	_	
135-14	24771-24775	were	_	
135-15	24776-24785	conducted	_	
135-16	24786-24791	using	_	
135-17	24792-24793	R	_	
135-18	24794-24800	Studio	_	
135-19	24801-24808	version	_	
135-20	24809-24816	1.0.136	_	
135-21	24817-24818	(	_	
135-22	24818-24835	www.r-project.org	_	
135-23	24835-24836	)	_	
135-24	24836-24837	.	_	

#Text=Statistical significance level was set at 0.05 (one-tailed; pairwise comparisons with directional hypotheses).
136-1	24838-24849	Statistical	_	
136-2	24850-24862	significance	_	
136-3	24863-24868	level	_	
136-4	24869-24872	was	_	
136-5	24873-24876	set	_	
136-6	24877-24879	at	_	
136-7	24880-24884	0.05	_	
136-8	24885-24886	(	_	
136-9	24886-24896	one-tailed	_	
136-10	24896-24897	;	_	
136-11	24898-24906	pairwise	_	
136-12	24907-24918	comparisons	_	
136-13	24919-24923	with	_	
136-14	24924-24935	directional	_	
136-15	24936-24946	hypotheses	_	
136-16	24946-24947	)	_	
136-17	24947-24948	.	_	

#Text=Unless otherwise stated all functional connectivity statistical analyses have a height threshold of p<0.01 at the voxel level and an extent threshold of FDR-corrected p<0.05.
137-1	24949-24955	Unless	_	
137-2	24956-24965	otherwise	_	
137-3	24966-24972	stated	_	
137-4	24973-24976	all	_	
137-5	24977-24987	functional	_	
137-6	24988-25000	connectivity	_	
137-7	25001-25012	statistical	_	
137-8	25013-25021	analyses	_	
137-9	25022-25026	have	_	
137-10	25027-25028	a	_	
137-11	25029-25035	height	_	
137-12	25036-25045	threshold	_	
137-13	25046-25048	of	_	
137-14	25049-25050	p	_	
137-15	25050-25051	<	_	
137-16	25051-25055	0.01	_	
137-17	25056-25058	at	_	
137-18	25059-25062	the	_	
137-19	25063-25068	voxel	_	
137-20	25069-25074	level	_	
137-21	25075-25078	and	_	
137-22	25079-25081	an	_	
137-23	25082-25088	extent	_	
137-24	25089-25098	threshold	_	
137-25	25099-25101	of	_	
137-26	25102-25115	FDR-corrected	_	
137-27	25116-25117	p	_	
137-28	25117-25118	<	_	
137-29	25118-25122	0.05	_	
137-30	25122-25123	.	_	

#Text=Results
#Text=Auditory Hallucinations
#Text=There was a significant reduction in AHs score one week post DMN-feedback training (df (10) = 2.3, p = 0.02, d = 0.57).
138-1	25124-25131	Results	_	
138-2	25132-25140	Auditory	_	
138-3	25141-25155	Hallucinations	_	
138-4	25156-25161	There	_	
138-5	25162-25165	was	_	
138-6	25166-25167	a	_	
138-7	25168-25179	significant	_	
138-8	25180-25189	reduction	_	
138-9	25190-25192	in	_	
138-10	25193-25196	AHs	_	
138-11	25197-25202	score	_	
138-12	25203-25206	one	_	
138-13	25207-25211	week	_	
138-14	25212-25216	post	_	
138-15	25217-25229	DMN-feedback	_	
138-16	25230-25238	training	_	
138-17	25239-25240	(	_	
138-18	25240-25242	df	_	
138-19	25243-25244	(	_	
138-20	25244-25246	10	_	
138-21	25246-25247	)	_	
138-22	25248-25249	=	_	
138-23	25250-25253	2.3	_	
138-24	25253-25254	,	_	
138-25	25255-25256	p	_	
138-26	25257-25258	=	_	
138-27	25259-25263	0.02	_	
138-28	25263-25264	,	_	
138-29	25265-25266	d	_	
138-30	25267-25268	=	_	
138-31	25269-25273	0.57	_	
138-32	25273-25274	)	_	
138-33	25274-25275	.	_	

#Text=There were no significant AHs score changes post SMC-feedback (df (6) = 1.0, p = 0.17, d = 0.2).
139-1	25276-25281	There	_	
139-2	25282-25286	were	_	
139-3	25287-25289	no	_	
139-4	25290-25301	significant	_	
139-5	25302-25305	AHs	_	
139-6	25306-25311	score	_	
139-7	25312-25319	changes	_	
139-8	25320-25324	post	_	
139-9	25325-25337	SMC-feedback	_	
139-10	25338-25339	(	_	
139-11	25339-25341	df	_	
139-12	25342-25343	(	_	
139-13	25343-25344	6	_	
139-14	25344-25345	)	_	
139-15	25346-25347	=	_	
139-16	25348-25351	1.0	_	
139-17	25351-25352	,	_	
139-18	25353-25354	p	_	
139-19	25355-25356	=	_	
139-20	25357-25361	0.17	_	
139-21	25361-25362	,	_	
139-22	25363-25364	d	_	
139-23	25365-25366	=	_	
139-24	25367-25370	0.2	_	
139-25	25370-25371	)	_	
139-26	25371-25372	.	_	

#Text=There were no significant differences in AH scores assessed before DMN-neurofeedback and AH assessed before SMC-feedback (df (12) = 0.9, p = 0.37, d = −0.4), i.e., AH scores returned to the levels before the first NFB session.
140-1	25373-25378	There	_	
140-2	25379-25383	were	_	
140-3	25384-25386	no	_	
140-4	25387-25398	significant	_	
140-5	25399-25410	differences	_	
140-6	25411-25413	in	_	
140-7	25414-25416	AH	_	
140-8	25417-25423	scores	_	
140-9	25424-25432	assessed	_	
140-10	25433-25439	before	_	
140-11	25440-25457	DMN-neurofeedback	_	
140-12	25458-25461	and	_	
140-13	25462-25464	AH	_	
140-14	25465-25473	assessed	_	
140-15	25474-25480	before	_	
140-16	25481-25493	SMC-feedback	_	
140-17	25494-25495	(	_	
140-18	25495-25497	df	_	
140-19	25498-25499	(	_	
140-20	25499-25501	12	_	
140-21	25501-25502	)	_	
140-22	25503-25504	=	_	
140-23	25505-25508	0.9	_	
140-24	25508-25509	,	_	
140-25	25510-25511	p	_	
140-26	25512-25513	=	_	
140-27	25514-25518	0.37	_	
140-28	25518-25519	,	_	
140-29	25520-25521	d	_	
140-30	25522-25523	=	_	
140-31	25524-25525	−	_	
140-32	25525-25528	0.4	_	
140-33	25528-25529	)	_	
140-34	25529-25530	,	_	
140-35	25531-25534	i.e	_	
140-36	25534-25535	.	_	
140-37	25535-25536	,	_	
140-38	25537-25539	AH	_	
140-39	25540-25546	scores	_	
140-40	25547-25555	returned	_	
140-41	25556-25558	to	_	
140-42	25559-25562	the	_	
140-43	25563-25569	levels	_	
140-44	25570-25576	before	_	
140-45	25577-25580	the	_	
140-46	25581-25586	first	_	
140-47	25587-25590	NFB	_	
140-48	25591-25598	session	_	
140-49	25598-25599	.	_	

#Text=Mental noting performance
#Text=All participants successfully increased PDA by performing ‘mental noting’ while receiving real-time feedback (Average 59% SD (10.49)).
141-1	25600-25606	Mental	_	
141-2	25607-25613	noting	_	
141-3	25614-25625	performance	_	
141-4	25626-25629	All	_	
141-5	25630-25642	participants	_	
141-6	25643-25655	successfully	_	
141-7	25656-25665	increased	_	
141-8	25666-25669	PDA	_	
141-9	25670-25672	by	_	
141-10	25673-25683	performing	_	
141-11	25684-25685	‘	_	
141-12	25685-25691	mental	_	
141-13	25692-25698	noting	_	
141-14	25698-25699	’	_	
141-15	25700-25705	while	_	
141-16	25706-25715	receiving	_	
141-17	25716-25725	real-time	_	
141-18	25726-25734	feedback	_	
141-19	25735-25736	(	_	
141-20	25736-25743	Average	_	
141-21	25744-25747	59%	_	
141-22	25748-25750	SD	_	
141-23	25751-25752	(	_	
141-24	25752-25757	10.49	_	
141-25	25757-25758	)	_	
141-26	25758-25759	)	_	
141-27	25759-25760	.	_	

#Text=Chi-square goodness-of-fit (expected frequency) (to assess that individual performance was significantly different from chance) was significant (X2 = 4.4, df = 1, p = 0.03).
142-1	25761-25771	Chi-square	_	
142-2	25772-25787	goodness-of-fit	_	
142-3	25788-25789	(	_	
142-4	25789-25797	expected	_	
142-5	25798-25807	frequency	_	
142-6	25807-25808	)	_	
142-7	25809-25810	(	_	
142-8	25810-25812	to	_	
142-9	25813-25819	assess	_	
142-10	25820-25824	that	_	
142-11	25825-25835	individual	_	
142-12	25836-25847	performance	_	
142-13	25848-25851	was	_	
142-14	25852-25865	significantly	_	
142-15	25866-25875	different	_	
142-16	25876-25880	from	_	
142-17	25881-25887	chance	_	
142-18	25887-25888	)	_	
142-19	25889-25892	was	_	
142-20	25893-25904	significant	_	
142-21	25905-25906	(	_	
142-22	25906-25908	X2	_	
142-23	25909-25910	=	_	
142-24	25911-25914	4.4	_	
142-25	25914-25915	,	_	
142-26	25916-25918	df	_	
142-27	25919-25920	=	_	
142-28	25921-25922	1	_	
142-29	25922-25923	,	_	
142-30	25924-25925	p	_	
142-31	25926-25927	=	_	
142-32	25928-25932	0.03	_	
142-33	25932-25933	)	_	
142-34	25933-25934	.	_	

#Text=Finger Tapping performance
#Text=All participants successfully increased C-PDA by finger tapping the corresponding hand while receiving real-time feedback (Average 62% SD (10.87)).
143-1	25935-25941	Finger	_	
143-2	25942-25949	Tapping	_	
143-3	25950-25961	performance	_	
143-4	25962-25965	All	_	
143-5	25966-25978	participants	_	
143-6	25979-25991	successfully	_	
143-7	25992-26001	increased	_	
143-8	26002-26007	C-PDA	_	
143-9	26008-26010	by	_	
143-10	26011-26017	finger	_	
143-11	26018-26025	tapping	_	
143-12	26026-26029	the	_	
143-13	26030-26043	corresponding	_	
143-14	26044-26048	hand	_	
143-15	26049-26054	while	_	
143-16	26055-26064	receiving	_	
143-17	26065-26074	real-time	_	
143-18	26075-26083	feedback	_	
143-19	26084-26085	(	_	
143-20	26085-26092	Average	_	
143-21	26093-26096	62%	_	
143-22	26097-26099	SD	_	
143-23	26100-26101	(	_	
143-24	26101-26106	10.87	_	
143-25	26106-26107	)	_	
143-26	26107-26108	)	_	
143-27	26108-26109	.	_	

#Text=Chi-square goodness-of-fit (expected frequency) (to assess that individual performance was significantly different from chance) was significant (X2 = 11, df = 1, p = 0.0009).
144-1	26110-26120	Chi-square	_	
144-2	26121-26136	goodness-of-fit	_	
144-3	26137-26138	(	_	
144-4	26138-26146	expected	_	
144-5	26147-26156	frequency	_	
144-6	26156-26157	)	_	
144-7	26158-26159	(	_	
144-8	26159-26161	to	_	
144-9	26162-26168	assess	_	
144-10	26169-26173	that	_	
144-11	26174-26184	individual	_	
144-12	26185-26196	performance	_	
144-13	26197-26200	was	_	
144-14	26201-26214	significantly	_	
144-15	26215-26224	different	_	
144-16	26225-26229	from	_	
144-17	26230-26236	chance	_	
144-18	26236-26237	)	_	
144-19	26238-26241	was	_	
144-20	26242-26253	significant	_	
144-21	26254-26255	(	_	
144-22	26255-26257	X2	_	
144-23	26258-26259	=	_	
144-24	26260-26262	11	_	
144-25	26262-26263	,	_	
144-26	26264-26266	df	_	
144-27	26267-26268	=	_	
144-28	26269-26270	1	_	
144-29	26270-26271	,	_	
144-30	26272-26273	p	_	
144-31	26274-26275	=	_	
144-32	26276-26282	0.0009	_	
144-33	26282-26283	)	_	
144-34	26283-26284	.	_	

#Text=Resting State for rtDMN
#Text=Paired t-test comparing RS-post > RS-pre revealed a significant increase in anticorrelation between the MPFC and the ACC and the rDLPFC at RS-post, and a significant reduction in connectivity between the MPFC and the PCC (Figure 2A).
145-1	26285-26292	Resting	_	
145-2	26293-26298	State	_	
145-3	26299-26302	for	_	
145-4	26303-26308	rtDMN	_	
145-5	26309-26315	Paired	_	
145-6	26316-26322	t-test	_	
145-7	26323-26332	comparing	_	
145-8	26333-26340	RS-post	_	
145-9	26341-26342	>	_	
145-10	26343-26349	RS-pre	_	
145-11	26350-26358	revealed	_	
145-12	26359-26360	a	_	
145-13	26361-26372	significant	_	
145-14	26373-26381	increase	_	
145-15	26382-26384	in	_	
145-16	26385-26400	anticorrelation	_	
145-17	26401-26408	between	_	
145-18	26409-26412	the	_	
145-19	26413-26417	MPFC	_	
145-20	26418-26421	and	_	
145-21	26422-26425	the	_	
145-22	26426-26429	ACC	_	
145-23	26430-26433	and	_	
145-24	26434-26437	the	_	
145-25	26438-26444	rDLPFC	_	
145-26	26445-26447	at	_	
145-27	26448-26455	RS-post	_	
145-28	26455-26456	,	_	
145-29	26457-26460	and	_	
145-30	26461-26462	a	_	
145-31	26463-26474	significant	_	
145-32	26475-26484	reduction	_	
145-33	26485-26487	in	_	
145-34	26488-26500	connectivity	_	
145-35	26501-26508	between	_	
145-36	26509-26512	the	_	
145-37	26513-26517	MPFC	_	
145-38	26518-26521	and	_	
145-39	26522-26525	the	_	
145-40	26526-26529	PCC	_	
145-41	26530-26531	(	_	
145-42	26531-26537	Figure	_	
145-43	26538-26540	2A	_	
145-44	26540-26541	)	_	
145-45	26541-26542	.	_	

#Text=There was a significant correlation between the change in AH individual scores (ΔAHs Score) and the change in the STG and the MPFC connectivity (ΔSTG-MPFC) in each individual subject (Figure 3), indicating that a greater reduction in the STG-MPFC connectivity post neurofeedback was correlated with a greater reduction in AHs score post-neurofeedback.
146-1	26543-26548	There	_	
146-2	26549-26552	was	_	
146-3	26553-26554	a	_	
146-4	26555-26566	significant	_	
146-5	26567-26578	correlation	_	
146-6	26579-26586	between	_	
146-7	26587-26590	the	_	
146-8	26591-26597	change	_	
146-9	26598-26600	in	_	
146-10	26601-26603	AH	_	
146-11	26604-26614	individual	_	
146-12	26615-26621	scores	_	
146-13	26622-26623	(	_	
146-14	26623-26627	ΔAHs	_	
146-15	26628-26633	Score	_	
146-16	26633-26634	)	_	
146-17	26635-26638	and	_	
146-18	26639-26642	the	_	
146-19	26643-26649	change	_	
146-20	26650-26652	in	_	
146-21	26653-26656	the	_	
146-22	26657-26660	STG	_	
146-23	26661-26664	and	_	
146-24	26665-26668	the	_	
146-25	26669-26673	MPFC	_	
146-26	26674-26686	connectivity	_	
146-27	26687-26688	(	_	
146-28	26688-26697	ΔSTG-MPFC	_	
146-29	26697-26698	)	_	
146-30	26699-26701	in	_	
146-31	26702-26706	each	_	
146-32	26707-26717	individual	_	
146-33	26718-26725	subject	_	
146-34	26726-26727	(	_	
146-35	26727-26733	Figure	_	
146-36	26734-26735	3	_	
146-37	26735-26736	)	_	
146-38	26736-26737	,	_	
146-39	26738-26748	indicating	_	
146-40	26749-26753	that	_	
146-41	26754-26755	a	_	
146-42	26756-26763	greater	_	
146-43	26764-26773	reduction	_	
146-44	26774-26776	in	_	
146-45	26777-26780	the	_	
146-46	26781-26789	STG-MPFC	_	
146-47	26790-26802	connectivity	_	
146-48	26803-26807	post	_	
146-49	26808-26821	neurofeedback	_	
146-50	26822-26825	was	_	
146-51	26826-26836	correlated	_	
146-52	26837-26841	with	_	
146-53	26842-26843	a	_	
146-54	26844-26851	greater	_	
146-55	26852-26861	reduction	_	
146-56	26862-26864	in	_	
146-57	26865-26868	AHs	_	
146-58	26869-26874	score	_	
146-59	26875-26893	post-neurofeedback	_	
146-60	26893-26894	.	_	

#Text=Resting State for rt-SMC
#Text=Paired t-test using the significant clusters from the rtDMN analysis for the PCC, ACC and rDLPFC as ROIs revealed no significant change in anticorrelation after rt-SMC neurofeedback, between the MPFC and the ACC (t[6] = −0.23, p = 0.37) and rDLPFC (t[6] = −1.23, p = 0.26) nor between the MPFC and the PCC (t[6] = 0.67, p = 0.52) at post intervention (Fig 2B).
147-1	26895-26902	Resting	_	
147-2	26903-26908	State	_	
147-3	26909-26912	for	_	
147-4	26913-26919	rt-SMC	_	
147-5	26920-26926	Paired	_	
147-6	26927-26933	t-test	_	
147-7	26934-26939	using	_	
147-8	26940-26943	the	_	
147-9	26944-26955	significant	_	
147-10	26956-26964	clusters	_	
147-11	26965-26969	from	_	
147-12	26970-26973	the	_	
147-13	26974-26979	rtDMN	_	
147-14	26980-26988	analysis	_	
147-15	26989-26992	for	_	
147-16	26993-26996	the	_	
147-17	26997-27000	PCC	_	
147-18	27000-27001	,	_	
147-19	27002-27005	ACC	_	
147-20	27006-27009	and	_	
147-21	27010-27016	rDLPFC	_	
147-22	27017-27019	as	_	
147-23	27020-27024	ROIs	_	
147-24	27025-27033	revealed	_	
147-25	27034-27036	no	_	
147-26	27037-27048	significant	_	
147-27	27049-27055	change	_	
147-28	27056-27058	in	_	
147-29	27059-27074	anticorrelation	_	
147-30	27075-27080	after	_	
147-31	27081-27087	rt-SMC	_	
147-32	27088-27101	neurofeedback	_	
147-33	27101-27102	,	_	
147-34	27103-27110	between	_	
147-35	27111-27114	the	_	
147-36	27115-27119	MPFC	_	
147-37	27120-27123	and	_	
147-38	27124-27127	the	_	
147-39	27128-27131	ACC	_	
147-40	27132-27133	(	_	
147-41	27133-27134	t	_	
147-42	27134-27135	[	_	
147-43	27135-27136	6	_	
147-44	27136-27137	]	_	
147-45	27138-27139	=	_	
147-46	27140-27141	−	_	
147-47	27141-27145	0.23	_	
147-48	27145-27146	,	_	
147-49	27147-27148	p	_	
147-50	27149-27150	=	_	
147-51	27151-27155	0.37	_	
147-52	27155-27156	)	_	
147-53	27157-27160	and	_	
147-54	27161-27167	rDLPFC	_	
147-55	27168-27169	(	_	
147-56	27169-27170	t	_	
147-57	27170-27171	[	_	
147-58	27171-27172	6	_	
147-59	27172-27173	]	_	
147-60	27174-27175	=	_	
147-61	27176-27177	−	_	
147-62	27177-27181	1.23	_	
147-63	27181-27182	,	_	
147-64	27183-27184	p	_	
147-65	27185-27186	=	_	
147-66	27187-27191	0.26	_	
147-67	27191-27192	)	_	
147-68	27193-27196	nor	_	
147-69	27197-27204	between	_	
147-70	27205-27208	the	_	
147-71	27209-27213	MPFC	_	
147-72	27214-27217	and	_	
147-73	27218-27221	the	_	
147-74	27222-27225	PCC	_	
147-75	27226-27227	(	_	
147-76	27227-27228	t	_	
147-77	27228-27229	[	_	
147-78	27229-27230	6	_	
147-79	27230-27231	]	_	
147-80	27232-27233	=	_	
147-81	27234-27238	0.67	_	
147-82	27238-27239	,	_	
147-83	27240-27241	p	_	
147-84	27242-27243	=	_	
147-85	27244-27248	0.52	_	
147-86	27248-27249	)	_	
147-87	27250-27252	at	_	
147-88	27253-27257	post	_	
147-89	27258-27270	intervention	_	
147-90	27271-27272	(	_	
147-91	27272-27275	Fig	_	
147-92	27276-27278	2B	_	
147-93	27278-27279	)	_	
147-94	27279-27280	.	_	

#Text=There was also no correlation between the change in the AHs score (ΔAHs Score) and the change in the STG and the MPFC connectivity (ΔSTG-MPFC) after rtSMC (r2 = −0.23, p = 0.41).
148-1	27281-27286	There	_	
148-2	27287-27290	was	_	
148-3	27291-27295	also	_	
148-4	27296-27298	no	_	
148-5	27299-27310	correlation	_	
148-6	27311-27318	between	_	
148-7	27319-27322	the	_	
148-8	27323-27329	change	_	
148-9	27330-27332	in	_	
148-10	27333-27336	the	_	
148-11	27337-27340	AHs	_	
148-12	27341-27346	score	_	
148-13	27347-27348	(	_	
148-14	27348-27352	ΔAHs	_	
148-15	27353-27358	Score	_	
148-16	27358-27359	)	_	
148-17	27360-27363	and	_	
148-18	27364-27367	the	_	
148-19	27368-27374	change	_	
148-20	27375-27377	in	_	
148-21	27378-27381	the	_	
148-22	27382-27385	STG	_	
148-23	27386-27389	and	_	
148-24	27390-27393	the	_	
148-25	27394-27398	MPFC	_	
148-26	27399-27411	connectivity	_	
148-27	27412-27413	(	_	
148-28	27413-27422	ΔSTG-MPFC	_	
148-29	27422-27423	)	_	
148-30	27424-27429	after	_	
148-31	27430-27435	rtSMC	_	
148-32	27436-27437	(	_	
148-33	27437-27439	r2	_	
148-34	27440-27441	=	_	
148-35	27442-27443	−	_	
148-36	27443-27447	0.23	_	
148-37	27447-27448	,	_	
148-38	27449-27450	p	_	
148-39	27451-27452	=	_	
148-40	27453-27457	0.41	_	
148-41	27457-27458	)	_	
148-42	27458-27459	.	_	

#Text=Discussion
#Text=In this study, we demonstrated, for the first time, that a single rt-fMRI neurofeedback session designed to modulate the DMN-CEN BOLD activity differential using meditation practice resulted in both neural and clinical changes in SZ patients with AHs.
149-1	27460-27470	Discussion	_	
149-2	27471-27473	In	_	
149-3	27474-27478	this	_	
149-4	27479-27484	study	_	
149-5	27484-27485	,	_	
149-6	27486-27488	we	_	
149-7	27489-27501	demonstrated	_	
149-8	27501-27502	,	_	
149-9	27503-27506	for	_	
149-10	27507-27510	the	_	
149-11	27511-27516	first	_	
149-12	27517-27521	time	_	
149-13	27521-27522	,	_	
149-14	27523-27527	that	_	
149-15	27528-27529	a	_	
149-16	27530-27536	single	_	
149-17	27537-27544	rt-fMRI	_	
149-18	27545-27558	neurofeedback	_	
149-19	27559-27566	session	_	
149-20	27567-27575	designed	_	
149-21	27576-27578	to	_	
149-22	27579-27587	modulate	_	
149-23	27588-27591	the	_	
149-24	27592-27599	DMN-CEN	_	
149-25	27600-27604	BOLD	_	
149-26	27605-27613	activity	_	
149-27	27614-27626	differential	_	
149-28	27627-27632	using	_	
149-29	27633-27643	meditation	_	
149-30	27644-27652	practice	_	
149-31	27653-27661	resulted	_	
149-32	27662-27664	in	_	
149-33	27665-27669	both	_	
149-34	27670-27676	neural	_	
149-35	27677-27680	and	_	
149-36	27681-27689	clinical	_	
149-37	27690-27697	changes	_	
149-38	27698-27700	in	_	
149-39	27701-27703	SZ	_	
149-40	27704-27712	patients	_	
149-41	27713-27717	with	_	
149-42	27718-27721	AHs	_	
149-43	27721-27722	.	_	

#Text=This modulation of the DMN-CEN BOLD activity differential led to both reduced connectivity within the DMN hubs (MPFC and PCC) and to increased anticorrelation between the DMN and the CEN (DLPFC).
150-1	27723-27727	This	_	
150-2	27728-27738	modulation	_	
150-3	27739-27741	of	_	
150-4	27742-27745	the	_	
150-5	27746-27753	DMN-CEN	_	
150-6	27754-27758	BOLD	_	
150-7	27759-27767	activity	_	
150-8	27768-27780	differential	_	
150-9	27781-27784	led	_	
150-10	27785-27787	to	_	
150-11	27788-27792	both	_	
150-12	27793-27800	reduced	_	
150-13	27801-27813	connectivity	_	
150-14	27814-27820	within	_	
150-15	27821-27824	the	_	
150-16	27825-27828	DMN	_	
150-17	27829-27833	hubs	_	
150-18	27834-27835	(	_	
150-19	27835-27839	MPFC	_	
150-20	27840-27843	and	_	
150-21	27844-27847	PCC	_	
150-22	27847-27848	)	_	
150-23	27849-27852	and	_	
150-24	27853-27855	to	_	
150-25	27856-27865	increased	_	
150-26	27866-27881	anticorrelation	_	
150-27	27882-27889	between	_	
150-28	27890-27893	the	_	
150-29	27894-27897	DMN	_	
150-30	27898-27901	and	_	
150-31	27902-27905	the	_	
150-32	27906-27909	CEN	_	
150-33	27910-27911	(	_	
150-34	27911-27916	DLPFC	_	
150-35	27916-27917	)	_	
150-36	27917-27918	.	_	

#Text=Importantly, there was a reduction in AHs symptom severity between pre and post rt-fMRI DMN-CEN neurofeedback.
151-1	27919-27930	Importantly	_	
151-2	27930-27931	,	_	
151-3	27932-27937	there	_	
151-4	27938-27941	was	_	
151-5	27942-27943	a	_	
151-6	27944-27953	reduction	_	
151-7	27954-27956	in	_	
151-8	27957-27960	AHs	_	
151-9	27961-27968	symptom	_	
151-10	27969-27977	severity	_	
151-11	27978-27985	between	_	
151-12	27986-27989	pre	_	
151-13	27990-27993	and	_	
151-14	27994-27998	post	_	
151-15	27999-28006	rt-fMRI	_	
151-16	28007-28014	DMN-CEN	_	
151-17	28015-28028	neurofeedback	_	
151-18	28028-28029	.	_	

#Text=Furthermore, the reduction in the individual AHs scores was correlated with each individual’s reduction in the mPFC-STG connectivity.
152-1	28030-28041	Furthermore	_	
152-2	28041-28042	,	_	
152-3	28043-28046	the	_	
152-4	28047-28056	reduction	_	
152-5	28057-28059	in	_	
152-6	28060-28063	the	_	
152-7	28064-28074	individual	_	
152-8	28075-28078	AHs	_	
152-9	28079-28085	scores	_	
152-10	28086-28089	was	_	
152-11	28090-28100	correlated	_	
152-12	28101-28105	with	_	
152-13	28106-28110	each	_	
152-14	28111-28121	individual	_	
152-15	28121-28122	’	_	
152-16	28122-28123	s	_	
152-17	28124-28133	reduction	_	
152-18	28134-28136	in	_	
152-19	28137-28140	the	_	
152-20	28141-28149	mPFC-STG	_	
152-21	28150-28162	connectivity	_	
152-22	28162-28163	.	_	

#Text=In contrast, the control condition involving rt-SMC-neurofeedback was not associated with brain changes observed after the DMN focused neurofeedback session nor with AHs reductions, thus supporting a role of DMN structures in AHs generation.
153-1	28164-28166	In	_	
153-2	28167-28175	contrast	_	
153-3	28175-28176	,	_	
153-4	28177-28180	the	_	
153-5	28181-28188	control	_	
153-6	28189-28198	condition	_	
153-7	28199-28208	involving	_	
153-8	28209-28229	rt-SMC-neurofeedback	_	
153-9	28230-28233	was	_	
153-10	28234-28237	not	_	
153-11	28238-28248	associated	_	
153-12	28249-28253	with	_	
153-13	28254-28259	brain	_	
153-14	28260-28267	changes	_	
153-15	28268-28276	observed	_	
153-16	28277-28282	after	_	
153-17	28283-28286	the	_	
153-18	28287-28290	DMN	_	
153-19	28291-28298	focused	_	
153-20	28299-28312	neurofeedback	_	
153-21	28313-28320	session	_	
153-22	28321-28324	nor	_	
153-23	28325-28329	with	_	
153-24	28330-28333	AHs	_	
153-25	28334-28344	reductions	_	
153-26	28344-28345	,	_	
153-27	28346-28350	thus	_	
153-28	28351-28361	supporting	_	
153-29	28362-28363	a	_	
153-30	28364-28368	role	_	
153-31	28369-28371	of	_	
153-32	28372-28375	DMN	_	
153-33	28376-28386	structures	_	
153-34	28387-28389	in	_	
153-35	28390-28393	AHs	_	
153-36	28394-28404	generation	_	
153-37	28404-28405	.	_	

#Text=The critical role of the DMN in SZ symptomatology has been highlighted by several studies.
154-1	28406-28409	The	_	
154-2	28410-28418	critical	_	
154-3	28419-28423	role	_	
154-4	28424-28426	of	_	
154-5	28427-28430	the	_	
154-6	28431-28434	DMN	_	
154-7	28435-28437	in	_	
154-8	28438-28440	SZ	_	
154-9	28441-28455	symptomatology	_	
154-10	28456-28459	has	_	
154-11	28460-28464	been	_	
154-12	28465-28476	highlighted	_	
154-13	28477-28479	by	_	
154-14	28480-28487	several	_	
154-15	28488-28495	studies	_	
154-16	28495-28496	.	_	

#Text=For example, the DMN hyperconnectivity has been associated with positive symptoms.
155-1	28497-28500	For	_	
155-2	28501-28508	example	_	
155-3	28508-28509	,	_	
155-4	28510-28513	the	_	
155-5	28514-28517	DMN	_	
155-6	28518-28535	hyperconnectivity	_	
155-7	28536-28539	has	_	
155-8	28540-28544	been	_	
155-9	28545-28555	associated	_	
155-10	28556-28560	with	_	
155-11	28561-28569	positive	_	
155-12	28570-28578	symptoms	_	
155-13	28578-28579	.	_	

#Text=Specifically, AHs have been linked to aberrant DMN activation, to within DMN network hyperconnectivity, and between-STG-MPFC hyperconnectivity.
156-1	28580-28592	Specifically	_	
156-2	28592-28593	,	_	
156-3	28594-28597	AHs	_	
156-4	28598-28602	have	_	
156-5	28603-28607	been	_	
156-6	28608-28614	linked	_	
156-7	28615-28617	to	_	
156-8	28618-28626	aberrant	_	
156-9	28627-28630	DMN	_	
156-10	28631-28641	activation	_	
156-11	28641-28642	,	_	
156-12	28643-28645	to	_	
156-13	28646-28652	within	_	
156-14	28653-28656	DMN	_	
156-15	28657-28664	network	_	
156-16	28665-28682	hyperconnectivity	_	
156-17	28682-28683	,	_	
156-18	28684-28687	and	_	
156-19	28688-28704	between-STG-MPFC	_	
156-20	28705-28722	hyperconnectivity	_	
156-21	28722-28723	.	_	

#Text=The involvement of DMN structures in AHs was also highlighted recently by.
157-1	28724-28727	The	_	
157-2	28728-28739	involvement	_	
157-3	28740-28742	of	_	
157-4	28743-28746	DMN	_	
157-5	28747-28757	structures	_	
157-6	28758-28760	in	_	
157-7	28761-28764	AHs	_	
157-8	28765-28768	was	_	
157-9	28769-28773	also	_	
157-10	28774-28785	highlighted	_	
157-11	28786-28794	recently	_	
157-12	28795-28797	by	_	
157-13	28797-28798	.	_	

#Text=The authors identified a potential AHs network, consisting of 25 nodes substantially overlapping with the DMN and language processing networks.
158-1	28799-28802	The	_	
158-2	28803-28810	authors	_	
158-3	28811-28821	identified	_	
158-4	28822-28823	a	_	
158-5	28824-28833	potential	_	
158-6	28834-28837	AHs	_	
158-7	28838-28845	network	_	
158-8	28845-28846	,	_	
158-9	28847-28857	consisting	_	
158-10	28858-28860	of	_	
158-11	28861-28863	25	_	
158-12	28864-28869	nodes	_	
158-13	28870-28883	substantially	_	
158-14	28884-28895	overlapping	_	
158-15	28896-28900	with	_	
158-16	28901-28904	the	_	
158-17	28905-28908	DMN	_	
158-18	28909-28912	and	_	
158-19	28913-28921	language	_	
158-20	28922-28932	processing	_	
158-21	28933-28941	networks	_	
158-22	28941-28942	.	_	

#Text=In addition, the relationship between reduced DMN-DLPFC anticorrelations, SZ symptomatology, and cognitive impairment has been noted in previous studies Reduced DMN-DLPFC anticorrelations may contribute to thought disorder in SZ and impairments in attention and working memory.
159-1	28943-28945	In	_	
159-2	28946-28954	addition	_	
159-3	28954-28955	,	_	
159-4	28956-28959	the	_	
159-5	28960-28972	relationship	_	
159-6	28973-28980	between	_	
159-7	28981-28988	reduced	_	
159-8	28989-28998	DMN-DLPFC	_	
159-9	28999-29015	anticorrelations	_	
159-10	29015-29016	,	_	
159-11	29017-29019	SZ	_	
159-12	29020-29034	symptomatology	_	
159-13	29034-29035	,	_	
159-14	29036-29039	and	_	
159-15	29040-29049	cognitive	_	
159-16	29050-29060	impairment	_	
159-17	29061-29064	has	_	
159-18	29065-29069	been	_	
159-19	29070-29075	noted	_	
159-20	29076-29078	in	_	
159-21	29079-29087	previous	_	
159-22	29088-29095	studies	_	
159-23	29096-29103	Reduced	_	
159-24	29104-29113	DMN-DLPFC	_	
159-25	29114-29130	anticorrelations	_	
159-26	29131-29134	may	_	
159-27	29135-29145	contribute	_	
159-28	29146-29148	to	_	
159-29	29149-29156	thought	_	
159-30	29157-29165	disorder	_	
159-31	29166-29168	in	_	
159-32	29169-29171	SZ	_	
159-33	29172-29175	and	_	
159-34	29176-29187	impairments	_	
159-35	29188-29190	in	_	
159-36	29191-29200	attention	_	
159-37	29201-29204	and	_	
159-38	29205-29212	working	_	
159-39	29213-29219	memory	_	
159-40	29219-29220	.	_	

#Text=They are also associated with over-inclusive self-referential processing that may lead to the misattribution of self-generated information to an external source or “override” bottom-up information in determining the final percept it terms of its source.
160-1	29221-29225	They	_	
160-2	29226-29229	are	_	
160-3	29230-29234	also	_	
160-4	29235-29245	associated	_	
160-5	29246-29250	with	_	
160-6	29251-29265	over-inclusive	_	
160-7	29266-29282	self-referential	_	
160-8	29283-29293	processing	_	
160-9	29294-29298	that	_	
160-10	29299-29302	may	_	
160-11	29303-29307	lead	_	
160-12	29308-29310	to	_	
160-13	29311-29314	the	_	
160-14	29315-29329	misattribution	_	
160-15	29330-29332	of	_	
160-16	29333-29347	self-generated	_	
160-17	29348-29359	information	_	
160-18	29360-29362	to	_	
160-19	29363-29365	an	_	
160-20	29366-29374	external	_	
160-21	29375-29381	source	_	
160-22	29382-29384	or	_	
160-23	29385-29386	“	_	
160-24	29386-29394	override	_	
160-25	29394-29395	”	_	
160-26	29396-29405	bottom-up	_	
160-27	29406-29417	information	_	
160-28	29418-29420	in	_	
160-29	29421-29432	determining	_	
160-30	29433-29436	the	_	
160-31	29437-29442	final	_	
160-32	29443-29450	percept	_	
160-33	29451-29453	it	_	
160-34	29454-29459	terms	_	
160-35	29460-29462	of	_	
160-36	29463-29466	its	_	
160-37	29467-29473	source	_	
160-38	29473-29474	.	_	

#Text=The DLPFC has also been directly implicated in the AHs.
161-1	29475-29478	The	_	
161-2	29479-29484	DLPFC	_	
161-3	29485-29488	has	_	
161-4	29489-29493	also	_	
161-5	29494-29498	been	_	
161-6	29499-29507	directly	_	
161-7	29508-29518	implicated	_	
161-8	29519-29521	in	_	
161-9	29522-29525	the	_	
161-10	29526-29529	AHs	_	
161-11	29529-29530	.	_	

#Text=In a review on resting state networks and their contribution to AHs, argue that AHs severity is related to a tighter coupling between the DMN and the CEN.
162-1	29531-29533	In	_	
162-2	29534-29535	a	_	
162-3	29536-29542	review	_	
162-4	29543-29545	on	_	
162-5	29546-29553	resting	_	
162-6	29554-29559	state	_	
162-7	29560-29568	networks	_	
162-8	29569-29572	and	_	
162-9	29573-29578	their	_	
162-10	29579-29591	contribution	_	
162-11	29592-29594	to	_	
162-12	29595-29598	AHs	_	
162-13	29598-29599	,	_	
162-14	29600-29605	argue	_	
162-15	29606-29610	that	_	
162-16	29611-29614	AHs	_	
162-17	29615-29623	severity	_	
162-18	29624-29626	is	_	
162-19	29627-29634	related	_	
162-20	29635-29637	to	_	
162-21	29638-29639	a	_	
162-22	29640-29647	tighter	_	
162-23	29648-29656	coupling	_	
162-24	29657-29664	between	_	
162-25	29665-29668	the	_	
162-26	29669-29672	DMN	_	
162-27	29673-29676	and	_	
162-28	29677-29680	the	_	
162-29	29681-29684	CEN	_	
162-30	29684-29685	.	_	

#Text=The present results do not address the exact mechanism which contributes to the increase in the DMN-CEN anticorrelations.
163-1	29686-29689	The	_	
163-2	29690-29697	present	_	
163-3	29698-29705	results	_	
163-4	29706-29708	do	_	
163-5	29709-29712	not	_	
163-6	29713-29720	address	_	
163-7	29721-29724	the	_	
163-8	29725-29730	exact	_	
163-9	29731-29740	mechanism	_	
163-10	29741-29746	which	_	
163-11	29747-29758	contributes	_	
163-12	29759-29761	to	_	
163-13	29762-29765	the	_	
163-14	29766-29774	increase	_	
163-15	29775-29777	in	_	
163-16	29778-29781	the	_	
163-17	29782-29789	DMN-CEN	_	
163-18	29790-29806	anticorrelations	_	
163-19	29806-29807	.	_	

#Text=However, the current results demonstrate that these increases in anticorrelation modulate the changes in the MPFC-PCC and the MPFC-STG connectivity.
164-1	29808-29815	However	_	
164-2	29815-29816	,	_	
164-3	29817-29820	the	_	
164-4	29821-29828	current	_	
164-5	29829-29836	results	_	
164-6	29837-29848	demonstrate	_	
164-7	29849-29853	that	_	
164-8	29854-29859	these	_	
164-9	29860-29869	increases	_	
164-10	29870-29872	in	_	
164-11	29873-29888	anticorrelation	_	
164-12	29889-29897	modulate	_	
164-13	29898-29901	the	_	
164-14	29902-29909	changes	_	
164-15	29910-29912	in	_	
164-16	29913-29916	the	_	
164-17	29917-29925	MPFC-PCC	_	
164-18	29926-29929	and	_	
164-19	29930-29933	the	_	
164-20	29934-29942	MPFC-STG	_	
164-21	29943-29955	connectivity	_	
164-22	29955-29956	.	_	

#Text=Furthermore, our results directly link the MPFC-STG connectivity to AHs.
165-1	29957-29968	Furthermore	_	
165-2	29968-29969	,	_	
165-3	29970-29973	our	_	
165-4	29974-29981	results	_	
165-5	29982-29990	directly	_	
165-6	29991-29995	link	_	
165-7	29996-29999	the	_	
165-8	30000-30008	MPFC-STG	_	
165-9	30009-30021	connectivity	_	
165-10	30022-30024	to	_	
165-11	30025-30028	AHs	_	
165-12	30028-30029	.	_	

#Text=These results provide support for the role of DMN-STG coupling abnormalities in AHs, and for the role of both the STG – implicated in auditory, language and self referential processes – and of MPFC -- implicated in self referential processes -- in the experience of AHs.
166-1	30030-30035	These	_	
166-2	30036-30043	results	_	
166-3	30044-30051	provide	_	
166-4	30052-30059	support	_	
166-5	30060-30063	for	_	
166-6	30064-30067	the	_	
166-7	30068-30072	role	_	
166-8	30073-30075	of	_	
166-9	30076-30083	DMN-STG	_	
166-10	30084-30092	coupling	_	
166-11	30093-30106	abnormalities	_	
166-12	30107-30109	in	_	
166-13	30110-30113	AHs	_	
166-14	30113-30114	,	_	
166-15	30115-30118	and	_	
166-16	30119-30122	for	_	
166-17	30123-30126	the	_	
166-18	30127-30131	role	_	
166-19	30132-30134	of	_	
166-20	30135-30139	both	_	
166-21	30140-30143	the	_	
166-22	30144-30147	STG	_	
166-23	30148-30149	–	_	
166-24	30150-30160	implicated	_	
166-25	30161-30163	in	_	
166-26	30164-30172	auditory	_	
166-27	30172-30173	,	_	
166-28	30174-30182	language	_	
166-29	30183-30186	and	_	
166-30	30187-30191	self	_	
166-31	30192-30203	referential	_	
166-32	30204-30213	processes	_	
166-33	30214-30215	–	_	
166-34	30216-30219	and	_	
166-35	30220-30222	of	_	
166-36	30223-30227	MPFC	_	
166-37	30228-30229	-	_	
166-38	30229-30230	-	_	
166-39	30231-30241	implicated	_	
166-40	30242-30244	in	_	
166-41	30245-30249	self	_	
166-42	30250-30261	referential	_	
166-43	30262-30271	processes	_	
166-44	30272-30273	-	_	
166-45	30273-30274	-	_	
166-46	30275-30277	in	_	
166-47	30278-30281	the	_	
166-48	30282-30292	experience	_	
166-49	30293-30295	of	_	
166-50	30296-30299	AHs	_	
166-51	30299-30300	.	_	

#Text=The current findings seem to lend support for the resting state hypothesis of auditory verbal hallucinations (AVH) proposed by Northhoff.
167-1	30301-30304	The	_	
167-2	30305-30312	current	_	
167-3	30313-30321	findings	_	
167-4	30322-30326	seem	_	
167-5	30327-30329	to	_	
167-6	30330-30334	lend	_	
167-7	30335-30342	support	_	
167-8	30343-30346	for	_	
167-9	30347-30350	the	_	
167-10	30351-30358	resting	_	
167-11	30359-30364	state	_	
167-12	30365-30375	hypothesis	_	
167-13	30376-30378	of	_	
167-14	30379-30387	auditory	_	
167-15	30388-30394	verbal	_	
167-16	30395-30409	hallucinations	_	
167-17	30410-30411	(	_	
167-18	30411-30414	AVH	_	
167-19	30414-30415	)	_	
167-20	30416-30424	proposed	_	
167-21	30425-30427	by	_	
167-22	30428-30437	Northhoff	_	
167-23	30437-30438	.	_	

#Text=According to the Northoff hypothesis, AYH’s are related to abnormal spontaneous brain activity within the slow frequency range (0.01 to 0.1Hz as in BOLD signal) resulting in abnormal MPFC-STG resting state hyperconnectivity which it turn causes an abnormal balance of internal vs external stimulus processing.
168-1	30439-30448	According	_	
168-2	30449-30451	to	_	
168-3	30452-30455	the	_	
168-4	30456-30464	Northoff	_	
168-5	30465-30475	hypothesis	_	
168-6	30475-30476	,	_	
168-7	30477-30480	AYH	_	
168-8	30480-30481	’	_	
168-9	30481-30482	s	_	
168-10	30483-30486	are	_	
168-11	30487-30494	related	_	
168-12	30495-30497	to	_	
168-13	30498-30506	abnormal	_	
168-14	30507-30518	spontaneous	_	
168-15	30519-30524	brain	_	
168-16	30525-30533	activity	_	
168-17	30534-30540	within	_	
168-18	30541-30544	the	_	
168-19	30545-30549	slow	_	
168-20	30550-30559	frequency	_	
168-21	30560-30565	range	_	
168-22	30566-30567	(	_	
168-23	30567-30571	0.01	_	
168-24	30572-30574	to	_	
168-25	30575-30580	0.1Hz	_	
168-26	30581-30583	as	_	
168-27	30584-30586	in	_	
168-28	30587-30591	BOLD	_	
168-29	30592-30598	signal	_	
168-30	30598-30599	)	_	
168-31	30600-30609	resulting	_	
168-32	30610-30612	in	_	
168-33	30613-30621	abnormal	_	
168-34	30622-30630	MPFC-STG	_	
168-35	30631-30638	resting	_	
168-36	30639-30644	state	_	
168-37	30645-30662	hyperconnectivity	_	
168-38	30663-30668	which	_	
168-39	30669-30671	it	_	
168-40	30672-30676	turn	_	
168-41	30677-30683	causes	_	
168-42	30684-30686	an	_	
168-43	30687-30695	abnormal	_	
168-44	30696-30703	balance	_	
168-45	30704-30706	of	_	
168-46	30707-30715	internal	_	
168-47	30716-30718	vs	_	
168-48	30719-30727	external	_	
168-49	30728-30736	stimulus	_	
168-50	30737-30747	processing	_	
168-51	30747-30748	.	_	

#Text=Neurofeedback targeting STG-DMN may help re-balance internal vs external processing and decrease the experience of AVH.
169-1	30749-30762	Neurofeedback	_	
169-2	30763-30772	targeting	_	
169-3	30773-30780	STG-DMN	_	
169-4	30781-30784	may	_	
169-5	30785-30789	help	_	
169-6	30790-30800	re-balance	_	
169-7	30801-30809	internal	_	
169-8	30810-30812	vs	_	
169-9	30813-30821	external	_	
169-10	30822-30832	processing	_	
169-11	30833-30836	and	_	
169-12	30837-30845	decrease	_	
169-13	30846-30849	the	_	
169-14	30850-30860	experience	_	
169-15	30861-30863	of	_	
169-16	30864-30867	AVH	_	
169-17	30867-30868	.	_	

#Text=More broadly, these results provide support for the role of resting state networks in the pathophysiology of AHs.
170-1	30869-30873	More	_	
170-2	30874-30881	broadly	_	
170-3	30881-30882	,	_	
170-4	30883-30888	these	_	
170-5	30889-30896	results	_	
170-6	30897-30904	provide	_	
170-7	30905-30912	support	_	
170-8	30913-30916	for	_	
170-9	30917-30920	the	_	
170-10	30921-30925	role	_	
170-11	30926-30928	of	_	
170-12	30929-30936	resting	_	
170-13	30937-30942	state	_	
170-14	30943-30951	networks	_	
170-15	30952-30954	in	_	
170-16	30955-30958	the	_	
170-17	30959-30974	pathophysiology	_	
170-18	30975-30977	of	_	
170-19	30978-30981	AHs	_	
170-20	30981-30982	.	_	

#Text=Furthermore, the findings reported in this paper point to the effectiveness of meditation as a means to impact brain organization; it seems especially effective when combined with rt-fMRI neurofeedback which gives participants direct insight into their brain activity.
171-1	30983-30994	Furthermore	_	
171-2	30994-30995	,	_	
171-3	30996-30999	the	_	
171-4	31000-31008	findings	_	
171-5	31009-31017	reported	_	
171-6	31018-31020	in	_	
171-7	31021-31025	this	_	
171-8	31026-31031	paper	_	
171-9	31032-31037	point	_	
171-10	31038-31040	to	_	
171-11	31041-31044	the	_	
171-12	31045-31058	effectiveness	_	
171-13	31059-31061	of	_	
171-14	31062-31072	meditation	_	
171-15	31073-31075	as	_	
171-16	31076-31077	a	_	
171-17	31078-31083	means	_	
171-18	31084-31086	to	_	
171-19	31087-31093	impact	_	
171-20	31094-31099	brain	_	
171-21	31100-31112	organization	_	
171-22	31112-31113	;	_	
171-23	31114-31116	it	_	
171-24	31117-31122	seems	_	
171-25	31123-31133	especially	_	
171-26	31134-31143	effective	_	
171-27	31144-31148	when	_	
171-28	31149-31157	combined	_	
171-29	31158-31162	with	_	
171-30	31163-31170	rt-fMRI	_	
171-31	31171-31184	neurofeedback	_	
171-32	31185-31190	which	_	
171-33	31191-31196	gives	_	
171-34	31197-31209	participants	_	
171-35	31210-31216	direct	_	
171-36	31217-31224	insight	_	
171-37	31225-31229	into	_	
171-38	31230-31235	their	_	
171-39	31236-31241	brain	_	
171-40	31242-31250	activity	_	
171-41	31250-31251	.	_	

#Text=The neural effects reported in this study are consistent with prior studies which suggest that meditation is associated with decreased activity in the DMN and improves activation and connectivity amongst brain areas associated with cognitive control and self-regulation (e.g., DLPFC).
172-1	31252-31255	The	_	
172-2	31256-31262	neural	_	
172-3	31263-31270	effects	_	
172-4	31271-31279	reported	_	
172-5	31280-31282	in	_	
172-6	31283-31287	this	_	
172-7	31288-31293	study	_	
172-8	31294-31297	are	_	
172-9	31298-31308	consistent	_	
172-10	31309-31313	with	_	
172-11	31314-31319	prior	_	
172-12	31320-31327	studies	_	
172-13	31328-31333	which	_	
172-14	31334-31341	suggest	_	
172-15	31342-31346	that	_	
172-16	31347-31357	meditation	_	
172-17	31358-31360	is	_	
172-18	31361-31371	associated	_	
172-19	31372-31376	with	_	
172-20	31377-31386	decreased	_	
172-21	31387-31395	activity	_	
172-22	31396-31398	in	_	
172-23	31399-31402	the	_	
172-24	31403-31406	DMN	_	
172-25	31407-31410	and	_	
172-26	31411-31419	improves	_	
172-27	31420-31430	activation	_	
172-28	31431-31434	and	_	
172-29	31435-31447	connectivity	_	
172-30	31448-31455	amongst	_	
172-31	31456-31461	brain	_	
172-32	31462-31467	areas	_	
172-33	31468-31478	associated	_	
172-34	31479-31483	with	_	
172-35	31484-31493	cognitive	_	
172-36	31494-31501	control	_	
172-37	31502-31505	and	_	
172-38	31506-31521	self-regulation	_	
172-39	31522-31523	(	_	
172-40	31523-31526	e.g	_	
172-41	31526-31527	.	_	
172-42	31527-31528	,	_	
172-43	31529-31534	DLPFC	_	
172-44	31534-31535	)	_	
172-45	31535-31536	.	_	

#Text=We believe that the current findings support the use of ‘mental noting’, enhanced by real time fMRI feedback, as a complementary treatment of AHs in SZ patients.
173-1	31537-31539	We	_	
173-2	31540-31547	believe	_	
173-3	31548-31552	that	_	
173-4	31553-31556	the	_	
173-5	31557-31564	current	_	
173-6	31565-31573	findings	_	
173-7	31574-31581	support	_	
173-8	31582-31585	the	_	
173-9	31586-31589	use	_	
173-10	31590-31592	of	_	
173-11	31593-31594	‘	_	
173-12	31594-31600	mental	_	
173-13	31601-31607	noting	_	
173-14	31607-31608	’	_	
173-15	31608-31609	,	_	
173-16	31610-31618	enhanced	_	
173-17	31619-31621	by	_	
173-18	31622-31626	real	_	
173-19	31627-31631	time	_	
173-20	31632-31636	fMRI	_	
173-21	31637-31645	feedback	_	
173-22	31645-31646	,	_	
173-23	31647-31649	as	_	
173-24	31650-31651	a	_	
173-25	31652-31665	complementary	_	
173-26	31666-31675	treatment	_	
173-27	31676-31678	of	_	
173-28	31679-31682	AHs	_	
173-29	31683-31685	in	_	
173-30	31686-31688	SZ	_	
173-31	31689-31697	patients	_	
173-32	31697-31698	.	_	

#Text=This conclusion is further supported by a recent study in healthy volunteers that showed that meditation enhanced by rt-fMRI NF is effective in changing the relationship between DMN-CEN and salience networks.
174-1	31699-31703	This	_	
174-2	31704-31714	conclusion	_	
174-3	31715-31717	is	_	
174-4	31718-31725	further	_	
174-5	31726-31735	supported	_	
174-6	31736-31738	by	_	
174-7	31739-31740	a	_	
174-8	31741-31747	recent	_	
174-9	31748-31753	study	_	
174-10	31754-31756	in	_	
174-11	31757-31764	healthy	_	
174-12	31765-31775	volunteers	_	
174-13	31776-31780	that	_	
174-14	31781-31787	showed	_	
174-15	31788-31792	that	_	
174-16	31793-31803	meditation	_	
174-17	31804-31812	enhanced	_	
174-18	31813-31815	by	_	
174-19	31816-31823	rt-fMRI	_	
174-20	31824-31826	NF	_	
174-21	31827-31829	is	_	
174-22	31830-31839	effective	_	
174-23	31840-31842	in	_	
174-24	31843-31851	changing	_	
174-25	31852-31855	the	_	
174-26	31856-31868	relationship	_	
174-27	31869-31876	between	_	
174-28	31877-31884	DMN-CEN	_	
174-29	31885-31888	and	_	
174-30	31889-31897	salience	_	
174-31	31898-31906	networks	_	
174-32	31906-31907	.	_	

#Text=Limitations
#Text=Similarly to the STG based rt-fMRI neurofeedback study, the sample size was small and thus the reported effects should be treated as preliminary.
175-1	31908-31919	Limitations	_	
175-2	31920-31929	Similarly	_	
175-3	31930-31932	to	_	
175-4	31933-31936	the	_	
175-5	31937-31940	STG	_	
175-6	31941-31946	based	_	
175-7	31947-31954	rt-fMRI	_	
175-8	31955-31968	neurofeedback	_	
175-9	31969-31974	study	_	
175-10	31974-31975	,	_	
175-11	31976-31979	the	_	
175-12	31980-31986	sample	_	
175-13	31987-31991	size	_	
175-14	31992-31995	was	_	
175-15	31996-32001	small	_	
175-16	32002-32005	and	_	
175-17	32006-32010	thus	_	
175-18	32011-32014	the	_	
175-19	32015-32023	reported	_	
175-20	32024-32031	effects	_	
175-21	32032-32038	should	_	
175-22	32039-32041	be	_	
175-23	32042-32049	treated	_	
175-24	32050-32052	as	_	
175-25	32053-32064	preliminary	_	
175-26	32064-32065	.	_	

#Text=Furthermore, the control condition using the SMC as a target region was not the standard sham condition where the task is identical but the feedback region varies, due to concerns related to our patients wellbeing as described in Part I.
176-1	32066-32077	Furthermore	_	
176-2	32077-32078	,	_	
176-3	32079-32082	the	_	
176-4	32083-32090	control	_	
176-5	32091-32100	condition	_	
176-6	32101-32106	using	_	
176-7	32107-32110	the	_	
176-8	32111-32114	SMC	_	
176-9	32115-32117	as	_	
176-10	32118-32119	a	_	
176-11	32120-32126	target	_	
176-12	32127-32133	region	_	
176-13	32134-32137	was	_	
176-14	32138-32141	not	_	
176-15	32142-32145	the	_	
176-16	32146-32154	standard	_	
176-17	32155-32159	sham	_	
176-18	32160-32169	condition	_	
176-19	32170-32175	where	_	
176-20	32176-32179	the	_	
176-21	32180-32184	task	_	
176-22	32185-32187	is	_	
176-23	32188-32197	identical	_	
176-24	32198-32201	but	_	
176-25	32202-32205	the	_	
176-26	32206-32214	feedback	_	
176-27	32215-32221	region	_	
176-28	32222-32228	varies	_	
176-29	32228-32229	,	_	
176-30	32230-32233	due	_	
176-31	32234-32236	to	_	
176-32	32237-32245	concerns	_	
176-33	32246-32253	related	_	
176-34	32254-32256	to	_	
176-35	32257-32260	our	_	
176-36	32261-32269	patients	_	
176-37	32270-32279	wellbeing	_	
176-38	32280-32282	as	_	
176-39	32283-32292	described	_	
176-40	32293-32295	in	_	
176-41	32296-32300	Part	_	
176-42	32301-32302	I	_	
176-43	32302-32303	.	_	

#Text=Thus, the question of the effects of meditation relative to meditation aided with NFB, tested head to head in one subject group, was not addressed in the current design: we plan to address it in a future study.
177-1	32304-32308	Thus	_	
177-2	32308-32309	,	_	
177-3	32310-32313	the	_	
177-4	32314-32322	question	_	
177-5	32323-32325	of	_	
177-6	32326-32329	the	_	
177-7	32330-32337	effects	_	
177-8	32338-32340	of	_	
177-9	32341-32351	meditation	_	
177-10	32352-32360	relative	_	
177-11	32361-32363	to	_	
177-12	32364-32374	meditation	_	
177-13	32375-32380	aided	_	
177-14	32381-32385	with	_	
177-15	32386-32389	NFB	_	
177-16	32389-32390	,	_	
177-17	32391-32397	tested	_	
177-18	32398-32402	head	_	
177-19	32403-32405	to	_	
177-20	32406-32410	head	_	
177-21	32411-32413	in	_	
177-22	32414-32417	one	_	
177-23	32418-32425	subject	_	
177-24	32426-32431	group	_	
177-25	32431-32432	,	_	
177-26	32433-32436	was	_	
177-27	32437-32440	not	_	
177-28	32441-32450	addressed	_	
177-29	32451-32453	in	_	
177-30	32454-32457	the	_	
177-31	32458-32465	current	_	
177-32	32466-32472	design	_	
177-33	32472-32473	:	_	
177-34	32474-32476	we	_	
177-35	32477-32481	plan	_	
177-36	32482-32484	to	_	
177-37	32485-32492	address	_	
177-38	32493-32495	it	_	
177-39	32496-32498	in	_	
177-40	32499-32500	a	_	
177-41	32501-32507	future	_	
177-42	32508-32513	study	_	
177-43	32513-32514	.	_	

#Text=The current study has been designed as a proof of concept study since at the time of the study design there was no evidence that neurofeedback can be used to reduce AHs in schizophrenia.
178-1	32515-32518	The	_	
178-2	32519-32526	current	_	
178-3	32527-32532	study	_	
178-4	32533-32536	has	_	
178-5	32537-32541	been	_	
178-6	32542-32550	designed	_	
178-7	32551-32553	as	_	
178-8	32554-32555	a	_	
178-9	32556-32561	proof	_	
178-10	32562-32564	of	_	
178-11	32565-32572	concept	_	
178-12	32573-32578	study	_	
178-13	32579-32584	since	_	
178-14	32585-32587	at	_	
178-15	32588-32591	the	_	
178-16	32592-32596	time	_	
178-17	32597-32599	of	_	
178-18	32600-32603	the	_	
178-19	32604-32609	study	_	
178-20	32610-32616	design	_	
178-21	32617-32622	there	_	
178-22	32623-32626	was	_	
178-23	32627-32629	no	_	
178-24	32630-32638	evidence	_	
178-25	32639-32643	that	_	
178-26	32644-32657	neurofeedback	_	
178-27	32658-32661	can	_	
178-28	32662-32664	be	_	
178-29	32665-32669	used	_	
178-30	32670-32672	to	_	
178-31	32673-32679	reduce	_	
178-32	32680-32683	AHs	_	
178-33	32684-32686	in	_	
178-34	32687-32700	schizophrenia	_	
178-35	32700-32701	.	_	

#Text=The results obtained in this study where one session of NFB aided by meditation was sufficient to produce significant AVH reductions, nicely dovetail with a study by.
179-1	32702-32705	The	_	
179-2	32706-32713	results	_	
179-3	32714-32722	obtained	_	
179-4	32723-32725	in	_	
179-5	32726-32730	this	_	
179-6	32731-32736	study	_	
179-7	32737-32742	where	_	
179-8	32743-32746	one	_	
179-9	32747-32754	session	_	
179-10	32755-32757	of	_	
179-11	32758-32761	NFB	_	
179-12	32762-32767	aided	_	
179-13	32768-32770	by	_	
179-14	32771-32781	meditation	_	
179-15	32782-32785	was	_	
179-16	32786-32796	sufficient	_	
179-17	32797-32799	to	_	
179-18	32800-32807	produce	_	
179-19	32808-32819	significant	_	
179-20	32820-32823	AVH	_	
179-21	32824-32834	reductions	_	
179-22	32834-32835	,	_	
179-23	32836-32842	nicely	_	
179-24	32843-32851	dovetail	_	
179-25	32852-32856	with	_	
179-26	32857-32858	a	_	
179-27	32859-32864	study	_	
179-28	32865-32867	by	_	
179-29	32867-32868	.	_	

#Text=In that study, three weeks of mindful meditation by itself, practiced daily, were needed to achieve significant reductions in AVH.
180-1	32869-32871	In	_	
180-2	32872-32876	that	_	
180-3	32877-32882	study	_	
180-4	32882-32883	,	_	
180-5	32884-32889	three	_	
180-6	32890-32895	weeks	_	
180-7	32896-32898	of	_	
180-8	32899-32906	mindful	_	
180-9	32907-32917	meditation	_	
180-10	32918-32920	by	_	
180-11	32921-32927	itself	_	
180-12	32927-32928	,	_	
180-13	32929-32938	practiced	_	
180-14	32939-32944	daily	_	
180-15	32944-32945	,	_	
180-16	32946-32950	were	_	
180-17	32951-32957	needed	_	
180-18	32958-32960	to	_	
180-19	32961-32968	achieve	_	
180-20	32969-32980	significant	_	
180-21	32981-32991	reductions	_	
180-22	32992-32994	in	_	
180-23	32995-32998	AVH	_	
180-24	32998-32999	.	_	

#Text=Together, these results encourage us to think that neurofeedback and meditation jointly are effective means of achieving desired neural and clinical changes.
181-1	33000-33008	Together	_	
181-2	33008-33009	,	_	
181-3	33010-33015	these	_	
181-4	33016-33023	results	_	
181-5	33024-33033	encourage	_	
181-6	33034-33036	us	_	
181-7	33037-33039	to	_	
181-8	33040-33045	think	_	
181-9	33046-33050	that	_	
181-10	33051-33064	neurofeedback	_	
181-11	33065-33068	and	_	
181-12	33069-33079	meditation	_	
181-13	33080-33087	jointly	_	
181-14	33088-33091	are	_	
181-15	33092-33101	effective	_	
181-16	33102-33107	means	_	
181-17	33108-33110	of	_	
181-18	33111-33120	achieving	_	
181-19	33121-33128	desired	_	
181-20	33129-33135	neural	_	
181-21	33136-33139	and	_	
181-22	33140-33148	clinical	_	
181-23	33149-33156	changes	_	
181-24	33156-33157	.	_	

#Text=It is currently not clear what factors contributed to the slow rate of AHs reductions observed in the Sheng et al study.
182-1	33158-33160	It	_	
182-2	33161-33163	is	_	
182-3	33164-33173	currently	_	
182-4	33174-33177	not	_	
182-5	33178-33183	clear	_	
182-6	33184-33188	what	_	
182-7	33189-33196	factors	_	
182-8	33197-33208	contributed	_	
182-9	33209-33211	to	_	
182-10	33212-33215	the	_	
182-11	33216-33220	slow	_	
182-12	33221-33225	rate	_	
182-13	33226-33228	of	_	
182-14	33229-33232	AHs	_	
182-15	33233-33243	reductions	_	
182-16	33244-33252	observed	_	
182-17	33253-33255	in	_	
182-18	33256-33259	the	_	
182-19	33260-33265	Sheng	_	
182-20	33266-33268	et	_	
182-21	33269-33271	al	_	
182-22	33272-33277	study	_	
182-23	33277-33278	.	_	

#Text=However, schizophrenia is associated with reductions in self-awareness, introspection and metacognitive abilities.
183-1	33279-33286	However	_	
183-2	33286-33287	,	_	
183-3	33288-33301	schizophrenia	_	
183-4	33302-33304	is	_	
183-5	33305-33315	associated	_	
183-6	33316-33320	with	_	
183-7	33321-33331	reductions	_	
183-8	33332-33334	in	_	
183-9	33335-33349	self-awareness	_	
183-10	33349-33350	,	_	
183-11	33351-33364	introspection	_	
183-12	33365-33368	and	_	
183-13	33369-33382	metacognitive	_	
183-14	33383-33392	abilities	_	
183-15	33392-33393	.	_	

#Text=These deficits may have contributed to the slow rate of improvement when meditation only was used as a therapeutic approach.
184-1	33394-33399	These	_	
184-2	33400-33408	deficits	_	
184-3	33409-33412	may	_	
184-4	33413-33417	have	_	
184-5	33418-33429	contributed	_	
184-6	33430-33432	to	_	
184-7	33433-33436	the	_	
184-8	33437-33441	slow	_	
184-9	33442-33446	rate	_	
184-10	33447-33449	of	_	
184-11	33450-33461	improvement	_	
184-12	33462-33466	when	_	
184-13	33467-33477	meditation	_	
184-14	33478-33482	only	_	
184-15	33483-33486	was	_	
184-16	33487-33491	used	_	
184-17	33492-33494	as	_	
184-18	33495-33496	a	_	
184-19	33497-33508	therapeutic	_	
184-20	33509-33517	approach	_	
184-21	33517-33518	.	_	

#Text=Thus, feedback from the appropriate brain regions may aid in achieving therapeutic treatment goals in this patient group.
185-1	33519-33523	Thus	_	
185-2	33523-33524	,	_	
185-3	33525-33533	feedback	_	
185-4	33534-33538	from	_	
185-5	33539-33542	the	_	
185-6	33543-33554	appropriate	_	
185-7	33555-33560	brain	_	
185-8	33561-33568	regions	_	
185-9	33569-33572	may	_	
185-10	33573-33576	aid	_	
185-11	33577-33579	in	_	
185-12	33580-33589	achieving	_	
185-13	33590-33601	therapeutic	_	
185-14	33602-33611	treatment	_	
185-15	33612-33617	goals	_	
185-16	33618-33620	in	_	
185-17	33621-33625	this	_	
185-18	33626-33633	patient	_	
185-19	33634-33639	group	_	
185-20	33639-33640	.	_	

#Text=At the very least, the results obtained in the current study suggest that NFB from the brain regions involved in meditation contributes to effects that can be observed after just one NFB session.
186-1	33641-33643	At	_	
186-2	33644-33647	the	_	
186-3	33648-33652	very	_	
186-4	33653-33658	least	_	
186-5	33658-33659	,	_	
186-6	33660-33663	the	_	
186-7	33664-33671	results	_	
186-8	33672-33680	obtained	_	
186-9	33681-33683	in	_	
186-10	33684-33687	the	_	
186-11	33688-33695	current	_	
186-12	33696-33701	study	_	
186-13	33702-33709	suggest	_	
186-14	33710-33714	that	_	
186-15	33715-33718	NFB	_	
186-16	33719-33723	from	_	
186-17	33724-33727	the	_	
186-18	33728-33733	brain	_	
186-19	33734-33741	regions	_	
186-20	33742-33750	involved	_	
186-21	33751-33753	in	_	
186-22	33754-33764	meditation	_	
186-23	33765-33776	contributes	_	
186-24	33777-33779	to	_	
186-25	33780-33787	effects	_	
186-26	33788-33792	that	_	
186-27	33793-33796	can	_	
186-28	33797-33799	be	_	
186-29	33800-33808	observed	_	
186-30	33809-33814	after	_	
186-31	33815-33819	just	_	
186-32	33820-33823	one	_	
186-33	33824-33827	NFB	_	
186-34	33828-33835	session	_	
186-35	33835-33836	.	_	

#Text=Finally, we note that as a result of the patients participating in the control condition (SMC), we did not get the relevant network modulation, and we did not see reduction of AVH.
187-1	33837-33844	Finally	_	
187-2	33844-33845	,	_	
187-3	33846-33848	we	_	
187-4	33849-33853	note	_	
187-5	33854-33858	that	_	
187-6	33859-33861	as	_	
187-7	33862-33863	a	_	
187-8	33864-33870	result	_	
187-9	33871-33873	of	_	
187-10	33874-33877	the	_	
187-11	33878-33886	patients	_	
187-12	33887-33900	participating	_	
187-13	33901-33903	in	_	
187-14	33904-33907	the	_	
187-15	33908-33915	control	_	
187-16	33916-33925	condition	_	
187-17	33926-33927	(	_	
187-18	33927-33930	SMC	_	
187-19	33930-33931	)	_	
187-20	33931-33932	,	_	
187-21	33933-33935	we	_	
187-22	33936-33939	did	_	
187-23	33940-33943	not	_	
187-24	33944-33947	get	_	
187-25	33948-33951	the	_	
187-26	33952-33960	relevant	_	
187-27	33961-33968	network	_	
187-28	33969-33979	modulation	_	
187-29	33979-33980	,	_	
187-30	33981-33984	and	_	
187-31	33985-33987	we	_	
187-32	33988-33991	did	_	
187-33	33992-33995	not	_	
187-34	33996-33999	see	_	
187-35	34000-34009	reduction	_	
187-36	34010-34012	of	_	
187-37	34013-34016	AVH	_	
187-38	34016-34017	.	_	

#Text=Overall Conclusions for Part I and Part II.
188-1	34018-34025	Overall	_	
188-2	34026-34037	Conclusions	_	
188-3	34038-34041	for	_	
188-4	34042-34046	Part	_	
188-5	34047-34048	I	_	
188-6	34049-34052	and	_	
188-7	34053-34057	Part	_	
188-8	34058-34060	II	_	
188-9	34060-34061	.	_	

#Text=In the study using experimental designs discussed in Part I and Part II, we pursued a hypothesis that AHs are generated from a network of brain regions where each region separately, and in interactions with other brain regions, contributes to AHs reported by SZ patients.
189-1	34062-34064	In	_	
189-2	34065-34068	the	_	
189-3	34069-34074	study	_	
189-4	34075-34080	using	_	
189-5	34081-34093	experimental	_	
189-6	34094-34101	designs	_	
189-7	34102-34111	discussed	_	
189-8	34112-34114	in	_	
189-9	34115-34119	Part	_	
189-10	34120-34121	I	_	
189-11	34122-34125	and	_	
189-12	34126-34130	Part	_	
189-13	34131-34133	II	_	
189-14	34133-34134	,	_	
189-15	34135-34137	we	_	
189-16	34138-34145	pursued	_	
189-17	34146-34147	a	_	
189-18	34148-34158	hypothesis	_	
189-19	34159-34163	that	_	
189-20	34164-34167	AHs	_	
189-21	34168-34171	are	_	
189-22	34172-34181	generated	_	
189-23	34182-34186	from	_	
189-24	34187-34188	a	_	
189-25	34189-34196	network	_	
189-26	34197-34199	of	_	
189-27	34200-34205	brain	_	
189-28	34206-34213	regions	_	
189-29	34214-34219	where	_	
189-30	34220-34224	each	_	
189-31	34225-34231	region	_	
189-32	34232-34242	separately	_	
189-33	34242-34243	,	_	
189-34	34244-34247	and	_	
189-35	34248-34250	in	_	
189-36	34251-34263	interactions	_	
189-37	34264-34268	with	_	
189-38	34269-34274	other	_	
189-39	34275-34280	brain	_	
189-40	34281-34288	regions	_	
189-41	34288-34289	,	_	
189-42	34290-34301	contributes	_	
189-43	34302-34304	to	_	
189-44	34305-34308	AHs	_	
189-45	34309-34317	reported	_	
189-46	34318-34320	by	_	
189-47	34321-34323	SZ	_	
189-48	34324-34332	patients	_	
189-49	34332-34333	.	_	

#Text=We further hypothesized that the rt–fMRI neurofeedback intervention would lead to a reduction in AHs.
190-1	34334-34336	We	_	
190-2	34337-34344	further	_	
190-3	34345-34357	hypothesized	_	
190-4	34358-34362	that	_	
190-5	34363-34366	the	_	
190-6	34367-34374	rt–fMRI	_	
190-7	34375-34388	neurofeedback	_	
190-8	34389-34401	intervention	_	
190-9	34402-34407	would	_	
190-10	34408-34412	lead	_	
190-11	34413-34415	to	_	
190-12	34416-34417	a	_	
190-13	34418-34427	reduction	_	
190-14	34428-34430	in	_	
190-15	34431-34434	AHs	_	
190-16	34434-34435	.	_	

#Text=We adopted two different approaches to test this hypothesis.
191-1	34436-34438	We	_	
191-2	34439-34446	adopted	_	
191-3	34447-34450	two	_	
191-4	34451-34460	different	_	
191-5	34461-34471	approaches	_	
191-6	34472-34474	to	_	
191-7	34475-34479	test	_	
191-8	34480-34484	this	_	
191-9	34485-34495	hypothesis	_	
191-10	34495-34496	.	_	

#Text=In Part I of the paper we narrowly focused on the STG BOLD activation changes and showed that reducing the STG activation in the task of ignoring all sounds was associated with AHs reduction.
192-1	34497-34499	In	_	
192-2	34500-34504	Part	_	
192-3	34505-34506	I	_	
192-4	34507-34509	of	_	
192-5	34510-34513	the	_	
192-6	34514-34519	paper	_	
192-7	34520-34522	we	_	
192-8	34523-34531	narrowly	_	
192-9	34532-34539	focused	_	
192-10	34540-34542	on	_	
192-11	34543-34546	the	_	
192-12	34547-34550	STG	_	
192-13	34551-34555	BOLD	_	
192-14	34556-34566	activation	_	
192-15	34567-34574	changes	_	
192-16	34575-34578	and	_	
192-17	34579-34585	showed	_	
192-18	34586-34590	that	_	
192-19	34591-34599	reducing	_	
192-20	34600-34603	the	_	
192-21	34604-34607	STG	_	
192-22	34608-34618	activation	_	
192-23	34619-34621	in	_	
192-24	34622-34625	the	_	
192-25	34626-34630	task	_	
192-26	34631-34633	of	_	
192-27	34634-34642	ignoring	_	
192-28	34643-34646	all	_	
192-29	34647-34653	sounds	_	
192-30	34654-34657	was	_	
192-31	34658-34668	associated	_	
192-32	34669-34673	with	_	
192-33	34674-34677	AHs	_	
192-34	34678-34687	reduction	_	
192-35	34687-34688	.	_	

#Text=In Part II of the paper, we explicitly focused on AHs network–wide connectivity in a task that targeted DMN–CEN differential activations.
193-1	34689-34691	In	_	
193-2	34692-34696	Part	_	
193-3	34697-34699	II	_	
193-4	34700-34702	of	_	
193-5	34703-34706	the	_	
193-6	34707-34712	paper	_	
193-7	34712-34713	,	_	
193-8	34714-34716	we	_	
193-9	34717-34727	explicitly	_	
193-10	34728-34735	focused	_	
193-11	34736-34738	on	_	
193-12	34739-34742	AHs	_	
193-13	34743-34755	network–wide	_	
193-14	34756-34768	connectivity	_	
193-15	34769-34771	in	_	
193-16	34772-34773	a	_	
193-17	34774-34778	task	_	
193-18	34779-34783	that	_	
193-19	34784-34792	targeted	_	
193-20	34793-34800	DMN–CEN	_	
193-21	34801-34813	differential	_	
193-22	34814-34825	activations	_	
193-23	34825-34826	.	_	

#Text=This approach resulted in network–wide connectivity changes accompanied by reduction in AHs.
194-1	34827-34831	This	_	
194-2	34832-34840	approach	_	
194-3	34841-34849	resulted	_	
194-4	34850-34852	in	_	
194-5	34853-34865	network–wide	_	
194-6	34866-34878	connectivity	_	
194-7	34879-34886	changes	_	
194-8	34887-34898	accompanied	_	
194-9	34899-34901	by	_	
194-10	34902-34911	reduction	_	
194-11	34912-34914	in	_	
194-12	34915-34918	AHs	_	
194-13	34918-34919	.	_	

#Text=Furthermore, individual subjects’ ΔDMN–STG connectivity was correlated with individuals ΔAHs in post– relative to pre–rt–fMRI neurofeedback comparisons.
195-1	34920-34931	Furthermore	_	
195-2	34931-34932	,	_	
195-3	34933-34943	individual	_	
195-4	34944-34952	subjects	_	
195-5	34952-34953	’	_	
195-6	34954-34962	ΔDMN–STG	_	
195-7	34963-34975	connectivity	_	
195-8	34976-34979	was	_	
195-9	34980-34990	correlated	_	
195-10	34991-34995	with	_	
195-11	34996-35007	individuals	_	
195-12	35008-35012	ΔAHs	_	
195-13	35013-35015	in	_	
195-14	35016-35020	post	_	
195-15	35020-35021	–	_	
195-16	35022-35030	relative	_	
195-17	35031-35033	to	_	
195-18	35034-35045	pre–rt–fMRI	_	
195-19	35046-35059	neurofeedback	_	
195-20	35060-35071	comparisons	_	
195-21	35071-35072	.	_	

#Text=Thus, targeting both the STG and targeting a network–wide connectivity was associated with AH reductions.
196-1	35073-35077	Thus	_	
196-2	35077-35078	,	_	
196-3	35079-35088	targeting	_	
196-4	35089-35093	both	_	
196-5	35094-35097	the	_	
196-6	35098-35101	STG	_	
196-7	35102-35105	and	_	
196-8	35106-35115	targeting	_	
196-9	35116-35117	a	_	
196-10	35118-35130	network–wide	_	
196-11	35131-35143	connectivity	_	
196-12	35144-35147	was	_	
196-13	35148-35158	associated	_	
196-14	35159-35163	with	_	
196-15	35164-35166	AH	_	
196-16	35167-35177	reductions	_	
196-17	35177-35178	.	_	

#Text=These results support the hypothesis put forth (:) in this investigation that perturbing one element of the brain network is going to impact all elements of this network.
197-1	35179-35184	These	_	
197-2	35185-35192	results	_	
197-3	35193-35200	support	_	
197-4	35201-35204	the	_	
197-5	35205-35215	hypothesis	_	
197-6	35216-35219	put	_	
197-7	35220-35225	forth	_	
197-8	35226-35227	(	_	
197-9	35227-35228	:	_	
197-10	35228-35229	)	_	
197-11	35230-35232	in	_	
197-12	35233-35237	this	_	
197-13	35238-35251	investigation	_	
197-14	35252-35256	that	_	
197-15	35257-35267	perturbing	_	
197-16	35268-35271	one	_	
197-17	35272-35279	element	_	
197-18	35280-35282	of	_	
197-19	35283-35286	the	_	
197-20	35287-35292	brain	_	
197-21	35293-35300	network	_	
197-22	35301-35303	is	_	
197-23	35304-35309	going	_	
197-24	35310-35312	to	_	
197-25	35313-35319	impact	_	
197-26	35320-35323	all	_	
197-27	35324-35332	elements	_	
197-28	35333-35335	of	_	
197-29	35336-35340	this	_	
197-30	35341-35348	network	_	
197-31	35348-35349	.	_	

#Text=Further support for this perspective comes from recently published studies of rt-fMRI neuro feedback where AHs reductions were associated with changes belonging to AHs network rather than pertaining to the target region for neurofeedback, as described above.
198-1	35350-35357	Further	_	
198-2	35358-35365	support	_	
198-3	35366-35369	for	_	
198-4	35370-35374	this	_	
198-5	35375-35386	perspective	_	
198-6	35387-35392	comes	_	
198-7	35393-35397	from	_	
198-8	35398-35406	recently	_	
198-9	35407-35416	published	_	
198-10	35417-35424	studies	_	
198-11	35425-35427	of	_	
198-12	35428-35435	rt-fMRI	_	
198-13	35436-35441	neuro	_	
198-14	35442-35450	feedback	_	
198-15	35451-35456	where	_	
198-16	35457-35460	AHs	_	
198-17	35461-35471	reductions	_	
198-18	35472-35476	were	_	
198-19	35477-35487	associated	_	
198-20	35488-35492	with	_	
198-21	35493-35500	changes	_	
198-22	35501-35510	belonging	_	
198-23	35511-35513	to	_	
198-24	35514-35517	AHs	_	
198-25	35518-35525	network	_	
198-26	35526-35532	rather	_	
198-27	35533-35537	than	_	
198-28	35538-35548	pertaining	_	
198-29	35549-35551	to	_	
198-30	35552-35555	the	_	
198-31	35556-35562	target	_	
198-32	35563-35569	region	_	
198-33	35570-35573	for	_	
198-34	35574-35587	neurofeedback	_	
198-35	35587-35588	,	_	
198-36	35589-35591	as	_	
198-37	35592-35601	described	_	
198-38	35602-35607	above	_	
198-39	35607-35608	.	_	

#Text=The current study is the first to test the effectiveness of two different approaches to rt-fMRI neurofeedback in pursuit of AHs reductions in one group of subjects.
199-1	35609-35612	The	_	
199-2	35613-35620	current	_	
199-3	35621-35626	study	_	
199-4	35627-35629	is	_	
199-5	35630-35633	the	_	
199-6	35634-35639	first	_	
199-7	35640-35642	to	_	
199-8	35643-35647	test	_	
199-9	35648-35651	the	_	
199-10	35652-35665	effectiveness	_	
199-11	35666-35668	of	_	
199-12	35669-35672	two	_	
199-13	35673-35682	different	_	
199-14	35683-35693	approaches	_	
199-15	35694-35696	to	_	
199-16	35697-35704	rt-fMRI	_	
199-17	35705-35718	neurofeedback	_	
199-18	35719-35721	in	_	
199-19	35722-35729	pursuit	_	
199-20	35730-35732	of	_	
199-21	35733-35736	AHs	_	
199-22	35737-35747	reductions	_	
199-23	35748-35750	in	_	
199-24	35751-35754	one	_	
199-25	35755-35760	group	_	
199-26	35761-35763	of	_	
199-27	35764-35772	subjects	_	
199-28	35772-35773	.	_	

#Text=The results of this study also have important implications for neurofeedback studies in terms of designing effective approaches to the intervention.
200-1	35774-35777	The	_	
200-2	35778-35785	results	_	
200-3	35786-35788	of	_	
200-4	35789-35793	this	_	
200-5	35794-35799	study	_	
200-6	35800-35804	also	_	
200-7	35805-35809	have	_	
200-8	35810-35819	important	_	
200-9	35820-35832	implications	_	
200-10	35833-35836	for	_	
200-11	35837-35850	neurofeedback	_	
200-12	35851-35858	studies	_	
200-13	35859-35861	in	_	
200-14	35862-35867	terms	_	
200-15	35868-35870	of	_	
200-16	35871-35880	designing	_	
200-17	35881-35890	effective	_	
200-18	35891-35901	approaches	_	
200-19	35902-35904	to	_	
200-20	35905-35908	the	_	
200-21	35909-35921	intervention	_	
200-22	35921-35922	.	_	

#Text=Both the results of the STG- and DMN-focused neurofeedback sessions suggest that selecting a task that has a known impact on the target brain region contributes to a robust outcome.
201-1	35923-35927	Both	_	
201-2	35928-35931	the	_	
201-3	35932-35939	results	_	
201-4	35940-35942	of	_	
201-5	35943-35946	the	_	
201-6	35947-35950	STG	_	
201-7	35950-35951	-	_	
201-8	35952-35955	and	_	
201-9	35956-35967	DMN-focused	_	
201-10	35968-35981	neurofeedback	_	
201-11	35982-35990	sessions	_	
201-12	35991-35998	suggest	_	
201-13	35999-36003	that	_	
201-14	36004-36013	selecting	_	
201-15	36014-36015	a	_	
201-16	36016-36020	task	_	
201-17	36021-36025	that	_	
201-18	36026-36029	has	_	
201-19	36030-36031	a	_	
201-20	36032-36037	known	_	
201-21	36038-36044	impact	_	
201-22	36045-36047	on	_	
201-23	36048-36051	the	_	
201-24	36052-36058	target	_	
201-25	36059-36064	brain	_	
201-26	36065-36071	region	_	
201-27	36072-36083	contributes	_	
201-28	36084-36086	to	_	
201-29	36087-36088	a	_	
201-30	36089-36095	robust	_	
201-31	36096-36103	outcome	_	
201-32	36103-36104	.	_	

#Text=Furthermore, the present results do not seem to support the conclusions of the recent study which identified a network of brain regions involved in AHs and concluded that AHs interventions should involve all brain regions belonging to that_network.
202-1	36105-36116	Furthermore	_	
202-2	36116-36117	,	_	
202-3	36118-36121	the	_	
202-4	36122-36129	present	_	
202-5	36130-36137	results	_	
202-6	36138-36140	do	_	
202-7	36141-36144	not	_	
202-8	36145-36149	seem	_	
202-9	36150-36152	to	_	
202-10	36153-36160	support	_	
202-11	36161-36164	the	_	
202-12	36165-36176	conclusions	_	
202-13	36177-36179	of	_	
202-14	36180-36183	the	_	
202-15	36184-36190	recent	_	
202-16	36191-36196	study	_	
202-17	36197-36202	which	_	
202-18	36203-36213	identified	_	
202-19	36214-36215	a	_	
202-20	36216-36223	network	_	
202-21	36224-36226	of	_	
202-22	36227-36232	brain	_	
202-23	36233-36240	regions	_	
202-24	36241-36249	involved	_	
202-25	36250-36252	in	_	
202-26	36253-36256	AHs	_	
202-27	36257-36260	and	_	
202-28	36261-36270	concluded	_	
202-29	36271-36275	that	_	
202-30	36276-36279	AHs	_	
202-31	36280-36293	interventions	_	
202-32	36294-36300	should	_	
202-33	36301-36308	involve	_	
202-34	36309-36312	all	_	
202-35	36313-36318	brain	_	
202-36	36319-36326	regions	_	
202-37	36327-36336	belonging	_	
202-38	36337-36339	to	_	
202-39	36340-36352	that_network	_	
202-40	36352-36353	.	_	

#Text=While we reach a similar conclusion that indeed AHs are the product of abnormalities across an AH brain network, we suggest that an intervention targeting just one brain region will have network-wide consequences with clinical relevance.
203-1	36354-36359	While	_	
203-2	36360-36362	we	_	
203-3	36363-36368	reach	_	
203-4	36369-36370	a	_	
203-5	36371-36378	similar	_	
203-6	36379-36389	conclusion	_	
203-7	36390-36394	that	_	
203-8	36395-36401	indeed	_	
203-9	36402-36405	AHs	_	
203-10	36406-36409	are	_	
203-11	36410-36413	the	_	
203-12	36414-36421	product	_	
203-13	36422-36424	of	_	
203-14	36425-36438	abnormalities	_	
203-15	36439-36445	across	_	
203-16	36446-36448	an	_	
203-17	36449-36451	AH	_	
203-18	36452-36457	brain	_	
203-19	36458-36465	network	_	
203-20	36465-36466	,	_	
203-21	36467-36469	we	_	
203-22	36470-36477	suggest	_	
203-23	36478-36482	that	_	
203-24	36483-36485	an	_	
203-25	36486-36498	intervention	_	
203-26	36499-36508	targeting	_	
203-27	36509-36513	just	_	
203-28	36514-36517	one	_	
203-29	36518-36523	brain	_	
203-30	36524-36530	region	_	
203-31	36531-36535	will	_	
203-32	36536-36540	have	_	
203-33	36541-36553	network-wide	_	
203-34	36554-36566	consequences	_	
203-35	36567-36571	with	_	
203-36	36572-36580	clinical	_	
203-37	36581-36590	relevance	_	
203-38	36590-36591	.	_	

#Text=Supplementary Material
#Text=This is a PDF file of an unedited manuscript that has been accepted for publication.
204-1	36592-36605	Supplementary	_	
204-2	36606-36614	Material	_	
204-3	36615-36619	This	_	
204-4	36620-36622	is	_	
204-5	36623-36624	a	_	
204-6	36625-36628	PDF	_	
204-7	36629-36633	file	_	
204-8	36634-36636	of	_	
204-9	36637-36639	an	_	
204-10	36640-36648	unedited	_	
204-11	36649-36659	manuscript	_	
204-12	36660-36664	that	_	
204-13	36665-36668	has	_	
204-14	36669-36673	been	_	
204-15	36674-36682	accepted	_	
204-16	36683-36686	for	_	
204-17	36687-36698	publication	_	
204-18	36698-36699	.	_	

#Text=As a service to our customers we are providing this early version of the manuscript.
205-1	36700-36702	As	_	
205-2	36703-36704	a	_	
205-3	36705-36712	service	_	
205-4	36713-36715	to	_	
205-5	36716-36719	our	_	
205-6	36720-36729	customers	_	
205-7	36730-36732	we	_	
205-8	36733-36736	are	_	
205-9	36737-36746	providing	_	
205-10	36747-36751	this	_	
205-11	36752-36757	early	_	
205-12	36758-36765	version	_	
205-13	36766-36768	of	_	
205-14	36769-36772	the	_	
205-15	36773-36783	manuscript	_	
205-16	36783-36784	.	_	

#Text=The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form.
206-1	36785-36788	The	_	
206-2	36789-36799	manuscript	_	
206-3	36800-36804	will	_	
206-4	36805-36812	undergo	_	
206-5	36813-36824	copyediting	_	
206-6	36824-36825	,	_	
206-7	36826-36837	typesetting	_	
206-8	36837-36838	,	_	
206-9	36839-36842	and	_	
206-10	36843-36849	review	_	
206-11	36850-36852	of	_	
206-12	36853-36856	the	_	
206-13	36857-36866	resulting	_	
206-14	36867-36872	proof	_	
206-15	36873-36879	before	_	
206-16	36880-36882	it	_	
206-17	36883-36885	is	_	
206-18	36886-36895	published	_	
206-19	36896-36898	in	_	
206-20	36899-36902	its	_	
206-21	36903-36908	final	_	
206-22	36909-36913	form	_	
206-23	36913-36914	.	_	

#Text=Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
207-1	36915-36921	Please	_	
207-2	36922-36926	note	_	
207-3	36927-36931	that	_	
207-4	36932-36938	during	_	
207-5	36939-36942	the	_	
207-6	36943-36953	production	_	
207-7	36954-36961	process	_	
207-8	36962-36968	errors	_	
207-9	36969-36972	may	_	
207-10	36973-36975	be	_	
207-11	36976-36986	discovered	_	
207-12	36987-36992	which	_	
207-13	36993-36998	could	_	
207-14	36999-37005	affect	_	
207-15	37006-37009	the	_	
207-16	37010-37017	content	_	
207-17	37017-37018	,	_	
207-18	37019-37022	and	_	
207-19	37023-37026	all	_	
207-20	37027-37032	legal	_	
207-21	37033-37044	disclaimers	_	
207-22	37045-37049	that	_	
207-23	37050-37055	apply	_	
207-24	37056-37058	to	_	
207-25	37059-37062	the	_	
207-26	37063-37070	journal	_	
207-27	37071-37078	pertain	_	
207-28	37078-37079	.	_	

#Text=Competing interests: The authors have NO affiliations with or involvement in any organization or entity with any financial interest, or non-financial interest in the subject matter or materials discussed in this manuscript
#Text=References
#Text=The effect of focused attention and open monitoring meditation on attention network function in healthy volunteers
#Text=Hearing voices in the resting brain: A review of intrinsic functional connectivity research on auditory verbal hallucinations
#Text=Cognitive basis of hallucinations in schizophrenia: role of top-down information processing
#Text=Resting-state functional connectivity alterations in the default network of schizophrenia patients with persistent auditory verbal hallucinations
#Text=From State-to-Trait Meditation: Reconfiguration of Central Executive and Default Mode Networks
#Text=Probabilistic independent component analysis for functional magnetic resonance imaging
#Text=A component based noise correction method (CompCor) for BOLD and perfusion based fMRI
#Text=Alterations in task-induced activity and resting-state fluctuations in visual and DMN areas revealed in long-term meditators
#Text=Self-disturbances as a possible premorbid indicator of schizophrenia risk: A neurodevelopmental perspective
#Text=Meditation experience is associated with differences in default mode network activity and connectivity
#Text=The Brain’s Default Network
#Text=Exploring the effects of cognitive remediation on metacognition in people with schizophrenia
#Text=Anticorrelations in resting state networks without global signal regression
#Text=Abnormal Medial Prefrontal Cortex Resting-State Connectivity in Bipolar Disorder and Schizophrenia
#Text=Causal interactions between fronto-parietal central executive and default-mode networks in humans
#Text=Mindfulness- and Acceptance-based Interventions for Psychosis: A Systematic Review and Meta-analysis
#Text=Interaction of language, auditory and memory brain networks in auditory verbal hallucinations
#Text=Self-referential reflective activity and its relationship with rest: a PET study
#Text=When less means more: deactivations during encoding that predict subsequent memory
#Text=A meta-analysis of functional neuroimaging studies of self- and other judgments reveals a spatial gradient for mentalizing in medial prefrontal cortex
#Text=The human brain is intrinsically organized into dynamic, anticorrelated functional networks
#Text=Interrater and intermethod reliability of default mode network selection
#Text=Spontaneous low-frequency BOLD signal fluctuations: an fMRI investigation of the resting-state default mode of brain function hypothesis
#Text=Meditation-State Functional Connectivity (msFC): Strengthening of the Dorsal Attention Network and Beyond
#Text=
#Text=Functional connectivity in the resting brain: A network analysis of the default mode hypothesis
#Text=Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function
#Text=Functional connectivity between task-positive and task-negative brain areas and its relation to working memory performance
#Text=Effects of Meditation Experience on Functional Connectivity of Distributed Brain Networks
#Text=Neuroscience of Self and Self-Regulation
#Text=Aberrant intrinsic brain activity and cognitive deficit in first-episode treatment-naive patients with schizophrenia
#Text=Computing moment-to-moment BOLD activation for real-time neurofeedback
#Text=Temporoparietal Transcranial Magnetic Stimulation for Auditory Hallucinations: Safety, Efficacy and Moderators in a Fifty Patient Sample
#Text=Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations
#Text=An anterior-to-posterior shift in midline cortical activity in schizophrenia during self-reflection
#Text=“Hearing voices”: auditory hallucinations as failure of top-down control of bottom-up perceptual processes
#Text=Cortical activations during auditory verbal hallucinations in schizophrenia: a coordinate-based meta-analysis
#Text=The neurodynamic organization of modality-dependent hallucinations
#Text=FSL
#Text=Neural correlates of self-reflection
#Text=Influence of meditation on anti-correlated networks in the brain
#Text=Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain, and Illness
#Text=Resting-state anticorrelations between medial and lateral prefrontal cortex: association with working memory, aging, and individual differences
#Text=Finding the Self?
208-1	37080-37089	Competing	_	
208-2	37090-37099	interests	_	
208-3	37099-37100	:	_	
208-4	37101-37104	The	_	
208-5	37105-37112	authors	_	
208-6	37113-37117	have	_	
208-7	37118-37120	NO	_	
208-8	37121-37133	affiliations	_	
208-9	37134-37138	with	_	
208-10	37139-37141	or	_	
208-11	37142-37153	involvement	_	
208-12	37154-37156	in	_	
208-13	37157-37160	any	_	
208-14	37161-37173	organization	_	
208-15	37174-37176	or	_	
208-16	37177-37183	entity	_	
208-17	37184-37188	with	_	
208-18	37189-37192	any	_	
208-19	37193-37202	financial	_	
208-20	37203-37211	interest	_	
208-21	37211-37212	,	_	
208-22	37213-37215	or	_	
208-23	37216-37229	non-financial	_	
208-24	37230-37238	interest	_	
208-25	37239-37241	in	_	
208-26	37242-37245	the	_	
208-27	37246-37253	subject	_	
208-28	37254-37260	matter	_	
208-29	37261-37263	or	_	
208-30	37264-37273	materials	_	
208-31	37274-37283	discussed	_	
208-32	37284-37286	in	_	
208-33	37287-37291	this	_	
208-34	37292-37302	manuscript	_	
208-35	37303-37313	References	_	
208-36	37314-37317	The	_	
208-37	37318-37324	effect	_	
208-38	37325-37327	of	_	
208-39	37328-37335	focused	_	
208-40	37336-37345	attention	_	
208-41	37346-37349	and	_	
208-42	37350-37354	open	_	
208-43	37355-37365	monitoring	_	
208-44	37366-37376	meditation	_	
208-45	37377-37379	on	_	
208-46	37380-37389	attention	_	
208-47	37390-37397	network	_	
208-48	37398-37406	function	_	
208-49	37407-37409	in	_	
208-50	37410-37417	healthy	_	
208-51	37418-37428	volunteers	_	
208-52	37429-37436	Hearing	_	
208-53	37437-37443	voices	_	
208-54	37444-37446	in	_	
208-55	37447-37450	the	_	
208-56	37451-37458	resting	_	
208-57	37459-37464	brain	_	
208-58	37464-37465	:	_	
208-59	37466-37467	A	_	
208-60	37468-37474	review	_	
208-61	37475-37477	of	_	
208-62	37478-37487	intrinsic	_	
208-63	37488-37498	functional	_	
208-64	37499-37511	connectivity	_	
208-65	37512-37520	research	_	
208-66	37521-37523	on	_	
208-67	37524-37532	auditory	_	
208-68	37533-37539	verbal	_	
208-69	37540-37554	hallucinations	_	
208-70	37555-37564	Cognitive	_	
208-71	37565-37570	basis	_	
208-72	37571-37573	of	_	
208-73	37574-37588	hallucinations	_	
208-74	37589-37591	in	_	
208-75	37592-37605	schizophrenia	_	
208-76	37605-37606	:	_	
208-77	37607-37611	role	_	
208-78	37612-37614	of	_	
208-79	37615-37623	top-down	_	
208-80	37624-37635	information	_	
208-81	37636-37646	processing	_	
208-82	37647-37660	Resting-state	_	
208-83	37661-37671	functional	_	
208-84	37672-37684	connectivity	_	
208-85	37685-37696	alterations	_	
208-86	37697-37699	in	_	
208-87	37700-37703	the	_	
208-88	37704-37711	default	_	
208-89	37712-37719	network	_	
208-90	37720-37722	of	_	
208-91	37723-37736	schizophrenia	_	
208-92	37737-37745	patients	_	
208-93	37746-37750	with	_	
208-94	37751-37761	persistent	_	
208-95	37762-37770	auditory	_	
208-96	37771-37777	verbal	_	
208-97	37778-37792	hallucinations	_	
208-98	37793-37797	From	_	
208-99	37798-37812	State-to-Trait	_	
208-100	37813-37823	Meditation	_	
208-101	37823-37824	:	_	
208-102	37825-37840	Reconfiguration	_	
208-103	37841-37843	of	_	
208-104	37844-37851	Central	_	
208-105	37852-37861	Executive	_	
208-106	37862-37865	and	_	
208-107	37866-37873	Default	_	
208-108	37874-37878	Mode	_	
208-109	37879-37887	Networks	_	
208-110	37888-37901	Probabilistic	_	
208-111	37902-37913	independent	_	
208-112	37914-37923	component	_	
208-113	37924-37932	analysis	_	
208-114	37933-37936	for	_	
208-115	37937-37947	functional	_	
208-116	37948-37956	magnetic	_	
208-117	37957-37966	resonance	_	
208-118	37967-37974	imaging	_	
208-119	37975-37976	A	_	
208-120	37977-37986	component	_	
208-121	37987-37992	based	_	
208-122	37993-37998	noise	_	
208-123	37999-38009	correction	_	
208-124	38010-38016	method	_	
208-125	38017-38018	(	_	
208-126	38018-38025	CompCor	_	
208-127	38025-38026	)	_	
208-128	38027-38030	for	_	
208-129	38031-38035	BOLD	_	
208-130	38036-38039	and	_	
208-131	38040-38049	perfusion	_	
208-132	38050-38055	based	_	
208-133	38056-38060	fMRI	_	
208-134	38061-38072	Alterations	_	
208-135	38073-38075	in	_	
208-136	38076-38088	task-induced	_	
208-137	38089-38097	activity	_	
208-138	38098-38101	and	_	
208-139	38102-38115	resting-state	_	
208-140	38116-38128	fluctuations	_	
208-141	38129-38131	in	_	
208-142	38132-38138	visual	_	
208-143	38139-38142	and	_	
208-144	38143-38146	DMN	_	
208-145	38147-38152	areas	_	
208-146	38153-38161	revealed	_	
208-147	38162-38164	in	_	
208-148	38165-38174	long-term	_	
208-149	38175-38185	meditators	_	
208-150	38186-38203	Self-disturbances	_	
208-151	38204-38206	as	_	
208-152	38207-38208	a	_	
208-153	38209-38217	possible	_	
208-154	38218-38227	premorbid	_	
208-155	38228-38237	indicator	_	
208-156	38238-38240	of	_	
208-157	38241-38254	schizophrenia	_	
208-158	38255-38259	risk	_	
208-159	38259-38260	:	_	
208-160	38261-38262	A	_	
208-161	38263-38281	neurodevelopmental	_	
208-162	38282-38293	perspective	_	
208-163	38294-38304	Meditation	_	
208-164	38305-38315	experience	_	
208-165	38316-38318	is	_	
208-166	38319-38329	associated	_	
208-167	38330-38334	with	_	
208-168	38335-38346	differences	_	
208-169	38347-38349	in	_	
208-170	38350-38357	default	_	
208-171	38358-38362	mode	_	
208-172	38363-38370	network	_	
208-173	38371-38379	activity	_	
208-174	38380-38383	and	_	
208-175	38384-38396	connectivity	_	
208-176	38397-38400	The	_	
208-177	38401-38406	Brain	_	
208-178	38406-38407	’	_	
208-179	38407-38408	s	_	
208-180	38409-38416	Default	_	
208-181	38417-38424	Network	_	
208-182	38425-38434	Exploring	_	
208-183	38435-38438	the	_	
208-184	38439-38446	effects	_	
208-185	38447-38449	of	_	
208-186	38450-38459	cognitive	_	
208-187	38460-38471	remediation	_	
208-188	38472-38474	on	_	
208-189	38475-38488	metacognition	_	
208-190	38489-38491	in	_	
208-191	38492-38498	people	_	
208-192	38499-38503	with	_	
208-193	38504-38517	schizophrenia	_	
208-194	38518-38534	Anticorrelations	_	
208-195	38535-38537	in	_	
208-196	38538-38545	resting	_	
208-197	38546-38551	state	_	
208-198	38552-38560	networks	_	
208-199	38561-38568	without	_	
208-200	38569-38575	global	_	
208-201	38576-38582	signal	_	
208-202	38583-38593	regression	_	
208-203	38594-38602	Abnormal	_	
208-204	38603-38609	Medial	_	
208-205	38610-38620	Prefrontal	_	
208-206	38621-38627	Cortex	_	
208-207	38628-38641	Resting-State	_	
208-208	38642-38654	Connectivity	_	
208-209	38655-38657	in	_	
208-210	38658-38665	Bipolar	_	
208-211	38666-38674	Disorder	_	
208-212	38675-38678	and	_	
208-213	38679-38692	Schizophrenia	_	
208-214	38693-38699	Causal	_	
208-215	38700-38712	interactions	_	
208-216	38713-38720	between	_	
208-217	38721-38736	fronto-parietal	_	
208-218	38737-38744	central	_	
208-219	38745-38754	executive	_	
208-220	38755-38758	and	_	
208-221	38759-38771	default-mode	_	
208-222	38772-38780	networks	_	
208-223	38781-38783	in	_	
208-224	38784-38790	humans	_	
208-225	38791-38802	Mindfulness	_	
208-226	38802-38803	-	_	
208-227	38804-38807	and	_	
208-228	38808-38824	Acceptance-based	_	
208-229	38825-38838	Interventions	_	
208-230	38839-38842	for	_	
208-231	38843-38852	Psychosis	_	
208-232	38852-38853	:	_	
208-233	38854-38855	A	_	
208-234	38856-38866	Systematic	_	
208-235	38867-38873	Review	_	
208-236	38874-38877	and	_	
208-237	38878-38891	Meta-analysis	_	
208-238	38892-38903	Interaction	_	
208-239	38904-38906	of	_	
208-240	38907-38915	language	_	
208-241	38915-38916	,	_	
208-242	38917-38925	auditory	_	
208-243	38926-38929	and	_	
208-244	38930-38936	memory	_	
208-245	38937-38942	brain	_	
208-246	38943-38951	networks	_	
208-247	38952-38954	in	_	
208-248	38955-38963	auditory	_	
208-249	38964-38970	verbal	_	
208-250	38971-38985	hallucinations	_	
208-251	38986-39002	Self-referential	_	
208-252	39003-39013	reflective	_	
208-253	39014-39022	activity	_	
208-254	39023-39026	and	_	
208-255	39027-39030	its	_	
208-256	39031-39043	relationship	_	
208-257	39044-39048	with	_	
208-258	39049-39053	rest	_	
208-259	39053-39054	:	_	
208-260	39055-39056	a	_	
208-261	39057-39060	PET	_	
208-262	39061-39066	study	_	
208-263	39067-39071	When	_	
208-264	39072-39076	less	_	
208-265	39077-39082	means	_	
208-266	39083-39087	more	_	
208-267	39087-39088	:	_	
208-268	39089-39102	deactivations	_	
208-269	39103-39109	during	_	
208-270	39110-39118	encoding	_	
208-271	39119-39123	that	_	
208-272	39124-39131	predict	_	
208-273	39132-39142	subsequent	_	
208-274	39143-39149	memory	_	
208-275	39150-39151	A	_	
208-276	39152-39165	meta-analysis	_	
208-277	39166-39168	of	_	
208-278	39169-39179	functional	_	
208-279	39180-39192	neuroimaging	_	
208-280	39193-39200	studies	_	
208-281	39201-39203	of	_	
208-282	39204-39208	self	_	
208-283	39208-39209	-	_	
208-284	39210-39213	and	_	
208-285	39214-39219	other	_	
208-286	39220-39229	judgments	_	
208-287	39230-39237	reveals	_	
208-288	39238-39239	a	_	
208-289	39240-39247	spatial	_	
208-290	39248-39256	gradient	_	
208-291	39257-39260	for	_	
208-292	39261-39272	mentalizing	_	
208-293	39273-39275	in	_	
208-294	39276-39282	medial	_	
208-295	39283-39293	prefrontal	_	
208-296	39294-39300	cortex	_	
208-297	39301-39304	The	_	
208-298	39305-39310	human	_	
208-299	39311-39316	brain	_	
208-300	39317-39319	is	_	
208-301	39320-39333	intrinsically	_	
208-302	39334-39343	organized	_	
208-303	39344-39348	into	_	
208-304	39349-39356	dynamic	_	
208-305	39356-39357	,	_	
208-306	39358-39372	anticorrelated	_	
208-307	39373-39383	functional	_	
208-308	39384-39392	networks	_	
208-309	39393-39403	Interrater	_	
208-310	39404-39407	and	_	
208-311	39408-39419	intermethod	_	
208-312	39420-39431	reliability	_	
208-313	39432-39434	of	_	
208-314	39435-39442	default	_	
208-315	39443-39447	mode	_	
208-316	39448-39455	network	_	
208-317	39456-39465	selection	_	
208-318	39466-39477	Spontaneous	_	
208-319	39478-39491	low-frequency	_	
208-320	39492-39496	BOLD	_	
208-321	39497-39503	signal	_	
208-322	39504-39516	fluctuations	_	
208-323	39516-39517	:	_	
208-324	39518-39520	an	_	
208-325	39521-39525	fMRI	_	
208-326	39526-39539	investigation	_	
208-327	39540-39542	of	_	
208-328	39543-39546	the	_	
208-329	39547-39560	resting-state	_	
208-330	39561-39568	default	_	
208-331	39569-39573	mode	_	
208-332	39574-39576	of	_	
208-333	39577-39582	brain	_	
208-334	39583-39591	function	_	
208-335	39592-39602	hypothesis	_	
208-336	39603-39619	Meditation-State	_	
208-337	39620-39630	Functional	_	
208-338	39631-39643	Connectivity	_	
208-339	39644-39645	(	_	
208-340	39645-39649	msFC	_	
208-341	39649-39650	)	_	
208-342	39650-39651	:	_	
208-343	39652-39665	Strengthening	_	
208-344	39666-39668	of	_	
208-345	39669-39672	the	_	
208-346	39673-39679	Dorsal	_	
208-347	39680-39689	Attention	_	
208-348	39690-39697	Network	_	
208-349	39698-39701	and	_	
208-350	39702-39708	Beyond	_	
208-351	39710-39720	Functional	_	
208-352	39721-39733	connectivity	_	
208-353	39734-39736	in	_	
208-354	39737-39740	the	_	
208-355	39741-39748	resting	_	
208-356	39749-39754	brain	_	
208-357	39754-39755	:	_	
208-358	39756-39757	A	_	
208-359	39758-39765	network	_	
208-360	39766-39774	analysis	_	
208-361	39775-39777	of	_	
208-362	39778-39781	the	_	
208-363	39782-39789	default	_	
208-364	39790-39794	mode	_	
208-365	39795-39805	hypothesis	_	
208-366	39806-39812	Medial	_	
208-367	39813-39823	prefrontal	_	
208-368	39824-39830	cortex	_	
208-369	39831-39834	and	_	
208-370	39835-39851	self-referential	_	
208-371	39852-39858	mental	_	
208-372	39859-39867	activity	_	
208-373	39867-39868	:	_	
208-374	39869-39877	relation	_	
208-375	39878-39880	to	_	
208-376	39881-39882	a	_	
208-377	39883-39890	default	_	
208-378	39891-39895	mode	_	
208-379	39896-39898	of	_	
208-380	39899-39904	brain	_	
208-381	39905-39913	function	_	
208-382	39914-39924	Functional	_	
208-383	39925-39937	connectivity	_	
208-384	39938-39945	between	_	
208-385	39946-39959	task-positive	_	
208-386	39960-39963	and	_	
208-387	39964-39977	task-negative	_	
208-388	39978-39983	brain	_	
208-389	39984-39989	areas	_	
208-390	39990-39993	and	_	
208-391	39994-39997	its	_	
208-392	39998-40006	relation	_	
208-393	40007-40009	to	_	
208-394	40010-40017	working	_	
208-395	40018-40024	memory	_	
208-396	40025-40036	performance	_	
208-397	40037-40044	Effects	_	
208-398	40045-40047	of	_	
208-399	40048-40058	Meditation	_	
208-400	40059-40069	Experience	_	
208-401	40070-40072	on	_	
208-402	40073-40083	Functional	_	
208-403	40084-40096	Connectivity	_	
208-404	40097-40099	of	_	
208-405	40100-40111	Distributed	_	
208-406	40112-40117	Brain	_	
208-407	40118-40126	Networks	_	
208-408	40127-40139	Neuroscience	_	
208-409	40140-40142	of	_	
208-410	40143-40147	Self	_	
208-411	40148-40151	and	_	
208-412	40152-40167	Self-Regulation	_	
208-413	40168-40176	Aberrant	_	
208-414	40177-40186	intrinsic	_	
208-415	40187-40192	brain	_	
208-416	40193-40201	activity	_	
208-417	40202-40205	and	_	
208-418	40206-40215	cognitive	_	
208-419	40216-40223	deficit	_	
208-420	40224-40226	in	_	
208-421	40227-40240	first-episode	_	
208-422	40241-40256	treatment-naive	_	
208-423	40257-40265	patients	_	
208-424	40266-40270	with	_	
208-425	40271-40284	schizophrenia	_	
208-426	40285-40294	Computing	_	
208-427	40295-40311	moment-to-moment	_	
208-428	40312-40316	BOLD	_	
208-429	40317-40327	activation	_	
208-430	40328-40331	for	_	
208-431	40332-40341	real-time	_	
208-432	40342-40355	neurofeedback	_	
208-433	40356-40371	Temporoparietal	_	
208-434	40372-40384	Transcranial	_	
208-435	40385-40393	Magnetic	_	
208-436	40394-40405	Stimulation	_	
208-437	40406-40409	for	_	
208-438	40410-40418	Auditory	_	
208-439	40419-40433	Hallucinations	_	
208-440	40433-40434	:	_	
208-441	40435-40441	Safety	_	
208-442	40441-40442	,	_	
208-443	40443-40451	Efficacy	_	
208-444	40452-40455	and	_	
208-445	40456-40466	Moderators	_	
208-446	40467-40469	in	_	
208-447	40470-40471	a	_	
208-448	40472-40477	Fifty	_	
208-449	40478-40485	Patient	_	
208-450	40486-40492	Sample	_	
208-451	40493-40505	Transcranial	_	
208-452	40506-40514	magnetic	_	
208-453	40515-40526	stimulation	_	
208-454	40527-40529	of	_	
208-455	40530-40534	left	_	
208-456	40535-40550	temporoparietal	_	
208-457	40551-40557	cortex	_	
208-458	40558-40561	and	_	
208-459	40562-40582	medication-resistant	_	
208-460	40583-40591	auditory	_	
208-461	40592-40606	hallucinations	_	
208-462	40607-40609	An	_	
208-463	40610-40631	anterior-to-posterior	_	
208-464	40632-40637	shift	_	
208-465	40638-40640	in	_	
208-466	40641-40648	midline	_	
208-467	40649-40657	cortical	_	
208-468	40658-40666	activity	_	
208-469	40667-40669	in	_	
208-470	40670-40683	schizophrenia	_	
208-471	40684-40690	during	_	
208-472	40691-40706	self-reflection	_	
208-473	40707-40708	“	_	
208-474	40708-40715	Hearing	_	
208-475	40716-40722	voices	_	
208-476	40722-40723	”	_	
208-477	40723-40724	:	_	
208-478	40725-40733	auditory	_	
208-479	40734-40748	hallucinations	_	
208-480	40749-40751	as	_	
208-481	40752-40759	failure	_	
208-482	40760-40762	of	_	
208-483	40763-40771	top-down	_	
208-484	40772-40779	control	_	
208-485	40780-40782	of	_	
208-486	40783-40792	bottom-up	_	
208-487	40793-40803	perceptual	_	
208-488	40804-40813	processes	_	
208-489	40814-40822	Cortical	_	
208-490	40823-40834	activations	_	
208-491	40835-40841	during	_	
208-492	40842-40850	auditory	_	
208-493	40851-40857	verbal	_	
208-494	40858-40872	hallucinations	_	
208-495	40873-40875	in	_	
208-496	40876-40889	schizophrenia	_	
208-497	40889-40890	:	_	
208-498	40891-40892	a	_	
208-499	40893-40909	coordinate-based	_	
208-500	40910-40923	meta-analysis	_	
208-501	40924-40927	The	_	
208-502	40928-40940	neurodynamic	_	
208-503	40941-40953	organization	_	
208-504	40954-40956	of	_	
208-505	40957-40975	modality-dependent	_	
208-506	40976-40990	hallucinations	_	
208-507	40991-40994	FSL	_	
208-508	40995-41001	Neural	_	
208-509	41002-41012	correlates	_	
208-510	41013-41015	of	_	
208-511	41016-41031	self-reflection	_	
208-512	41032-41041	Influence	_	
208-513	41042-41044	of	_	
208-514	41045-41055	meditation	_	
208-515	41056-41058	on	_	
208-516	41059-41074	anti-correlated	_	
208-517	41075-41083	networks	_	
208-518	41084-41086	in	_	
208-519	41087-41090	the	_	
208-520	41091-41096	brain	_	
208-521	41097-41101	Full	_	
208-522	41102-41113	Catastrophe	_	
208-523	41114-41120	Living	_	
208-524	41120-41121	:	_	
208-525	41122-41127	Using	_	
208-526	41128-41131	the	_	
208-527	41132-41138	Wisdom	_	
208-528	41139-41141	of	_	
208-529	41142-41146	Your	_	
208-530	41147-41151	Body	_	
208-531	41152-41155	and	_	
208-532	41156-41160	Mind	_	
208-533	41161-41163	to	_	
208-534	41164-41168	Face	_	
208-535	41169-41175	Stress	_	
208-536	41175-41176	,	_	
208-537	41177-41181	Pain	_	
208-538	41181-41182	,	_	
208-539	41183-41186	and	_	
208-540	41187-41194	Illness	_	
208-541	41195-41208	Resting-state	_	
208-542	41209-41225	anticorrelations	_	
208-543	41226-41233	between	_	
208-544	41234-41240	medial	_	
208-545	41241-41244	and	_	
208-546	41245-41252	lateral	_	
208-547	41253-41263	prefrontal	_	
208-548	41264-41270	cortex	_	
208-549	41270-41271	:	_	
208-550	41272-41283	association	_	
208-551	41284-41288	with	_	
208-552	41289-41296	working	_	
208-553	41297-41303	memory	_	
208-554	41303-41304	,	_	
208-555	41305-41310	aging	_	
208-556	41310-41311	,	_	
208-557	41312-41315	and	_	
208-558	41316-41326	individual	_	
208-559	41327-41338	differences	_	
208-560	41339-41346	Finding	_	
208-561	41347-41350	the	_	
208-562	41351-41355	Self	_	
208-563	41355-41356	?	_	

#Text=An Event-Related fMRI Study
#Text=Competition between functional brain networks mediates behavioral variability
#Text=Mindfulness interventions for psychosis: a meta-analysis
#Text=Mediation analysis of triple networks revealed functional feature of mindfulness from real-time fMRI neurofeedback
#Text=The “paradoxical” engagement of the primary auditory cortex in patients with auditory verbal hallucinations: A meta-analysis of functional neuroimaging studies
#Text=Altered functional connectivity in brain networks underlying self-referential processing in delusions of reference in schizophrenia
#Text=Intracerebral source generators characterizing concentrative meditation
#Text=Abnormal connectivity between attentional, language and auditory networks in schizophrenia
#Text=Mindfulness- and acceptance-based interventions for psychosis: Our current understanding and a meta-analysis
#Text=Attention regulation and monitoring in meditation
#Text=Schizophrenia, recovery and the self: An introduction to the special issue on metacognition
#Text=Aberrant Dependence of Default Mode/Central Executive Network Interactions on Anterior Insular Salience Network Activity in Schizophrenia
#Text=Wandering Minds: The Default Network and Stimulus-Independent Thought
#Text=Meditation and psychiatry
#Text=A parametric manipulation of factors affecting task-induced deactivation in functional neuroimaging
#Text=Social psychology as a natural kind
#Text=The impact of global signal regression on resting state correlations: Are anti-correlated networks introduced?
209-1	41357-41359	An	_	
209-2	41360-41373	Event-Related	_	
209-3	41374-41378	fMRI	_	
209-4	41379-41384	Study	_	
209-5	41385-41396	Competition	_	
209-6	41397-41404	between	_	
209-7	41405-41415	functional	_	
209-8	41416-41421	brain	_	
209-9	41422-41430	networks	_	
209-10	41431-41439	mediates	_	
209-11	41440-41450	behavioral	_	
209-12	41451-41462	variability	_	
209-13	41463-41474	Mindfulness	_	
209-14	41475-41488	interventions	_	
209-15	41489-41492	for	_	
209-16	41493-41502	psychosis	_	
209-17	41502-41503	:	_	
209-18	41504-41505	a	_	
209-19	41506-41519	meta-analysis	_	
209-20	41520-41529	Mediation	_	
209-21	41530-41538	analysis	_	
209-22	41539-41541	of	_	
209-23	41542-41548	triple	_	
209-24	41549-41557	networks	_	
209-25	41558-41566	revealed	_	
209-26	41567-41577	functional	_	
209-27	41578-41585	feature	_	
209-28	41586-41588	of	_	
209-29	41589-41600	mindfulness	_	
209-30	41601-41605	from	_	
209-31	41606-41615	real-time	_	
209-32	41616-41620	fMRI	_	
209-33	41621-41634	neurofeedback	_	
209-34	41635-41638	The	_	
209-35	41639-41640	“	_	
209-36	41640-41651	paradoxical	_	
209-37	41651-41652	”	_	
209-38	41653-41663	engagement	_	
209-39	41664-41666	of	_	
209-40	41667-41670	the	_	
209-41	41671-41678	primary	_	
209-42	41679-41687	auditory	_	
209-43	41688-41694	cortex	_	
209-44	41695-41697	in	_	
209-45	41698-41706	patients	_	
209-46	41707-41711	with	_	
209-47	41712-41720	auditory	_	
209-48	41721-41727	verbal	_	
209-49	41728-41742	hallucinations	_	
209-50	41742-41743	:	_	
209-51	41744-41745	A	_	
209-52	41746-41759	meta-analysis	_	
209-53	41760-41762	of	_	
209-54	41763-41773	functional	_	
209-55	41774-41786	neuroimaging	_	
209-56	41787-41794	studies	_	
209-57	41795-41802	Altered	_	
209-58	41803-41813	functional	_	
209-59	41814-41826	connectivity	_	
209-60	41827-41829	in	_	
209-61	41830-41835	brain	_	
209-62	41836-41844	networks	_	
209-63	41845-41855	underlying	_	
209-64	41856-41872	self-referential	_	
209-65	41873-41883	processing	_	
209-66	41884-41886	in	_	
209-67	41887-41896	delusions	_	
209-68	41897-41899	of	_	
209-69	41900-41909	reference	_	
209-70	41910-41912	in	_	
209-71	41913-41926	schizophrenia	_	
209-72	41927-41940	Intracerebral	_	
209-73	41941-41947	source	_	
209-74	41948-41958	generators	_	
209-75	41959-41973	characterizing	_	
209-76	41974-41987	concentrative	_	
209-77	41988-41998	meditation	_	
209-78	41999-42007	Abnormal	_	
209-79	42008-42020	connectivity	_	
209-80	42021-42028	between	_	
209-81	42029-42040	attentional	_	
209-82	42040-42041	,	_	
209-83	42042-42050	language	_	
209-84	42051-42054	and	_	
209-85	42055-42063	auditory	_	
209-86	42064-42072	networks	_	
209-87	42073-42075	in	_	
209-88	42076-42089	schizophrenia	_	
209-89	42090-42101	Mindfulness	_	
209-90	42101-42102	-	_	
209-91	42103-42106	and	_	
209-92	42107-42123	acceptance-based	_	
209-93	42124-42137	interventions	_	
209-94	42138-42141	for	_	
209-95	42142-42151	psychosis	_	
209-96	42151-42152	:	_	
209-97	42153-42156	Our	_	
209-98	42157-42164	current	_	
209-99	42165-42178	understanding	_	
209-100	42179-42182	and	_	
209-101	42183-42184	a	_	
209-102	42185-42198	meta-analysis	_	
209-103	42199-42208	Attention	_	
209-104	42209-42219	regulation	_	
209-105	42220-42223	and	_	
209-106	42224-42234	monitoring	_	
209-107	42235-42237	in	_	
209-108	42238-42248	meditation	_	
209-109	42249-42262	Schizophrenia	_	
209-110	42262-42263	,	_	
209-111	42264-42272	recovery	_	
209-112	42273-42276	and	_	
209-113	42277-42280	the	_	
209-114	42281-42285	self	_	
209-115	42285-42286	:	_	
209-116	42287-42289	An	_	
209-117	42290-42302	introduction	_	
209-118	42303-42305	to	_	
209-119	42306-42309	the	_	
209-120	42310-42317	special	_	
209-121	42318-42323	issue	_	
209-122	42324-42326	on	_	
209-123	42327-42340	metacognition	_	
209-124	42341-42349	Aberrant	_	
209-125	42350-42360	Dependence	_	
209-126	42361-42363	of	_	
209-127	42364-42371	Default	_	
209-128	42372-42376	Mode	_	
209-129	42376-42377	/	_	
209-130	42377-42384	Central	_	
209-131	42385-42394	Executive	_	
209-132	42395-42402	Network	_	
209-133	42403-42415	Interactions	_	
209-134	42416-42418	on	_	
209-135	42419-42427	Anterior	_	
209-136	42428-42435	Insular	_	
209-137	42436-42444	Salience	_	
209-138	42445-42452	Network	_	
209-139	42453-42461	Activity	_	
209-140	42462-42464	in	_	
209-141	42465-42478	Schizophrenia	_	
209-142	42479-42488	Wandering	_	
209-143	42489-42494	Minds	_	
209-144	42494-42495	:	_	
209-145	42496-42499	The	_	
209-146	42500-42507	Default	_	
209-147	42508-42515	Network	_	
209-148	42516-42519	and	_	
209-149	42520-42540	Stimulus-Independent	_	
209-150	42541-42548	Thought	_	
209-151	42549-42559	Meditation	_	
209-152	42560-42563	and	_	
209-153	42564-42574	psychiatry	_	
209-154	42575-42576	A	_	
209-155	42577-42587	parametric	_	
209-156	42588-42600	manipulation	_	
209-157	42601-42603	of	_	
209-158	42604-42611	factors	_	
209-159	42612-42621	affecting	_	
209-160	42622-42634	task-induced	_	
209-161	42635-42647	deactivation	_	
209-162	42648-42650	in	_	
209-163	42651-42661	functional	_	
209-164	42662-42674	neuroimaging	_	
209-165	42675-42681	Social	_	
209-166	42682-42692	psychology	_	
209-167	42693-42695	as	_	
209-168	42696-42697	a	_	
209-169	42698-42705	natural	_	
209-170	42706-42710	kind	_	
209-171	42711-42714	The	_	
209-172	42715-42721	impact	_	
209-173	42722-42724	of	_	
209-174	42725-42731	global	_	
209-175	42732-42738	signal	_	
209-176	42739-42749	regression	_	
209-177	42750-42752	on	_	
209-178	42753-42760	resting	_	
209-179	42761-42766	state	_	
209-180	42767-42779	correlations	_	
209-181	42779-42780	:	_	
209-182	42781-42784	Are	_	
209-183	42785-42800	anti-correlated	_	
209-184	42801-42809	networks	_	
209-185	42810-42820	introduced	_	
209-186	42820-42821	?	_	

#Text=Are Auditory Hallucinations Related to the Brain’s Resting State Activity?
210-1	42822-42825	Are	_	
210-2	42826-42834	Auditory	_	
210-3	42835-42849	Hallucinations	_	
210-4	42850-42857	Related	_	
210-5	42858-42860	to	_	
210-6	42861-42864	the	_	
210-7	42865-42870	Brain	_	
210-8	42870-42871	’	_	
210-9	42871-42872	s	_	
210-10	42873-42880	Resting	_	
210-11	42881-42886	State	_	
210-12	42887-42895	Activity	_	
210-13	42895-42896	?	_	

#Text=A “Neurophenomenal Resting State Hypothesis.”
211-1	42897-42898	A	_	
211-2	42899-42900	“	_	
211-3	42900-42915	Neurophenomenal	_	
211-4	42916-42923	Resting	_	
211-5	42924-42929	State	_	
211-6	42930-42940	Hypothesis	_	
211-7	42940-42941	.	_	
211-8	42941-42942	”	_	

#Text=How do abnormalities in the brain’s spontaneous activity translate into symptoms in schizophrenia?
212-1	42943-42946	How	_	
212-2	42947-42949	do	_	
212-3	42950-42963	abnormalities	_	
212-4	42964-42966	in	_	
212-5	42967-42970	the	_	
212-6	42971-42976	brain	_	
212-7	42976-42977	’	_	
212-8	42977-42978	s	_	
212-9	42979-42990	spontaneous	_	
212-10	42991-42999	activity	_	
212-11	43000-43009	translate	_	
212-12	43010-43014	into	_	
212-13	43015-43023	symptoms	_	
212-14	43024-43026	in	_	
212-15	43027-43040	schizophrenia	_	
212-16	43040-43041	?	_	

#Text=From an overview of resting state activity findings to a proposed spatiotemporal psychopathology
#Text=Self-referential processing in our brain—A meta-analysis of imaging studies on the self
#Text=How can the brain’s resting state activity generate hallucinations?
213-1	43042-43046	From	_	
213-2	43047-43049	an	_	
213-3	43050-43058	overview	_	
213-4	43059-43061	of	_	
213-5	43062-43069	resting	_	
213-6	43070-43075	state	_	
213-7	43076-43084	activity	_	
213-8	43085-43093	findings	_	
213-9	43094-43096	to	_	
213-10	43097-43098	a	_	
213-11	43099-43107	proposed	_	
213-12	43108-43122	spatiotemporal	_	
213-13	43123-43138	psychopathology	_	
213-14	43139-43155	Self-referential	_	
213-15	43156-43166	processing	_	
213-16	43167-43169	in	_	
213-17	43170-43173	our	_	
213-18	43174-43181	brain—A	_	
213-19	43182-43195	meta-analysis	_	
213-20	43196-43198	of	_	
213-21	43199-43206	imaging	_	
213-22	43207-43214	studies	_	
213-23	43215-43217	on	_	
213-24	43218-43221	the	_	
213-25	43222-43226	self	_	
213-26	43227-43230	How	_	
213-27	43231-43234	can	_	
213-28	43235-43238	the	_	
213-29	43239-43244	brain	_	
213-30	43244-43245	’	_	
213-31	43245-43246	s	_	
213-32	43247-43254	resting	_	
213-33	43255-43260	state	_	
213-34	43261-43269	activity	_	
213-35	43270-43278	generate	_	
213-36	43279-43293	hallucinations	_	
213-37	43293-43294	?	_	

#Text=A “resting state hypothesis” of auditory verbal hallucinations
#Text=The assessment and analysis of handedness: the Edinburgh inventory
#Text=Altered brain connectivity in patients with schizophrenia is consistent across cognitive contexts
#Text=Real-time fMRI neurofeedback to down-regulate superior temporal gyrus activity in patients with schizophrenia and auditory hallucinations: a proof-of-concept study
#Text=Superior temporal gyrus and planum temporale in schizophrenia: a selective review
#Text=Generating Stimuli for Neuroscience Using PsychoPy
#Text=A default mode of brain function
#Text=Trouble at Rest: How Correlation Patterns and Group Differences Become Distorted After Global Signal Regression
#Text=Refining strategies for research on self-representations in emotional disorders
#Text=Practical Insight Meditation
#Text=Data-Driven Analysis of Functional Connectivity Reveals a Potential Auditory Verbal Hallucination Network
#Text=The effects of Mindfulness Meditation on hallucination and delusion in severe schizophrenia patients with more than 20 years’ medical history
#Text=Altered resting-state connectivity in subjects at ultra-high risk for psychosis: an fMRI study
#Text=Impaired introspective accuracy in schizophrenia: an independent predictor of functional outcomes
#Text=The effects of psychiatric history and age on self-regulation of the default mode network
#Text=Brain mechanisms underlying reality monitoring for heard and imagined words
#Text=Meditation improves self-regulation over the life span
#Text=Brief Mental Training Reorganizes Large-Scale Brain Networks
#Text=Functional connectivity of default mode network components: correlation, anticorrelation, and causality
#Text=Self-reflection and the brain: A theoretical review and meta-analysis of neuroimaging studies with implications for schizophrenia
#Text=Network analysis of auditory hallucinations in nonpsychotic individuals
#Text=Meditation is associated with increased brain network integration
#Text=Differentiating between self and others: an ALE meta-analysis of fMRI studies of self-recognition and theory of mind
#Text=Aberrant connectivity during self–other source monitoring in schizophrenia
#Text=The neural bases of momentary lapses in attention
#Text=
#Text=Understanding marijuana’s effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation
#Text=Default mode network activity and connectivity in psychopathology
#Text=Associations and dissociations between default and self-reference networks in the human brain
#Text=Conn : A Functional Connectivity Toolbox for Correlated and Anticorrelated Brain Networks
#Text=Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia
#Text=The organization of the human cerebral cortex estimated by intrinsic functional connectivity
#Text=Structure and function of auditory cortex: music and speech
#Text=When the brain plays music: auditory-motor interactions in music perception and production
#Text=Top-down and bottom-up processes in speech comprehension
#Text=Neurofeedback of core language network nodes modulates connectivity with the default-mode network: A double-blind fMRI neurofeedback study on auditory verbal hallucinations
#Text=Schematic representation of the experimental procedure.
214-1	43295-43296	A	_	
214-2	43297-43298	“	_	
214-3	43298-43305	resting	_	
214-4	43306-43311	state	_	
214-5	43312-43322	hypothesis	_	
214-6	43322-43323	”	_	
214-7	43324-43326	of	_	
214-8	43327-43335	auditory	_	
214-9	43336-43342	verbal	_	
214-10	43343-43357	hallucinations	_	
214-11	43358-43361	The	_	
214-12	43362-43372	assessment	_	
214-13	43373-43376	and	_	
214-14	43377-43385	analysis	_	
214-15	43386-43388	of	_	
214-16	43389-43399	handedness	_	
214-17	43399-43400	:	_	
214-18	43401-43404	the	_	
214-19	43405-43414	Edinburgh	_	
214-20	43415-43424	inventory	_	
214-21	43425-43432	Altered	_	
214-22	43433-43438	brain	_	
214-23	43439-43451	connectivity	_	
214-24	43452-43454	in	_	
214-25	43455-43463	patients	_	
214-26	43464-43468	with	_	
214-27	43469-43482	schizophrenia	_	
214-28	43483-43485	is	_	
214-29	43486-43496	consistent	_	
214-30	43497-43503	across	_	
214-31	43504-43513	cognitive	_	
214-32	43514-43522	contexts	_	
214-33	43523-43532	Real-time	_	
214-34	43533-43537	fMRI	_	
214-35	43538-43551	neurofeedback	_	
214-36	43552-43554	to	_	
214-37	43555-43568	down-regulate	_	
214-38	43569-43577	superior	_	
214-39	43578-43586	temporal	_	
214-40	43587-43592	gyrus	_	
214-41	43593-43601	activity	_	
214-42	43602-43604	in	_	
214-43	43605-43613	patients	_	
214-44	43614-43618	with	_	
214-45	43619-43632	schizophrenia	_	
214-46	43633-43636	and	_	
214-47	43637-43645	auditory	_	
214-48	43646-43660	hallucinations	_	
214-49	43660-43661	:	_	
214-50	43662-43663	a	_	
214-51	43664-43680	proof-of-concept	_	
214-52	43681-43686	study	_	
214-53	43687-43695	Superior	_	
214-54	43696-43704	temporal	_	
214-55	43705-43710	gyrus	_	
214-56	43711-43714	and	_	
214-57	43715-43721	planum	_	
214-58	43722-43731	temporale	_	
214-59	43732-43734	in	_	
214-60	43735-43748	schizophrenia	_	
214-61	43748-43749	:	_	
214-62	43750-43751	a	_	
214-63	43752-43761	selective	_	
214-64	43762-43768	review	_	
214-65	43769-43779	Generating	_	
214-66	43780-43787	Stimuli	_	
214-67	43788-43791	for	_	
214-68	43792-43804	Neuroscience	_	
214-69	43805-43810	Using	_	
214-70	43811-43819	PsychoPy	_	
214-71	43820-43821	A	_	
214-72	43822-43829	default	_	
214-73	43830-43834	mode	_	
214-74	43835-43837	of	_	
214-75	43838-43843	brain	_	
214-76	43844-43852	function	_	
214-77	43853-43860	Trouble	_	
214-78	43861-43863	at	_	
214-79	43864-43868	Rest	_	
214-80	43868-43869	:	_	
214-81	43870-43873	How	_	
214-82	43874-43885	Correlation	_	
214-83	43886-43894	Patterns	_	
214-84	43895-43898	and	_	
214-85	43899-43904	Group	_	
214-86	43905-43916	Differences	_	
214-87	43917-43923	Become	_	
214-88	43924-43933	Distorted	_	
214-89	43934-43939	After	_	
214-90	43940-43946	Global	_	
214-91	43947-43953	Signal	_	
214-92	43954-43964	Regression	_	
214-93	43965-43973	Refining	_	
214-94	43974-43984	strategies	_	
214-95	43985-43988	for	_	
214-96	43989-43997	research	_	
214-97	43998-44000	on	_	
214-98	44001-44021	self-representations	_	
214-99	44022-44024	in	_	
214-100	44025-44034	emotional	_	
214-101	44035-44044	disorders	_	
214-102	44045-44054	Practical	_	
214-103	44055-44062	Insight	_	
214-104	44063-44073	Meditation	_	
214-105	44074-44085	Data-Driven	_	
214-106	44086-44094	Analysis	_	
214-107	44095-44097	of	_	
214-108	44098-44108	Functional	_	
214-109	44109-44121	Connectivity	_	
214-110	44122-44129	Reveals	_	
214-111	44130-44131	a	_	
214-112	44132-44141	Potential	_	
214-113	44142-44150	Auditory	_	
214-114	44151-44157	Verbal	_	
214-115	44158-44171	Hallucination	_	
214-116	44172-44179	Network	_	
214-117	44180-44183	The	_	
214-118	44184-44191	effects	_	
214-119	44192-44194	of	_	
214-120	44195-44206	Mindfulness	_	
214-121	44207-44217	Meditation	_	
214-122	44218-44220	on	_	
214-123	44221-44234	hallucination	_	
214-124	44235-44238	and	_	
214-125	44239-44247	delusion	_	
214-126	44248-44250	in	_	
214-127	44251-44257	severe	_	
214-128	44258-44271	schizophrenia	_	
214-129	44272-44280	patients	_	
214-130	44281-44285	with	_	
214-131	44286-44290	more	_	
214-132	44291-44295	than	_	
214-133	44296-44298	20	_	
214-134	44299-44304	years	_	
214-135	44304-44305	’	_	
214-136	44306-44313	medical	_	
214-137	44314-44321	history	_	
214-138	44322-44329	Altered	_	
214-139	44330-44343	resting-state	_	
214-140	44344-44356	connectivity	_	
214-141	44357-44359	in	_	
214-142	44360-44368	subjects	_	
214-143	44369-44371	at	_	
214-144	44372-44382	ultra-high	_	
214-145	44383-44387	risk	_	
214-146	44388-44391	for	_	
214-147	44392-44401	psychosis	_	
214-148	44401-44402	:	_	
214-149	44403-44405	an	_	
214-150	44406-44410	fMRI	_	
214-151	44411-44416	study	_	
214-152	44417-44425	Impaired	_	
214-153	44426-44439	introspective	_	
214-154	44440-44448	accuracy	_	
214-155	44449-44451	in	_	
214-156	44452-44465	schizophrenia	_	
214-157	44465-44466	:	_	
214-158	44467-44469	an	_	
214-159	44470-44481	independent	_	
214-160	44482-44491	predictor	_	
214-161	44492-44494	of	_	
214-162	44495-44505	functional	_	
214-163	44506-44514	outcomes	_	
214-164	44515-44518	The	_	
214-165	44519-44526	effects	_	
214-166	44527-44529	of	_	
214-167	44530-44541	psychiatric	_	
214-168	44542-44549	history	_	
214-169	44550-44553	and	_	
214-170	44554-44557	age	_	
214-171	44558-44560	on	_	
214-172	44561-44576	self-regulation	_	
214-173	44577-44579	of	_	
214-174	44580-44583	the	_	
214-175	44584-44591	default	_	
214-176	44592-44596	mode	_	
214-177	44597-44604	network	_	
214-178	44605-44610	Brain	_	
214-179	44611-44621	mechanisms	_	
214-180	44622-44632	underlying	_	
214-181	44633-44640	reality	_	
214-182	44641-44651	monitoring	_	
214-183	44652-44655	for	_	
214-184	44656-44661	heard	_	
214-185	44662-44665	and	_	
214-186	44666-44674	imagined	_	
214-187	44675-44680	words	_	
214-188	44681-44691	Meditation	_	
214-189	44692-44700	improves	_	
214-190	44701-44716	self-regulation	_	
214-191	44717-44721	over	_	
214-192	44722-44725	the	_	
214-193	44726-44730	life	_	
214-194	44731-44735	span	_	
214-195	44736-44741	Brief	_	
214-196	44742-44748	Mental	_	
214-197	44749-44757	Training	_	
214-198	44758-44769	Reorganizes	_	
214-199	44770-44781	Large-Scale	_	
214-200	44782-44787	Brain	_	
214-201	44788-44796	Networks	_	
214-202	44797-44807	Functional	_	
214-203	44808-44820	connectivity	_	
214-204	44821-44823	of	_	
214-205	44824-44831	default	_	
214-206	44832-44836	mode	_	
214-207	44837-44844	network	_	
214-208	44845-44855	components	_	
214-209	44855-44856	:	_	
214-210	44857-44868	correlation	_	
214-211	44868-44869	,	_	
214-212	44870-44885	anticorrelation	_	
214-213	44885-44886	,	_	
214-214	44887-44890	and	_	
214-215	44891-44900	causality	_	
214-216	44901-44916	Self-reflection	_	
214-217	44917-44920	and	_	
214-218	44921-44924	the	_	
214-219	44925-44930	brain	_	
214-220	44930-44931	:	_	
214-221	44932-44933	A	_	
214-222	44934-44945	theoretical	_	
214-223	44946-44952	review	_	
214-224	44953-44956	and	_	
214-225	44957-44970	meta-analysis	_	
214-226	44971-44973	of	_	
214-227	44974-44986	neuroimaging	_	
214-228	44987-44994	studies	_	
214-229	44995-44999	with	_	
214-230	45000-45012	implications	_	
214-231	45013-45016	for	_	
214-232	45017-45030	schizophrenia	_	
214-233	45031-45038	Network	_	
214-234	45039-45047	analysis	_	
214-235	45048-45050	of	_	
214-236	45051-45059	auditory	_	
214-237	45060-45074	hallucinations	_	
214-238	45075-45077	in	_	
214-239	45078-45090	nonpsychotic	_	
214-240	45091-45102	individuals	_	
214-241	45103-45113	Meditation	_	
214-242	45114-45116	is	_	
214-243	45117-45127	associated	_	
214-244	45128-45132	with	_	
214-245	45133-45142	increased	_	
214-246	45143-45148	brain	_	
214-247	45149-45156	network	_	
214-248	45157-45168	integration	_	
214-249	45169-45184	Differentiating	_	
214-250	45185-45192	between	_	
214-251	45193-45197	self	_	
214-252	45198-45201	and	_	
214-253	45202-45208	others	_	
214-254	45208-45209	:	_	
214-255	45210-45212	an	_	
214-256	45213-45216	ALE	_	
214-257	45217-45230	meta-analysis	_	
214-258	45231-45233	of	_	
214-259	45234-45238	fMRI	_	
214-260	45239-45246	studies	_	
214-261	45247-45249	of	_	
214-262	45250-45266	self-recognition	_	
214-263	45267-45270	and	_	
214-264	45271-45277	theory	_	
214-265	45278-45280	of	_	
214-266	45281-45285	mind	_	
214-267	45286-45294	Aberrant	_	
214-268	45295-45307	connectivity	_	
214-269	45308-45314	during	_	
214-270	45315-45325	self–other	_	
214-271	45326-45332	source	_	
214-272	45333-45343	monitoring	_	
214-273	45344-45346	in	_	
214-274	45347-45360	schizophrenia	_	
214-275	45361-45364	The	_	
214-276	45365-45371	neural	_	
214-277	45372-45377	bases	_	
214-278	45378-45380	of	_	
214-279	45381-45390	momentary	_	
214-280	45391-45397	lapses	_	
214-281	45398-45400	in	_	
214-282	45401-45410	attention	_	
214-283	45412-45425	Understanding	_	
214-284	45426-45435	marijuana	_	
214-285	45435-45436	’	_	
214-286	45436-45437	s	_	
214-287	45438-45445	effects	_	
214-288	45446-45448	on	_	
214-289	45449-45459	functional	_	
214-290	45460-45472	connectivity	_	
214-291	45473-45475	of	_	
214-292	45476-45479	the	_	
214-293	45480-45487	default	_	
214-294	45488-45492	mode	_	
214-295	45493-45500	network	_	
214-296	45501-45503	in	_	
214-297	45504-45512	patients	_	
214-298	45513-45517	with	_	
214-299	45518-45531	schizophrenia	_	
214-300	45532-45535	and	_	
214-301	45536-45548	co-occurring	_	
214-302	45549-45557	cannabis	_	
214-303	45558-45561	use	_	
214-304	45562-45570	disorder	_	
214-305	45570-45571	:	_	
214-306	45572-45573	A	_	
214-307	45574-45579	pilot	_	
214-308	45580-45593	investigation	_	
214-309	45594-45601	Default	_	
214-310	45602-45606	mode	_	
214-311	45607-45614	network	_	
214-312	45615-45623	activity	_	
214-313	45624-45627	and	_	
214-314	45628-45640	connectivity	_	
214-315	45641-45643	in	_	
214-316	45644-45659	psychopathology	_	
214-317	45660-45672	Associations	_	
214-318	45673-45676	and	_	
214-319	45677-45690	dissociations	_	
214-320	45691-45698	between	_	
214-321	45699-45706	default	_	
214-322	45707-45710	and	_	
214-323	45711-45725	self-reference	_	
214-324	45726-45734	networks	_	
214-325	45735-45737	in	_	
214-326	45738-45741	the	_	
214-327	45742-45747	human	_	
214-328	45748-45753	brain	_	
214-329	45754-45758	Conn	_	
214-330	45759-45760	:	_	
214-331	45761-45762	A	_	
214-332	45763-45773	Functional	_	
214-333	45774-45786	Connectivity	_	
214-334	45787-45794	Toolbox	_	
214-335	45795-45798	for	_	
214-336	45799-45809	Correlated	_	
214-337	45810-45813	and	_	
214-338	45814-45828	Anticorrelated	_	
214-339	45829-45834	Brain	_	
214-340	45835-45843	Networks	_	
214-341	45844-45857	Hyperactivity	_	
214-342	45858-45861	and	_	
214-343	45862-45879	hyperconnectivity	_	
214-344	45880-45882	of	_	
214-345	45883-45886	the	_	
214-346	45887-45894	default	_	
214-347	45895-45902	network	_	
214-348	45903-45905	in	_	
214-349	45906-45919	schizophrenia	_	
214-350	45920-45923	and	_	
214-351	45924-45926	in	_	
214-352	45927-45939	first-degree	_	
214-353	45940-45949	relatives	_	
214-354	45950-45952	of	_	
214-355	45953-45960	persons	_	
214-356	45961-45965	with	_	
214-357	45966-45979	schizophrenia	_	
214-358	45980-45983	The	_	
214-359	45984-45996	organization	_	
214-360	45997-45999	of	_	
214-361	46000-46003	the	_	
214-362	46004-46009	human	_	
214-363	46010-46018	cerebral	_	
214-364	46019-46025	cortex	_	
214-365	46026-46035	estimated	_	
214-366	46036-46038	by	_	
214-367	46039-46048	intrinsic	_	
214-368	46049-46059	functional	_	
214-369	46060-46072	connectivity	_	
214-370	46073-46082	Structure	_	
214-371	46083-46086	and	_	
214-372	46087-46095	function	_	
214-373	46096-46098	of	_	
214-374	46099-46107	auditory	_	
214-375	46108-46114	cortex	_	
214-376	46114-46115	:	_	
214-377	46116-46121	music	_	
214-378	46122-46125	and	_	
214-379	46126-46132	speech	_	
214-380	46133-46137	When	_	
214-381	46138-46141	the	_	
214-382	46142-46147	brain	_	
214-383	46148-46153	plays	_	
214-384	46154-46159	music	_	
214-385	46159-46160	:	_	
214-386	46161-46175	auditory-motor	_	
214-387	46176-46188	interactions	_	
214-388	46189-46191	in	_	
214-389	46192-46197	music	_	
214-390	46198-46208	perception	_	
214-391	46209-46212	and	_	
214-392	46213-46223	production	_	
214-393	46224-46232	Top-down	_	
214-394	46233-46236	and	_	
214-395	46237-46246	bottom-up	_	
214-396	46247-46256	processes	_	
214-397	46257-46259	in	_	
214-398	46260-46266	speech	_	
214-399	46267-46280	comprehension	_	
214-400	46281-46294	Neurofeedback	_	
214-401	46295-46297	of	_	
214-402	46298-46302	core	_	
214-403	46303-46311	language	_	
214-404	46312-46319	network	_	
214-405	46320-46325	nodes	_	
214-406	46326-46335	modulates	_	
214-407	46336-46348	connectivity	_	
214-408	46349-46353	with	_	
214-409	46354-46357	the	_	
214-410	46358-46370	default-mode	_	
214-411	46371-46378	network	_	
214-412	46378-46379	:	_	
214-413	46380-46381	A	_	
214-414	46382-46394	double-blind	_	
214-415	46395-46399	fMRI	_	
214-416	46400-46413	neurofeedback	_	
214-417	46414-46419	study	_	
214-418	46420-46422	on	_	
214-419	46423-46431	auditory	_	
214-420	46432-46438	verbal	_	
214-421	46439-46453	hallucinations	_	
214-422	46454-46463	Schematic	_	
214-423	46464-46478	representation	_	
214-424	46479-46481	of	_	
214-425	46482-46485	the	_	
214-426	46486-46498	experimental	_	
214-427	46499-46508	procedure	_	
214-428	46508-46509	.	_	

#Text=A) Baseline resting state (RS-pre) scan.
215-1	46510-46511	A	_	
215-2	46511-46512	)	_	
215-3	46513-46521	Baseline	_	
215-4	46522-46529	resting	_	
215-5	46530-46535	state	_	
215-6	46536-46537	(	_	
215-7	46537-46543	RS-pre	_	
215-8	46543-46544	)	_	
215-9	46545-46549	scan	_	
215-10	46549-46550	.	_	

#Text=B) Functional Localization of the default mode network (DMN in blue) and the central executive network (CEN in red).
216-1	46551-46552	B	_	
216-2	46552-46553	)	_	
216-3	46554-46564	Functional	_	
216-4	46565-46577	Localization	_	
216-5	46578-46580	of	_	
216-6	46581-46584	the	_	
216-7	46585-46592	default	_	
216-8	46593-46597	mode	_	
216-9	46598-46605	network	_	
216-10	46606-46607	(	_	
216-11	46607-46610	DMN	_	
216-12	46611-46613	in	_	
216-13	46614-46618	blue	_	
216-14	46618-46619	)	_	
216-15	46620-46623	and	_	
216-16	46624-46627	the	_	
216-17	46628-46635	central	_	
216-18	46636-46645	executive	_	
216-19	46646-46653	network	_	
216-20	46654-46655	(	_	
216-21	46655-46658	CEN	_	
216-22	46659-46661	in	_	
216-23	46662-46665	red	_	
216-24	46665-46666	)	_	
216-25	46666-46667	.	_	

#Text=C) rt-fMRI feedback process showing the online monitoring of brain states while performing “mental noting”.
217-1	46668-46669	C	_	
217-2	46669-46670	)	_	
217-3	46671-46678	rt-fMRI	_	
217-4	46679-46687	feedback	_	
217-5	46688-46695	process	_	
217-6	46696-46703	showing	_	
217-7	46704-46707	the	_	
217-8	46708-46714	online	_	
217-9	46715-46725	monitoring	_	
217-10	46726-46728	of	_	
217-11	46729-46734	brain	_	
217-12	46735-46741	states	_	
217-13	46742-46747	while	_	
217-14	46748-46758	performing	_	
217-15	46759-46760	“	_	
217-16	46760-46766	mental	_	
217-17	46767-46773	noting	_	
217-18	46773-46774	”	_	
217-19	46774-46775	.	_	

#Text=If rt-fMRI analysis resulted in a Positive Diametric Activity (PDA) score (red shadowing) the central white dot of the feedback display moved up towards the red circle.
218-1	46776-46778	If	_	
218-2	46779-46786	rt-fMRI	_	
218-3	46787-46795	analysis	_	
218-4	46796-46804	resulted	_	
218-5	46805-46807	in	_	
218-6	46808-46809	a	_	
218-7	46810-46818	Positive	_	
218-8	46819-46828	Diametric	_	
218-9	46829-46837	Activity	_	
218-10	46838-46839	(	_	
218-11	46839-46842	PDA	_	
218-12	46842-46843	)	_	
218-13	46844-46849	score	_	
218-14	46850-46851	(	_	
218-15	46851-46854	red	_	
218-16	46855-46864	shadowing	_	
218-17	46864-46865	)	_	
218-18	46866-46869	the	_	
218-19	46870-46877	central	_	
218-20	46878-46883	white	_	
218-21	46884-46887	dot	_	
218-22	46888-46890	of	_	
218-23	46891-46894	the	_	
218-24	46895-46903	feedback	_	
218-25	46904-46911	display	_	
218-26	46912-46917	moved	_	
218-27	46918-46920	up	_	
218-28	46921-46928	towards	_	
218-29	46929-46932	the	_	
218-30	46933-46936	red	_	
218-31	46937-46943	circle	_	
218-32	46943-46944	.	_	

#Text=When a negative PDA score was triggered (blue shadowing), the central white dot moved down towards the blue circle.
219-1	46945-46949	When	_	
219-2	46950-46951	a	_	
219-3	46952-46960	negative	_	
219-4	46961-46964	PDA	_	
219-5	46965-46970	score	_	
219-6	46971-46974	was	_	
219-7	46975-46984	triggered	_	
219-8	46985-46986	(	_	
219-9	46986-46990	blue	_	
219-10	46991-47000	shadowing	_	
219-11	47000-47001	)	_	
219-12	47001-47002	,	_	
219-13	47003-47006	the	_	
219-14	47007-47014	central	_	
219-15	47015-47020	white	_	
219-16	47021-47024	dot	_	
219-17	47025-47030	moved	_	
219-18	47031-47035	down	_	
219-19	47036-47043	towards	_	
219-20	47044-47047	the	_	
219-21	47048-47052	blue	_	
219-22	47053-47059	circle	_	
219-23	47059-47060	.	_	

#Text=D) Post rt-fMRI resting state.
220-1	47061-47062	D	_	
220-2	47062-47063	)	_	
220-3	47064-47068	Post	_	
220-4	47069-47076	rt-fMRI	_	
220-5	47077-47084	resting	_	
220-6	47085-47090	state	_	
220-7	47090-47091	.	_	

#Text=Regions showing a significant change in resting state functional connectivity (rsFC).
#Text=rsFC with Medial Prefrontal Cortex (MPFC) following either (A) real-time Default Mode Network (rtDMN) neurofeedback or (B) real-time Somato Motor Cortex (rtSMC) neurofeedback.
221-1	47092-47099	Regions	_	
221-2	47100-47107	showing	_	
221-3	47108-47109	a	_	
221-4	47110-47121	significant	_	
221-5	47122-47128	change	_	
221-6	47129-47131	in	_	
221-7	47132-47139	resting	_	
221-8	47140-47145	state	_	
221-9	47146-47156	functional	_	
221-10	47157-47169	connectivity	_	
221-11	47170-47171	(	_	
221-12	47171-47175	rsFC	_	
221-13	47175-47176	)	_	
221-14	47176-47177	.	_	
221-15	47178-47182	rsFC	_	
221-16	47183-47187	with	_	
221-17	47188-47194	Medial	_	
221-18	47195-47205	Prefrontal	_	
221-19	47206-47212	Cortex	_	
221-20	47213-47214	(	_	
221-21	47214-47218	MPFC	_	
221-22	47218-47219	)	_	
221-23	47220-47229	following	_	
221-24	47230-47236	either	_	
221-25	47237-47238	(	_	
221-26	47238-47239	A	_	
221-27	47239-47240	)	_	
221-28	47241-47250	real-time	_	
221-29	47251-47258	Default	_	
221-30	47259-47263	Mode	_	
221-31	47264-47271	Network	_	
221-32	47272-47273	(	_	
221-33	47273-47278	rtDMN	_	
221-34	47278-47279	)	_	
221-35	47280-47293	neurofeedback	_	
221-36	47294-47296	or	_	
221-37	47297-47298	(	_	
221-38	47298-47299	B	_	
221-39	47299-47300	)	_	
221-40	47301-47310	real-time	_	
221-41	47311-47317	Somato	_	
221-42	47318-47323	Motor	_	
221-43	47324-47330	Cortex	_	
221-44	47331-47332	(	_	
221-45	47332-47337	rtSMC	_	
221-46	47337-47338	)	_	
221-47	47339-47352	neurofeedback	_	
221-48	47352-47353	.	_	

#Text=Boxplots show the pre-to-post change functional connectivity z-scores for MPFC and Posterior Cingulate Cortex (PCC), right dorsolateral prefrontal cortex (rDLPFC) and anterior cingulate cortex (ACC) and MPFC-rDLPFC connectivity z-scores.
222-1	47354-47362	Boxplots	_	
222-2	47363-47367	show	_	
222-3	47368-47371	the	_	
222-4	47372-47383	pre-to-post	_	
222-5	47384-47390	change	_	
222-6	47391-47401	functional	_	
222-7	47402-47414	connectivity	_	
222-8	47415-47423	z-scores	_	
222-9	47424-47427	for	_	
222-10	47428-47432	MPFC	_	
222-11	47433-47436	and	_	
222-12	47437-47446	Posterior	_	
222-13	47447-47456	Cingulate	_	
222-14	47457-47463	Cortex	_	
222-15	47464-47465	(	_	
222-16	47465-47468	PCC	_	
222-17	47468-47469	)	_	
222-18	47469-47470	,	_	
222-19	47471-47476	right	_	
222-20	47477-47489	dorsolateral	_	
222-21	47490-47500	prefrontal	_	
222-22	47501-47507	cortex	_	
222-23	47508-47509	(	_	
222-24	47509-47515	rDLPFC	_	
222-25	47515-47516	)	_	
222-26	47517-47520	and	_	
222-27	47521-47529	anterior	_	
222-28	47530-47539	cingulate	_	
222-29	47540-47546	cortex	_	
222-30	47547-47548	(	_	
222-31	47548-47551	ACC	_	
222-32	47551-47552	)	_	
222-33	47553-47556	and	_	
222-34	47557-47568	MPFC-rDLPFC	_	
222-35	47569-47581	connectivity	_	
222-36	47582-47590	z-scores	_	
222-37	47590-47591	.	_	

#Text=All thresholds, cluster threshold p<0.05 FWE corrected.
223-1	47592-47595	All	_	
223-2	47596-47606	thresholds	_	
223-3	47606-47607	,	_	
223-4	47608-47615	cluster	_	
223-5	47616-47625	threshold	_	
223-6	47626-47627	p	_	
223-7	47627-47628	<	_	
223-8	47628-47632	0.05	_	
223-9	47633-47636	FWE	_	
223-10	47637-47646	corrected	_	
223-11	47646-47647	.	_	

#Text=Green circles show in MPFC seed region of interest (ROIs) used to determine the rsFC analysis.
224-1	47648-47653	Green	_	
224-2	47654-47661	circles	_	
224-3	47662-47666	show	_	
224-4	47667-47669	in	_	
224-5	47670-47674	MPFC	_	
224-6	47675-47679	seed	_	
224-7	47680-47686	region	_	
224-8	47687-47689	of	_	
224-9	47690-47698	interest	_	
224-10	47699-47700	(	_	
224-11	47700-47704	ROIs	_	
224-12	47704-47705	)	_	
224-13	47706-47710	used	_	
224-14	47711-47713	to	_	
224-15	47714-47723	determine	_	
224-16	47724-47727	the	_	
224-17	47728-47732	rsFC	_	
224-18	47733-47741	analysis	_	
224-19	47741-47742	.	_	

#Text=Correlation of change in auditory hallucinations and change in STG-MPFC connectivity.
225-1	47743-47754	Correlation	_	
225-2	47755-47757	of	_	
225-3	47758-47764	change	_	
225-4	47765-47767	in	_	
225-5	47768-47776	auditory	_	
225-6	47777-47791	hallucinations	_	
225-7	47792-47795	and	_	
225-8	47796-47802	change	_	
225-9	47803-47805	in	_	
225-10	47806-47814	STG-MPFC	_	
225-11	47815-47827	connectivity	_	
225-12	47827-47828	.	_	

#Text=Significant reduction (Pre-to-Post) of auditory hallucinations AHs (Δ AHs Score) with a reduction (Pre-to-Post) in STG-MPFC connectivity (Δ STG/MPFC) for resting state following real-time Default Mode Network neurofeedback.
226-1	47829-47840	Significant	_	
226-2	47841-47850	reduction	_	
226-3	47851-47852	(	_	
226-4	47852-47863	Pre-to-Post	_	
226-5	47863-47864	)	_	
226-6	47865-47867	of	_	
226-7	47868-47876	auditory	_	
226-8	47877-47891	hallucinations	_	
226-9	47892-47895	AHs	_	
226-10	47896-47897	(	_	
226-11	47897-47898	Δ	_	
226-12	47899-47902	AHs	_	
226-13	47903-47908	Score	_	
226-14	47908-47909	)	_	
226-15	47910-47914	with	_	
226-16	47915-47916	a	_	
226-17	47917-47926	reduction	_	
226-18	47927-47928	(	_	
226-19	47928-47939	Pre-to-Post	_	
226-20	47939-47940	)	_	
226-21	47941-47943	in	_	
226-22	47944-47952	STG-MPFC	_	
226-23	47953-47965	connectivity	_	
226-24	47966-47967	(	_	
226-25	47967-47968	Δ	_	
226-26	47969-47972	STG	_	
226-27	47972-47973	/	_	
226-28	47973-47977	MPFC	_	
226-29	47977-47978	)	_	
226-30	47979-47982	for	_	
226-31	47983-47990	resting	_	
226-32	47991-47996	state	_	
226-33	47997-48006	following	_	
226-34	48007-48016	real-time	_	
226-35	48017-48024	Default	_	
226-36	48025-48029	Mode	_	
226-37	48030-48037	Network	_	
226-38	48038-48051	neurofeedback	_	
226-39	48051-48052	.	_	

#Text=Highlights
#Text=A single session of real-time fMRI neurofeedback targeting default mode network (DMN) significantly increased its anticorrelations post neurofeedback.
227-1	48053-48063	Highlights	_	
227-2	48064-48065	A	_	
227-3	48066-48072	single	_	
227-4	48073-48080	session	_	
227-5	48081-48083	of	_	
227-6	48084-48093	real-time	_	
227-7	48094-48098	fMRI	_	
227-8	48099-48112	neurofeedback	_	
227-9	48113-48122	targeting	_	
227-10	48123-48130	default	_	
227-11	48131-48135	mode	_	
227-12	48136-48143	network	_	
227-13	48144-48145	(	_	
227-14	48145-48148	DMN	_	
227-15	48148-48149	)	_	
227-16	48150-48163	significantly	_	
227-17	48164-48173	increased	_	
227-18	48174-48177	its	_	
227-19	48178-48194	anticorrelations	_	
227-20	48195-48199	post	_	
227-21	48200-48213	neurofeedback	_	
227-22	48213-48214	.	_	

#Text=DMN targeted neurofeedback resulted in reduced severity of auditory hallucinations (AHs) in patients with pharmacology-resistant AHs.
228-1	48215-48218	DMN	_	
228-2	48219-48227	targeted	_	
228-3	48228-48241	neurofeedback	_	
228-4	48242-48250	resulted	_	
228-5	48251-48253	in	_	
228-6	48254-48261	reduced	_	
228-7	48262-48270	severity	_	
228-8	48271-48273	of	_	
228-9	48274-48282	auditory	_	
228-10	48283-48297	hallucinations	_	
228-11	48298-48299	(	_	
228-12	48299-48302	AHs	_	
228-13	48302-48303	)	_	
228-14	48304-48306	in	_	
228-15	48307-48315	patients	_	
228-16	48316-48320	with	_	
228-17	48321-48343	pharmacology-resistant	_	
228-18	48344-48347	AHs	_	
228-19	48347-48348	.	_	

#Text=There was a significant correlation between the increase in DMN - superior temporal gyrus connectivity and the reduction in AHs scores post neurofeedback.
229-1	48349-48354	There	_	
229-2	48355-48358	was	_	
229-3	48359-48360	a	_	
229-4	48361-48372	significant	_	
229-5	48373-48384	correlation	_	
229-6	48385-48392	between	_	
229-7	48393-48396	the	_	
229-8	48397-48405	increase	_	
229-9	48406-48408	in	_	
229-10	48409-48412	DMN	_	
229-11	48413-48414	-	_	
229-12	48415-48423	superior	_	
229-13	48424-48432	temporal	_	
229-14	48433-48438	gyrus	_	
229-15	48439-48451	connectivity	_	
229-16	48452-48455	and	_	
229-17	48456-48459	the	_	
229-18	48460-48469	reduction	_	
229-19	48470-48472	in	_	
229-20	48473-48476	AHs	_	
229-21	48477-48483	scores	_	
229-22	48484-48488	post	_	
229-23	48489-48502	neurofeedback	_	
229-24	48502-48503	.	_	
